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ABSTRACT 
The exploration of biodiversity (“bioprospecting”) provides mankind 
with an immense pool of novel organisms, molecules and information, which 
can be exploited for the development of innovative biotechnological processes 
and new ways to treat diseases. In the past decades, the marine environment 
emerged as an untapped source of biodiversity, and this study investigated the 
marine bacterial family Vibrionaceae (“vibrios”) for its potential as reservoir of 
novel biodiversity and of species relevant for the ecology of the marine 
environment.  
The characterization of a novel species, Vibrio galatheae, contributed to the 
understanding of the phylogeny and diversity of Vibrionaceae, while the use of 
growth conditions mimicking the niche of isolation showed that substrates that 
are abundant in the marine environment significantly influence the metabolism 
of vibrios. Indeed, during a screening of approximately three hundred strains, 
the number of vibrios capable to inhibit the growth of a fish pathogen was 
nearly doubled when isolates were grown on chitin, the most abundant 
polymer in the marine environment, as compared to when they were grown on 
mannose or glucose. This observation led to investigate at the transcriptome 
level the effects of chitin on the two vibrios Vibrio coralliilyticus and 
Photobacterium galatheae. It was shown that the dynamics of chitin colonization 
and utilization in these two species are similar to those reported for the well-
characterized chitin colonizer Vibrio cholerae. Bacteria reach chitinous surfaces 
by chemotaxis before adhering to it and completing their chitin 
degradation/utilization program. The complementation of this information with 
the metabolomic profiles of the strains suggested a possible role of secondary 
metabolites in chitin colonization, although further work is required to 
elucidate whether they are produced to antagonize competitors or to 
communicate with other colonizers and/or a potential host.  
In conclusion, this PhD study adds to the knowledge of Vibrionaceae as an 
untapped reservoir of biodiversity and important players in the ecology of the 
marine environment. Studying microbial eco-physiology is important not only 
for the development of ecological models, but also as foundation for 
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bioprospecting studies, where this knowledge may be used, for example, to 
elicit silent biosynthetic gene clusters during natural product discovery.  
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RESUMÈ (DANISH) 
Udforskningen af biodiversitet (“bioprospecting”) forsyner 
menneskeheden med en umådelig stor pulje af nye organismer, molekyler og 
information der kan bruges med det formål at udvikle innovative, 
bioteknologiske processer samt nye måder at behandle sygdomme på. Over de 
seneste årtier har særligt det marine miljø fremstået som en uudnyttet kilde til 
biodiversitet. Dette studie har undersøgt den marine bakteriefamilie 
Vibrionaceae (vibrioer) for dens potentiale som et reservoir af ukendt 
biodiversitet og af arter med relevans for det marine miljøs økologi.  
Karakteriseringen af en ny art, Vibrio galatheae, bidrog til forståelsen af 
Vibrionaceae-familiens fylogeny og diversitet, imens anvendelsen af 
vækstbetingelser der efterligner det miljø, hvori bakterierne blev isoleret, viste 
at substrater der er hyppigt forekommende i det marine miljø har en signifikant 
effekt på vibrioers metabolisme. Det viste sig, ved at screene tre hundrede 
stammer, at antallet af vibrioer der var i stand til at inhibere væksten af en 
fiskepatogen bakterie var næsten dobbelt så høj når isolaterne blev dyrket på 
kitin (den hyppigst forekommende biologiske polymer i det marine miljø) i 
forhold til når de blev dyrket på mannose eller glukose. Denne observation lå til 
grund for transkriptom-undersøgelser af kitins effekt på de to vibrioer Vibrio 
coralliilyticus og Photobacterium galatheae. Det blev påvist at mekanismer relateret 
til kolonisering og udnyttelse af kitin i disse to arter er tilsvarende dem der er 
kendt fra den velbeskrevne kitin-koloniserende bakterie Vibrio cholerae. 
Bakterier finder kitinholdige overflader ved kemotaksi før de klæber til 
overfladen og eksekverer deres kitinnedbrydnings- og udnyttelsesprogram. 
Komplementeringen af denne information med metabolismeprofiler af de 
undersøgte stammer antydede at sekundære metabolitter spiller en rolle i 
kitinkolonisering. Videre undersøgelser er dog nødvendige for at bestemme, 
hvorvidt de produceres for at antagonisere konkurrenter eller for at 
kommunikere med andre kolonisatorer og/eller en potentiel vært. 
Dermed bidrager dette ph.d.-studium til vores viden om Vibrionaceae som 
et uudnyttet reservoir af biodiversitet og som vigtige aktører i det marine miljøs 
økologi. Studier i mikrobiel økofysiologi er ikke alene vigtige for at udvikle 
økologiske modeller, men også som et fundament for studier i bioprospecting, 
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hvor sådan viden f.eks. kan anvendes til at elicitere ellers ikke-udtrykte 
biosyntetiske gen-clustre i forbindelse med opdagelsen af nye naturprodukter. 
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1 INTRODUCTION AND OUTLINE 
Mankind has for centuries made use of microorganisms and of molecules 
produced or derived from them. Microorganisms are used in biotechnological 
applications such as fermentations, bio-remediation and wastewater treatment. 
Microbial enzymes are used as biocatalysts in the food, detergent, textile and 
chemical industries (1), and small compounds produced by microorganisms 
represent a notable portion of all new molecular entities that are not of 
mammalian origin (2). The exploration of biodiversity (“bioprospecting”) is 
therefore needed for the identification of new microorganisms, enzymes or 
other molecules, which can be used to improve the above-mentioned processes 
and applications and, possibly, to develop new ones. 
Our group at the Technical University of Denmark studies marine 
bacteria as source of small molecules for therapeutic applications, as bio-control 
agents for the aquaculture industry and for their role in the ecology of the 
marine environment, e.g. their interaction with algae. We have a collection of 
marine bacteria that were isolated from locations all over the world during the 
global research expedition Galathea 3 (www.galathea3.dk) (Figure 1) based on 
their ability to inhibit the growth of the fish pathogen Vibrio anguillarum (3).  
 
Figure 1 Route of the Galathea 3 global research expedition. From http://www.galathea3.dk. 
All of the approximately 500 strains are Gram-negative, and three 
hundred of them belong to the family Vibrionaceae. This represents more than 
half of the whole collection. Whilst the Vibrionaceae family is well researched for 
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its pathogenic and symbiotic roles, its potential as source of bioactive 
compounds is emerging only now (4).  
Before this PhD project was started, a number of antibacterial and anti-
virulence compounds were isolated and identified from the Galathea 3 
Vibrionaceae collection. However, most of the strains seemed to have lost their 
ability to produce antibacterial compounds since their antagonistic activity 
against V. anguillarum could not be detected in the screening assay used in the 
laboratory (5). However, we knew such strains had the potential for the 
biosynthesis of these compounds because this ability was the one and only 
criterion of selection during the isolation procedure. This potential was also 
confirmed by the analysis of the genomes of several strains from the collection. 
In several cases, this analysis demonstrated the presence of multiple loci 
dedicated to the biosynthesis of secondary metabolites in a single genome (6), 
indicating the potential of a single strain for the production of several 
potentially bioactive compounds. 
In this PhD project I focused on “waking up” the biosynthetic potential of 
this family. I based my work on the assumption that secondary metabolites 
have ecological functions in Nature, e.g. defense and communication purposes. 
Therefore, as a number of research groups have been doing in recent years, I 
tried to elicit the expression of biosynthetic genes by growing the strains in 
conditions that simulate their natural environment, namely using substrates 
that are abundant in the sea. Also, in the initial screening and isolation 
procedure, bacterial colonies were tested for antibacterial activity after 3-7 days 
of incubation, hence allowing the producer to reach stationary phase where 
secondary metabolites are typically produced. Therefore, I also embarked on 
designing a screening strategy that would mimic the first procedure.  
Small molecules of microbial origin are the subject of Chapter 2 
(“Research on microbial natural products – merging ecology and 
bioprospecting”), where I provide a general overview about microbial natural 
products, with a focus on their importance for therapeutic application, the basis 
of their biosynthesis and their ecological role. Examples of molecules of 
terrestrial and marine origin, with a particular focus on the latter one, are 
provided. This topic is treated more thoroughly in Article 1. In the second part 
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of Chapter 2, I describe strategies currently in use to access silent biosynthetic 
gene cluster, introducing the rationale behind the work presented in Articles 2 
and 3.  
The use of natural substrates to manipulate the biosynthesis of secondary 
metabolites enabled also the gain of insights about the role of Vibrionaceae in 
marine ecology, with a particular focus on their role as degraders of chitin, 
which is the most abundant polymer in the marine environment. This is 
introduced in Chapter 3 (“The Vibrionaceae”), where the diversity and 
phylogeny of Vibrionaceae are discussed, too, as introduction to Article 4, in 
which a novel species is described. 
In Chapter 4 (“Conclusions and perspectives”) conclusive remarks and 
future perspective are presented, followed by Chapter 6, which contains the 
full-length research articles that were prepared as part of this PhD project.
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2 RESEARCH ON MICROBIAL NATURAL PRODUCTS – 
MERGING ECOLOGY AND BIOPROSPECTING 
Starting from the first antibiotic ever discovered, penicillin, produced by 
the filamentous fungus Penicillum rubens (7, 8), microbial secondary metabolites 
have been key components with therapeutic application in human and animal 
health. These small molecules (<1500 Da) exhibit a range of bioactivities: they 
are employed because of their antibiotic, anti-inflammatory, anti-parasitic, 
immunosuppressant and anti-cancer properties, among others.  
Towards the end of the twentieth century, however, screening of 
molecules synthesized by combinatorial chemistry was preferred over isolation 
and testing of compounds from natural sources. Despite huge economical 
investments from pharmaceutical companies, this strategy did not provide as 
many lead compounds as expected, and today there is a renewed interest in 
microbial natural products (9–11). A recent analysis by Patridge and colleagues 
(2) showed that approximately half of all new molecular entities that are not of 
mammalian origin are of microbial origin (“bacteria” and “fungi” in Figure 2). 
In parallel, strong experimental evidence emerged, that secondary metabolites 
have major roles in microbial intra- and interspecies interactions in Nature (12, 
13). For the most part, however, the role of these molecules in Nature has not 
been experimentally proven and this represents one of the intriguing questions 
in biology. 
 
Figure 2 New molecular entities of non-mammalian origin, divided by environmental source. From (2)  
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The characterization of natural products at several levels (e.g. 
biosynthesis, structure, bioactivity, ecological role) is therefore important since 
it provides molecules that could be used to treat human and animal diseases as 
well as insights into microbial ecology. 
2.1 Microbial bioactive secondary metabolites  
2.1.1 Sources of bioactive compounds – the marine environment 
Traditionally, soil filamentous fungi and Gram-positive Actinobacteria 
have provided the majority of bioactive compounds of microbial origin (2, 14, 
15). However, in recent years, technological advances enabled the isolation and 
exploitation of microorganisms from other environments, including deserts, 
oceans and the cryosphere (16).  
The marine environment has emerged as an untapped source of 
producers of bioactive natural products, which is not surprising when 
considering that 70% of the Earth’s surface is covered by oceans and thirty-three 
of the thirty-five known animal phyla are present in this environment (17). In 
the micro-scale, it is estimated that there are up to 106 and 109 microbial cells per 
milliliter of seawater and ocean-bottom sediment, respectively (18). Hence, 
marine microorganisms represent an immense resource to be explored in the 
search for bioactive natural products. Indeed, hundreds of molecules of 
microbial origin have already been isolated from the marine environment. The 
total number of compounds isolated from microorganisms is still relatively 
small as compared to the number of those isolated from marine invertebrates, 
but the percentage of molecules showing some kind of bioactivity is higher 
(Figure 3) (19). Furthermore one must consider that marine microorganisms 
have started to draw the attention of natural product researchers only in the 
past two decades, whilst marine invertebrates have been investigated for much 
longer. Hence, the overall picture might change in the next years.  
Several bioactive molecules that were initially thought to be produced by 
marine invertebrates are actually biosynthesized by their associated microbiota. 
The emblematic case is possibly the anticancer and anti-Alzheimer’s compound 
bryostatin 1, which was originally isolated in extracts from the bryozoan Bugula 
neritina (20). Later, the genetic information required for its biosynthesis was 
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found in the DNA of the bacterial symbiont Candidatus Endobugula sertula (21, 
22). 
Most of the bioactive compounds produced by marine bacteria have been 
isolated from Actinobacteria and Cyanobacteria (23). Whilst in the past marine 
Gram-positive bacteria were emphasized as sources of natural products much 
more than Gram-negative bacteria (24), today the group (e.g. Proteobacteria and 
Bacteroidetes) is being reevaluated (6, 25, 26), and Gram-negative bacterial 
groups such as the Roseobacter clade, the genus Pseudoalteromonas and the 
Vibrionaceae family (the subject of this PhD project) have provided novel 
bioactive compounds. 
 
Figure 3 Number of compounds isolated from marine microorganisms, marine algae and marine 
invertebrates, respectively. The analysis was done based on a database compiled by the authors of the 
study. From (19). 
Marine natural products have chemical features that distinguish them 
from molecules isolated from terrestrial environments, such as the 
incorporation of the halogen atoms bromide or chloride (Figure 4) (27, 28). This 
is the result of millions of years of evolution in an environment where factors 
like pressure, salinity and temperature led to the selection and maintenance of 
unique biosynthetic pathways (18, 29).  
In some cases, molecules that are produced by terrestrial microorganisms 
have also been isolated from marine bacteria. This is the case of the potent 
antibiotic andrimid (Figure 4), which was isolated from at least four terrestrial 
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species (30–33) as well as from the marine strains Vibrio coralliilyticus S2052 (5) 
and Vibrio splendidus SWAT-3 (34). Another example is the antibiotic holomycin 
(Figure 4), which was isolated first from the terrestrial species Yersinia ruckeri 
(35) and Streptomyces clavuligerus (36) and later from the marine Photobacterium 
galatheae (5). The presence of the same genetic information in organisms that 
live in distinct environments and are distantly related from a phylogenetic 
point of view probably originates from an ancestral biosynthetic gene cluster 
that was transferred via horizontal gene transfer (37, 38). The gene cluster 
encoding for the biosynthetic machinery necessary for the production of 
andrimid in Pantoea agglomerans is flanked by a pseudogene with homology to 
transposases, which might explain its detection in the genomes of unrelated 
species (38). 
 
Figure 4 Chemical structures of the marine halogenated compounds pentabromopseudilin and 
salinosporamide A, and of the cosmopolitan antibiotics holomycin and andrimid. 
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Several compounds of marine origin have been approved by the Food 
and Drug Administration (FDA) for clinical use or are undergoing clinical trials. 
For several of them, the real producer (invertebrate or microorganism) has not 
been identified yet (Table 1). 
Table 1 List of marine-derived compounds that are approved by FDA or that are in Phase I, II or II of drug 
development as of December 2015. ADC: Antibody Drug Conjugate. Modified from 
http://marinepharmacology.midwestern.edu/clinPipeline.htm. 
 
  
Clinical 
status
Compound name Trademark Marine organism
Chemical 
class
Disease area
Brentuximab vedotin (SGN-35) Adcetris® Mollusk/cyanobacteri ADC Cancer
Cytarabine (Ara-C) Cytosar-U® Sponge Nucleoside Cancer
Eribulin Mesylate (E7389) Halaven® Sponge Macrolide Cancer
Omega-3-acid ethyl esters Lovaza® Fish
Omega-3 
fatty acids
Hypertriglyceridemia
Ziconotide Prialt® Cone snail Peptide Severe Chronic Pain
Vidarabine (Ara-A) Vira-A® Sponge Nucleoside Antiviral 
Trabectedin (ET-743) Yondelis® Tunicate Alkaloid Cancer
Plitidepsin Aplidin® Tunicate Depsipeptide Cancer
Tetrodotoxin Tectin® Pufferfish
Guanidinium 
alkaloid
Chronic Pain
ABT-414 EGFRvIII - MMAF NA
Mollusk/ 
cyanobacterium
ADC Cancer
DMXBA NA Worm Alkaloid
Schizophrenia, 
Alzheimer Disease, 
Attention Deficit 
Hyperactivity 
Disorder
Glembatumumab Vedotin (CDX-011) NA
Mollusk/ 
cyanobacterium
ADC Cancer
Lurbinectedin (PM01183) NA Tunicate Alkaloid Cancer
AGS-16C3F NA
Mollusk/ 
cyanobacterium
ADC Cancer
Lifastuzumab vedotin DNIB0600A NA
Mollusk/ 
cyanobacterium
ADC Cancer
Pinatuzumab vedotin (DCDT-2980S) NA
Mollusk/ 
cyanobacterium
ADC Cancer
Polatuzumab vedotin (DCDS-4501A) NA
Mollusk/ 
cyanobacterium
ADC Cancer
GSK2857916 NA
Mollusk/ 
cyanobacterium
ADC Cancer
ASG-67E NA
Mollusk/ 
cyanobacterium
ADC Cancer
ASG-15ME NA
Mollusk/ 
cyanobacterium
ADC Cancer
ASG-22ME NA
Mollusk/ 
cyanobacterium
ADC Cancer
Bryostatin NA Bryozoan/ bacterium
Macrolide 
lactone
Cancer
DSTP3086S NA
Mollusk/ 
cyanobacterium
ADC Cancer
HuMax®-TF-ADC NA
Mollusk/ 
cyanobacterium
ADC Cancer
Marizomib (Salinosporamide A; NPI-0052) NA Bacterium
Beta-lactone-
gamma 
Cancer
MLN-0264 NA
Mollusk/ 
cyanobacterium
ADC Cancer
PM060184 NA Sponge Polyketide Cancer
SGN-CD19A NA
Mollusk/ 
cyanobacterium
ADC Cancer
SGN-LIV1A NA Mollusk/ ADC Cancer
Phase I
Phase I/II
Phase III
Phase II
FDA-
Approved
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2.1.2 Biosynthesis 
Microbial secondary metabolites belong to a range of chemical classes, 
including non-ribosomal peptides, polyketides, alkaloids and terpenoids. Their 
biosynthesis is catalyzed by enzymes and proteins encoded by genes which are 
often organized in a single locus, the so-called “biosynthetic gene cluster” 
(BGC). Beside the information required for the biosynthesis itself, BGCs often 
contain also genes encoding for: i) regulatory elements (e.g. transcriptional 
regulators) that control the expression of the biosynthetic genes, ii) tailoring 
enzymes that modify the molecule produced by the biosynthetic enzymes (e.g. 
glycosylation, alkylation and oxidation) and/or iii) for cellular components 
involved in the resistance to the produced compounds, when these compounds 
are toxic for the producer – a sort of “self-protection” (see below).  
Non-ribosomal peptides and polyketides are two classes of molecules 
which are encountered often when working with secondary metabolites from 
marine microorganisms, and which have been intensively studied. In both 
cases, the biosynthesis occurs through multifunctional protein complexes called 
non-ribosomal peptide synthetases (NRPS) and polyketide synthases (PKS), 
respectively. The organization and general mechanism of NRPS and PKS are 
comparable, with active domains that are organized in modular structures. The 
growing molecule is transferred from one module to the next one, where a new 
building block is added. The building blocks used by NRPSs are amino acids 
(usually < 20) that are condensed by transamination in an mRNA-independent 
process (39). For PKSs, building blocks are acetate and propionate, and the 
different units are bound together through condensation reactions (40). 
Hybrid pathways that include both PKS and NRPS domains are 
widespread in Nature. One example is again andrimid, where a PKS module 
builds a polyunsaturated fatty acid that is then connected by NRPS modules to 
the amino acids phenylalanine, valine and glycine (Figure 5) (41). 
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Figure 5 Biosynthesis of the antibiotic andrimid. Both PKS (green) and NRPS modules (blue) are required.  
Modified from (41). 
Terpenoids are biosynthesized by terpene synthases using precursors 
built from dimethylallyl diphosphate and isopentenyl diphosphate (Figure 6), 
which are joined in a head-to-tail fashion before being further processed (e.g. in 
cyclization reactions). Terpenoids are produced by a variety of organisms, 
including plants, and more than 35.000 different structures have been reported 
(42). In microorganisms, terpenoids have been isolated mostly from fungi (43), 
but the biosynthetic potential is widespread in cyanobacteria (44) and other 
Gram-negative bacteria (45). 
Alkaloids are nitrogen-containing compounds, in which the nitrogen 
atoms originate from amino acids either via transamination reactions or by 
direct incorporation of derivatives of amino acids such as ornithine, lysine, 
phenylalanine, tryptophan or histidine (42). The nitrogen-containing alkaloid 
core can be bound to other building blocks, such as amino acids, polyketides or 
terpenoids. As example, the iron-chelating molecule fluvibactin, isolated from 
Vibrio spp., contains the alkaloid norspermidine, three residues of 2,3-
dihydrobenzoic acid and one residue of threonine (Figure 6) (46). Alkaloids 
have been isolated from several marine microorganisms, including filamentous 
fungi (15), cyanobacteria (47), Pseudoalteromonas spp. (48), Vibrio spp. (4) and 
recently also from previously uncultured bacteria (26).  
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Figure 6 Chemical structure of the terpenoids building blocks dimethylallil diphosphate and isopentenyl 
diphosphate and of the iron-chelating compound fluvibactin, which has an alkaloid backbone. 
2.1.3 Ecological role  
In Nature, microorganisms live in complex communities that are highly 
dynamic with regard to their composition. Furthermore, they are constantly 
exposed to different and challenging environmental conditions: marine 
microorganisms are likely to encounter a great variety of habitats and niches 
because they are transported for considerable distances by oceanic currents (49). 
In order to increase their chances of survival, they produce a diverse pool of 
molecules that are involved in a range of phenomena, including defense against 
predators, antagonism, communication, nutrient uptake and protection against 
UV/oxidative stress. 
Defense against predators. Microorganisms produce molecules that can: i) act as 
deterrent for bacterivorous/fungivore organisms, such as protozoa and 
nematodes, or ii) in case of symbiosis, protect their host from predators. As 
examples, it was shown that freshwater isolates of Janthinobacterium lividum and 
Chromobacterium violaceum kill bacterivorous nanoflagellates by producing the 
alkaloid violet compound violacein (50), while Pseudoalteromonas tunicata and a 
Pheobacter sp. can prevent fouling organisms from settling on their host, the alga 
Ulva australis (51). 
Antagonism. The ability to produce molecules (antibiotics) capable to kill or 
slow the growth of competitors confers a strong advantage to micro-organisms 
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in low nutrients and/or colonization settings (13), such as during settlement on 
biotic surfaces (52). For example, an antibiotic producing marine strain (Vibrio 
sp. SWAT-3) completely inhibits the colonization of particles by Vibrio cholerae 
(34). Several examples of strains that produce antibacterial compounds only 
when challenged by other micro-organisms have been discovered (53, 54). 
As mentioned earlier in the chapter, BGC often include genes encoding 
cellular components that are involved in the mechanism of resistance, and this 
is very common for BGC encoding for the biosynthesis of antibiotics. One 
example is the BGC for the above-mentioned antibiotic andrimid, which 
inhibits fatty acids biosynthesis by targeting acetyl-CoA carboxyltransferases. 
The BGC includes one gene encoding for an acetyl-CoA carboxyltransferase 
bearing a mutation that prevents the binding of andrimid (33, 41). Resistance 
genes are subject to horizontal gene transfer, which occurs also at inter-species 
level (55–57), and are widespread in both soil (58) and the marine environment 
(59).  
Communication. In natural settings, antibiotics are rarely present in 
concentrations that are high enough to exert any growth inhibitory effect 
towards neighbor microorganisms. In the marine environment, water fluxes 
and currents quickly disperse any molecular gradient. Hence, it is thought that 
antibiotics might also have other roles, including cell-to-cell communication 
and enhancement of virulence (12, 13). 
Bacterial communication relies also on a particular mechanism, the so-
called quorum sensing (QS), in which bacteria produce small diffusible 
molecules called auto-inducers. These molecules are, for examples, N-acyl 
homoserine lactones (AHLs), AI-2 and diketopiperazines in Gram-negative 
bacteria (60) and small peptides in Gram-positive bacteria (61). When 
autoinducers reach a threshold concentration, population-wide behaviors (e.g. 
biofilm formation, antibiotic production, bioluminescence) are triggered (62).  
The luxI/luxR QS system of the marine bacterium Vibrio fischeri (Figure 7) 
has been the first one to be thoroughly characterized. The luxI gene encodes for 
an N-3-oxohexanoyl-homoserine lactone (3OC6HSL) synthase, while LuxR is a 
3OC6HSL-dependent transcriptional activator. When 3OC6HSL (the 
autoinducer) in the environment reaches a threshold concentration, LuxR is 
activated and the lux locus is transcribed. Such locus includes the luxI gene as 
well as genes encoding for the luciferase and the other proteins required for 
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bioluminescence, which is characteristic of V. fischeri, to occur (63). luxI/luxR 
type QS system are widespread among bacteria (62). 
 
Figure 7 Scheme of the Gram-negative LuxI/LuxR type QS system. When the concentration of the 
autoinducer molecules (red pentagons) reaches a threshold concentration, the LuxR transcriptional 
regulator is activated and the expression of target genes is induced. From (62). 
Nutrient uptake. Microorganisms have developed strategies to increase their 
chances to access nutrients whose concentration in Nature is often low. Among 
these strategies is the biosynthesis of siderophores, molecules that can 
solubilize, chelate and transport ferric iron into cells. Iron is required for several 
cellular processes, such as respiration and photosynthesis. When iron 
concentration in the surrounding environment is low, e.g. in the ocean where 
the average concentration of dissolved iron is below 0.2 nM (64), 
microorganisms secrete siderophores. The complex ferric iron-siderophore is 
recognized by membrane receptors and transported inside the cell. These 
transporters are present also in populations of “cheaters” that do not synthesize 
siderophores but benefit from their activity and presence in the environment 
(65), as exemplified by the fact that previously uncultured bacteria could be 
brought into culture by adding a siderophore-producing strain to the isolation 
plate (66). Some siderophores have been described also for other types of 
activity, such as protection from oxidative stress (67, 68), modulation of 
virulence (69) and antibacterial, as we saw during this PhD project for the 
above-mentioned compound fluvibactin (Article 2). 
Stress protection. In Nature, microorganisms often experience oxidative stress, 
for example due to reactive oxygen species produced as immune response by 
colonized/infected hosts or to exposure to UV light. Indeed, because of its high 
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energy content, UV light causes oxidation of cellular components in living 
organisms. One way microorganisms tackle this is through the production of 
molecules (pigments) containing a high number of conjugated double bonds 
that absorb the energy from UV light. For example, the yellow to brown 
pigment scytonemin (Figure 8) is excreted and deposited in the extracellular 
sheath of a number of cyanobacteria (70). A similar role has been suggested for 
the above-mentioned compound violacein (71) (Figure 8), which is produced by 
a range of bacteria, including Janthinobacterium lividum (50) and 
Pseudoalteromonas luteoviolacea (72). Other bacterial pigments thought to have a 
similar role are carotenoids, melanins, xanthomonadines and prodiginines. 
 
Figure 8 Chemical structures of the pigments scytonemin and violacein. 
2.2 How to access the biosynthetic potential 
The genomic era triggered a new approach to natural products research 
and ecology studies. Genome sequences provide us with an unprecedented 
amount of information helpful during experiment design and to validate 
ecological model and networks. To date, nearly five thousand complete 
prokaryotic genomes are publicly available, and this number is more than ten 
times larger when considering also non-closed genomes 
(http://www.ncbi.nlm.nih.gov/genome/browse/). The analysis (mining) of few 
of these genomes revealed that the natural products isolated so far represent 
just a small fraction of the potential harbored by microorganisms (6, 49, 73), and 
that also groups that traditionally have not been exploited in natural product 
discovery, such as anaerobic bacteria, represent an immense reservoir of 
secondary metabolites (74). Cimermancic and colleagues (75) analyzed 1154 
prokaryotic genomes and found that they contain a large number of families of 
BGC of unknown function. This indicates that much more effort must be done 
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in order to exploit this huge potential and, in view of the ecological role of 
microbial small molecules, to understand their function in Nature. 
A challenge in natural product discovery is that several BGC are silent (or 
cryptic), meaning that they are not expressed under standard laboratory 
conditions. The reason for this could be that different compounds are produced 
under different environmental conditions, ensuring an advantage over 
competing organisms (76). Several approaches have been developed to 
overcome this problem. Some of them are based on knowledge about the 
physiology and ecology of a microorganism and rely on the elicitation of the 
expression of the BGC in the natural host, while others are based on molecular 
biology techniques, which enable to manipulate the genetic context/regulation 
of the BGCs. 
 
2.2.1 Physiology and/or ecology-based strategies 
In Nature, secondary metabolites have a number of ecological functions 
(see above) and are often produced during specific growth stages and/or when 
encountering external stimuli. Therefore, one approach to induce the expression 
of BGC in laboratory setups is to simulate the growth conditions that the 
potential producers might encounter in their natural environment.  
One strain many compounds (OSMaC). Schiewe and colleagues (77) proposed an 
approach, in which culture parameters (e.g. media composition, pH, aeration) 
are manipulated. They named the approach “One Strain, Many Compounds 
(OSMaC). Using the OSMaC strategy, Bode et al (78) isolated more than one 
hundred compounds from six microorganisms. Parameters can be varied based 
on previous knowledge about the strain or the environment of isolation, and in 
some cases the adjustment of several growth parameters at once can be 
required to achieve elicitation of BGCs (79). Variations must be established on a 
case-by-case basis, as it is not possible to generalize and assume a priori that 
growth conditions that worked with one strain will work with another one as 
well. Some marine bacterial strains produce antibacterial compounds only 
when grown in cultivation systems simulating the intertidal environment of 
isolation, such as agar-coated rolling bottles (80) or “air-membrane surface” and 
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“rotating disc” bioreactors (81, 82). The use of low phosphate concentrations, 
similar to those encountered in the marine environment, drastically changed 
the profile of secondary metabolites in a Pseudovibrio sp., including the 
induction of the biosynthesis of the antibiotic tropodithietic acid (83).  
Our group demonstrated that shrimp chitin, which is the most abundant 
polymer in the marine environment, has a pronounced effect on the secondary 
metabolism of the marine bacterium Vibrio coralliilyticus. When grown on chitin, 
V. coralliilyticus doubles the amount of the antibiotic andrimid produced per cell 
as compared to when it is grown on glucose (84). As detailed in Chapter 3, 
genome analysis revealed that the ability to catabolize chitin is a common 
feature among members the Vibrionaceae family, of which V. coralliilyticus is a 
member. Hence, in this PhD project we investigated whether chitin affects the 
production of antibacterial compounds also in other members the Vibrionaceae 
family. We have included in the study other substrates (i.e. glucose and 
mannose) that are also abundant in the marine environment, since they are 
used by algae for protein glycosylation (85–87). We found more antibacterial 
strains on mannose than on glucose, but the highest effect was seen on chitin 
(Article 2) (Figure 9). In a follow-up study, we demonstrated using 
transcriptomics that indeed chitin affects the expression of a number of BGCs in 
Vibrio coralliilyticus and in Photobacterium galatheae.  
 
Figure 9 Number of Vibrionaceae strains 
antagonizing the growth of a target strain 
(Vibrio anguillarum) on three different 
substrates (glucose, mannose and chitin) 
that are abundant in the environment of 
isolation of the strains. From (Giubergia et 
al, Article 2). 
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Co-cultivation. The rationale that lies behind the use of co-cultivation to elicit 
the expression of BGCs is the ecological role that some secondary metabolites 
have in Nature, i.e. defense, competition and communication. When some 
microorganisms are exposed to others, they vary their secondary metabolite 
repertoire. Traxler and colleagues (88) reported this kind of behavior using 
MALDI-TOF imaging mass spectrometry; they showed that its exposure to 
other actinomycetes leads to a significant qualitative variation in the secondary 
metabolite profile of Streptomyces coelicolor. A variety of compounds with a 
range of bioactivities have been isolated using the co-cultivation approach, as 
reported in the recent reviews (53) and (89). 
Also the study of Charusanti and colleagues (90) is based on co-
cultivation. They adaptively evolved a Streptomyces clavuligerus strain in 
presence of the human and animal pathogen Staphylococcus aureus. After 
months of evolution, S. clavuligerus started to produce the antibiotic holomycin 
(which was not detected in culture extracts from the non-evolved control). 
Finally, although in his study he did not use direct co-cultivation, 
Seyedsayamdost (91) considered the dynamics of microbial inter-cellular 
communication in Nature and exposed the soil bacterium Burkholderia 
thailandensis to low concentrations of antibiotics and other molecules of 
microbial origin. With this strategy, he obtained the elicitation of previously 
cryptic BGCs. 
 
2.2.2 Other strategies 
Manipulation of regulatory elements. Requirements for this strategy are: i) 
culturability of the producer/host and ii) availability of a molecular toolbox for 
its genetic manipulation. One way to elicit the expression of BGCs is to modify 
or replace the natural promoters of the biosynthetic genes with inducible, 
strong or constitutive promoters. This has been done, for instance, by Olano 
and colleagues (92), who obtained the elicitation of a NRPS and a PKS-NRPS in 
Streptomyces albus J1074 by inserting a constitutive promoters upstream of the 
two BGCs.  
Alternatively, transcriptional (e.g. repressors or activators) or 
translational (e.g. ribosome or polymerase) elements can be manipulated. For 
example, the induction of the expression of putative activator genes that were 
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predicted to be part of the BGCs led to the discovery of aspyridones A and B in 
Aspergillus nidulans (93) and of the antibiotic and anticancer compounds 
stambomycins in Streptomyces ambofaciens (94). Interestingly, the same 
approach, once more in A. nidulans, revealed a regulatory cross talk between 
two BGCs. In their study, Bergmann and colleagues (95) put the expression of 
the regulator ScpR, whose encoding gene was part of the silent asperfuranone 
BGC, under the control of a constitutive promoter. This resulted in the 
expression of the asperfuranone BGC, but also of a NRPS-containing BGC. 
In 1996, Shima et al observed that a single mutation in the ribosomal 
protein S12 conferring streptomycin resistance to Streptomyces coelicolor induced 
the biosynthesis of the antibiotic actinorhodin (96). This was possibly the first 
example of the use of “ribosomal engineering” in natural product discovery. 
Since then, this approach has been exploited in several other studies using: i) 
the same type of single mutation; ii) inducing mutations in other proteins, such 
as in the β-subunit of the RNA polymerase (rpoB gene) conferring rifampicin 
resistance (97, 98) or iii) using cumulative drug resistance mutations (99). 
Ribosomal mutations have been obtained also through chemical mutagenesis 
using diethyl sulphate (100, 101). 
Metagenomic libraries. It is estimated the with the laboratory conditions and 
techniques currently in use, only 1% of all bacteria have been brought into 
culture, and the portion cultured is even lower (0.01-0.1%) for marine bacteria 
(102, 103). For approximately 70% of the known bacterial phyla, there is not a 
single culturable member (104). Therefore, metagenomic libraries, where 
environmental DNA is cloned into a host, represent a way to circumvent the 
issue of low culturability of microorganisms. The use of metagenomic libraries 
for sequence-based and functional bioactivity-based screenings not only 
enabled the isolation of novel bioactive compounds both from soil and marine-
derived libraries (105–108), but also contributed to reveal the widespread 
occurrence and variety of microbial BGC in the environment (109–112). Finally, 
it enabled the elucidation of the pathway for the biosynthesis of a number of 
known bioactive compounds, such as the antitumor molecules psymberin, 
ecteinascidin 743 (Yondelis®), and the already mentioned bryostatin 1. For all 
these molecules, the genetic information required for their biosynthesis was 
extracted from metagenomic libraries from sponges (21, 22, 113, 114). 
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Heterologous expression. The major limiting factors for this approach are the 
genetic toolboxes necessary to cope with the size of BGCs (in some cases up to 
100 kb), and the influence of the new genetic context on the expression of the 
cloned BGC (e.g. different codon usage compared to the original host or 
necessity to replace the BGC native promoter with a strong one optimized for 
the expression host). However, several strategies have been developed to 
overcome these limitations, and BGCs have successfully been cloned into a 
number of heterologous hosts, including Escherichia coli, Pseudomas putida and 
several Streptomyces species. One remarkable example is the cloning of a silent 
67-kb NRPS BGC from the marine actinomycete Sacchamonospora sp CNQ-490 in 
the expression host Streptomyces coelicolor, which led to the isolation of the 
antibiotic taromycin A (115), but many more are reported in literature, as 
recently reviewed in (116) and (76).  
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3 THE VIBRIONACEAE 
The Vibrionaceae (commonly called “vibrios”) are a family of Gram-
negative γ-proteobacteria that is widespread in aquatic environments, where 
they contribute to the cycling of organic matter (117). Vibrios are usually rod-
shaped and motile by means of one or more polar flagella (Figure 10), 
chemoorganotrophic and relatively easy to isolate and cultivate (118). They are 
considered among the most prevalent culturable bacteria in the ocean (117). The 
family includes species that are pathogenic to humans and/or animals, such as 
V. cholerae, V. parahaemolyticus and V. vulnificus, species that are symbiotic, such 
as V. fisheri and V. harveyi, but the majority of vibrios are commensal or 
mutualistic species (119). 
Vibrios have two chromosomes, with Chromosome I (Chr I, average size 
3.0 to 4.2 Mb) larger than Chromosome II (Chr II, average size 0.8 to 2.4 Mb) 
(120). Chr I harbors most of the essential genes, whereas Chr II carries species-
specific genes and has been suggested to play an important role in 
environmental adaptation (121, 122). The presence of two chromosomes is 
thought to facilitate rapid cell replication, which can take as little as ten minutes 
(121, 123). 
 
  
Figure 10 SEM micrograph of the type strain of 
Vibrio galatheae, the new species characterized in 
this thesis. The picture illustrates the curved rod-
shaped morphology and a polar flagellum typical of 
members of the Vibrionaceae family. (Picture taken 
by Ramona Valentina Mateiu, Centre for Electron 
Nanoscopy - Technical University of Denmark). 
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3.1 Diversity and phylogeny 
Based on 16S rRNA gene sequence analysis, the following genera are 
included in the Vibrionaceae family: Aliivibrio, Enterovibrio, Grimontia, 
Photobacterium, Salinivibrio and Vibrio. However, considering also phenotypic 
features, it has been suggested that the Vibrionaceae family should be split in 
four families: Salinivibrionaceae (genus Salinivibrio), Enterovibrionaceae (genera 
Enterovibrio and Grimontia), Photobacteriaceae (genus Photobacterium) and 
Vibrionaceae (genus Vibrio) (118, 124). The genus Aliivibrio is not included 
because it was proposed after the suggestion of the new families (125). 
However, practically no official agreement has been reached among taxonomist 
about which of the classification is the most accurate, and currently both of 
them can be found in literature. In this work, the definition based on the 16S 
rRNA gene sequence is considered. 
As per February 2016, more than 120 Vibrio and 25 Photobacterium (the 
two most abundant genera in the family, see below) species are reported in the 
“Prokaryotic Nomenclature Up-to-date List” of the German Collection of 
Microorganisms and Cell Cultures (www.dsmz.de). Strain characterization is 
usually done using a classic polyphasic approach, in which the combination of 
different techniques provides genotypic, chemotaxonomic and phenotypic 
information. The gold standard for the measure of the genetic distance between 
different strains has been DNA-DNA hybridization (DDH), where two strains 
are considered as belonging to different species if their DNAs are less than 70% 
similar, although for vibrios the limit has been suggested to be increased to 80% 
(118). DDH was developed in the 1970s, but it is not easy to implement (126). 
Instead, the increasing availability of inexpensive sequencing technologies 
opened up the possibility to obtain gene or whole genome sequences. 
Therefore, the average nucleotide identity (ANI) has been proposed and has a 
resolution for species definition comparable to DDH. Genomes whose 
comparison leads an ANI value <95% are considered to be from different 
species (127). 
An alternative way to infer genetic relatedness among strains is the 
comparison of their 16S rRNA gene sequences; however, in several cases, such 
as for vibrios, this approach does not provide the necessary resolution for 
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identification at the species level (126). Indeed, the threshold for 16S rRNA gene 
sequence based species differentiation is 97% similarity, but interspecies 16S 
rRNA-based relatedness among vibrios can be as high as 99%. Furthermore, in 
vibrios there are often several alleles of this gene (e.g. twelve in V. fischeri), 
which can lead to the assignment of a single strain to different species (128). For 
this reason, multilocus sequence analysis (MLSA) is preferred. In MLSA, 
hierarchical classification is based on a set of concatenated housekeeping genes 
(126). In vibrios, several genes have been proposed for this analysis, such as 
rpoA, recA, pyrH (124), ftsZ, gapA, gyrB, mreB and topA (129). Recently, the fur 
gene has been proposed as powerful unique phylogenetic marker for 
Vibrionaceae (130). 
In the course of this PhD, strain S2757 was identified as potential novel 
Vibrio species. The strain was originally isolated from a mussel in the Solomon 
Sea (Solomon Island) (3). Analysis of the 16S rRNA gene placed the strain into 
the Vibrionaceae family and showed 98.5, 98.3, 98.2 and 97.8 % similarity with 
the gene sequences from V. hepatarius, V. brasiliensis, V maritimus and V. tubiashii, 
respectively. However, according to MLSA analysis (genes 16S rRNA, gyrB, 
pyrH, recA, topA), V. tubiashii, V. sinaloensis, V. orientalis and V. xuii were the 
most closely related species. Similar results were obtained also with the fur 
gene-based analysis (Figure 11). These discrepancies between the different 
analyses made challenging the choice of the related strains to be used for the 
phenotypic and chemotaxonomic characterization. However, combination of 
the MLSA and fur gene based phylogenetic trees with DDH and ANI analyses 
helped in this choice. Ultimately, phenotypic and chemotaxonomic analyses 
confirmed that strain S2757 is the type strain of a new species, which has been 
described as Vibrio galatheae (Article 4). 
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Figure 11 Phylogenetic analyses of Vibrio galatheaeT and related type strains based on partial 16S rRNA 
gene sequences (top), concatenated genes (16S rRNA gyrB, pyrH, recA, topA) (middle) and complete fur 
gene sequence (bottom). Photobacterium aquaeT was used as outgroup. Bars, from top to bottom, indicate 
0.5, 2 and 5 % estimated sequence divergence, respectively.  
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3.2 Occurrence and ecological importance  
Vibrionaceae 16S rRNA gene sequences constitute 0.8% of all bacterial 
sequences (6% of all γ-proteobacteria sequences) in the dataset of the Tara 
research expedition (http://oceans.taraexpeditions.org/en/), which includes 
metagenomics data from different locations all over the world. In this dataset, 
among Vibrionaceae, Vibrio and Photobacterium are the most abundant genera 
(73% and the 16% of all the vibrios sequences, respectively) (Figure 12). These 
values are in agreement with previous metagenomics studies (131), and slightly 
lower (about 1%) than values obtained in studies where a hybridization 
approach was used (132). 
 
Figure 12 Relative abundance of the different genera of the Vibrionaceae family in the dataset of the Tara 
expedition based on 16S rRNA gene sequences. The genera Vibrio and Photobacterium are the most 
abundant. Modified from http://ocean-microbiome.embl.de/ 
Vibrios occur both as free-living cells and associated with abiotic and 
biotic surfaces. This is possible because of their ability to: i) utilize a range of 
nutrients (119) including aromatic hydrocarbons (133) and plastic films (134), ii) 
form biofilms even on non-nutritive surfaces (117, 118) and iii) switch to a 
dormant state (called “viable but not culturable”, VBNC) when environmental 
conditions are not optimal for growth (117). Vibrios have been isolated from 
plastic debris in the ocean (135), from areas contaminated by oil spills (136), 
from sediments as well as from the exterior surface of marine organisms such as 
fish, sponge, corals and zooplankton (118). Vibrios are also part of the resident 
gut microbiome of some marine animals (137, 138), although in general they do 
not appear to have host preference (139). 
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The relative abundance of vibrios is strongly related to water 
temperature and salinity (140). They are more abundant in subtropical and 
tropical regions, but can be found at all latitudes (132). This could be a 
consequence of the increase of the sea surface temperature (SST) caused by 
global warming. Indeed, SST has been related to an increase in the number of 
vibrio-associated diseases outbreaks also at latitudes where such infections 
have not been observed earlier (141, 142). Other parameters, such as nutrient 
availability, affect vibrios abundance. For example, a single Vibrio sp. 
constituted half of the population of a bacterial bloom in the English Channel, 
which was correlated with an increase in the abundance of the diatom 
Chaetoceros compressus (143), whereas the detection frequency of species such as 
V. parahaemolyticus, V. vulnificus and V. cholerae positively correlates to the 
abundance of chitinous zooplankton (144). 
Some species from the Vibrionaceae family have been intensively studied 
because of their role as symbionts or pathogens. V. fischeri and its host, the 
Hawaiian bobtail squid Eupryma scolopes, are one of the most studied host-
bacteria symbiosis models (145). In this relationship, the light-emitting V. 
fischeri  (see previous chapter) colonizes the light-organ of the squid, and the 
light it produces is used by the host in a camouflaging behavior 
(“counterillumination”) to escape predators (145, 146). Pathogenicity is linked 
to the production of virulence factors, such as hemolysins, toxins, siderophores 
and proteases. The ability to produce these virulence factors is often maintained 
by cells in the VBCN state (117). Among human pathogens, V. cholerae is 
responsible for epidemics of the acute diarrheal disease cholera, which can be 
lethal if not treated properly: in 2014, more than two thousands deaths have 
been reported worldwide to the World Health Organization due to V. cholerae 
infections (www.who.int). The reoccurrence of epidemics has been linked to the 
ability of the bacterium to survive in a variety of environmental reservoirs and 
vectors, including sediments, birds, crustaceans, zooplankton and bivalves 
(147). V. fluvialis and V. furnissii are two species closely related to V. cholerae, and 
in recent years interest towards them has been growing because of their 
established causative role in gastroenteritis outbreaks (148, 149). The food-borne 
pathogens V. parahaemolyticus and V. vulnificus are often acquired through the 
ingestion of raw seafood, such as oysters. V. vulnificus can cause primary 
septicemia and is responsible for the majority of sea-food related deaths in the 
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United States (150). Vibrio spp. such as V. anguillarum, V. harveyi, V. 
nigripulchritudo and V. vulnificus are among the major causative agents of fish 
and shellfish diseases (e.g. “early mortality syndrome”, “bright-red syndrome” 
or “luminous vibriosis” in lobsters and shrimps) and have caused enormous 
losses to the aquaculture industry over the years (151–153), while V. 
coralliilyticus and V. shilonii cause coral bleaching (154, 155). 
3.3 Vibrionaceae and chitin 
Chitin is a polysaccharide composed of (1à4)-β-linked units of the 
aminosugar N-acetylglucosamine (GlcNAc) (Figure 13). GlcNAc chains can be 
arranged in antiparallel, parallel or mixed configurations, originating 
α, β, and γ -chitin, respectively. After cellulose, chitin is the most abundant 
polymer on Earth, where it occurs as cellular component in several organisms 
such as fungi, molds, insects, diatoms and zooplankton. Despite estimations 
indicating that billions of tons of chitin are produced in the environment every 
year, with 1011 metric tons produced just in the aquatic biosphere (156), there are 
no reports of chitin accumulation in Nature (as reviewed in (157) and (158)). 
This is due to a rapid turnover of the polymer, with fungi and bacteria being the 
major players in the process. 
 
Figure 13 Structure of chitin.  
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Bacterial chitin degradation relies on the synthesis and secretion of chitin-
hydrolyzing enzymes, and results in the production of molecules that serve as 
carbon and nitrogen sources for the entire food web (156, 159, 160). In the 
marine environment, unculturable bacteria harbor a great potential for chitin 
degradation (161) but, among culturable bacteria, vibrios are considered to be 
among the most chitinolytic, although the major studies to elucidate the 
phenomenon focused on a limited number of species, mostly V. cholerae and V. 
furnissii. 
3.3.1 Association of Vibrionaceae with chitin surfaces 
The association of Vibrionaceae with chitinous surfaces in the marine 
environment (e.g. copepods, shrimps, crabs) is well known (118, 159, 162) and 
attracted the attention of several researchers. One reason for this is the 
important role of this bacterial family in the ecology and turnover of marine 
chitin (see above). Another reason is the concern due to the direct link between 
this association and their role as pathogens. As mentioned earlier, the 
abundance of chitinous plankton directly influences the abundance of the 
pathogenic species V. parahaemolyticus, V. vulnificus and V. cholerae (144). 
Cholera outbreaks correlate with copepod blooms, which in turn correspond to 
V. cholerae blooms (163, 164). Removal of plankton from water via filtration 
using a sari cloth led to a 48% reduction in cholera incidence (165). 
It has been suggested that chitin metabolism is an ancestral feature in 
Vibrionaceae (166), and that their spread presence in the ocean is a consequence 
of their ability to degrade chitin (167). Preheim and colleagues (139) observed 
that vibrios associate with both live and dead chitin-containing specimens. 
However, the frequency of this association is higher on dead specimens and 
discarded carapaces, and the authors suggested a saprophytic lifestyle. Keyhani 
and Roseman (156) proposed a model for the establishment of the association 
between vibrios and chitin (Figure 14). 
First, free-living bacteria randomly collide with chitin particles or are 
chemo-attracted by chitin-derived oligosaccharides released in the marine 
environment by chitin containing organisms. For example, this is at the basis of 
the above-mentioned symbiosis between V. fischeri and the squid E. scolopes. 
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Indeed, V. fischeri reaches the light organ of the latter by following a gradient of 
chitin oligosaccharides through the entrance pore (168). 
When bacteria reach the chitin surface, they adhere to it through specific 
membrane proteins (156), whose synthesis is common in vibrios (169, 170). The 
53 kDa GbpA protein mediates adhesion of V. cholerae both to zooplanklton and 
to human epithelial cells by binding GlcNAc (171). A similar role has been 
demonstrated for a specific calcium-dependent lectin in V. furnissii (172). This 
lectin is part of a complex apparatus that monitors continuously the level of 
nutrients in the environment, and starts a de-adhesion process when it is low. 
Detachment is followed by chemotaxis to a nutrient-richer environment. 
After adhesion to the chitin surface, bacteria start to produce several 
enzymes (e.g. chitinases, hexosaminidases) and proteins (e.g. porins and PTS 
systems) required to hydrolyze chitin, transport the hydrolysis products inside 
the cell and metabolize them. This is described in detail in the next section. 
 
 
Figure 14 Model proposed by Keyhani and Roseman for the establishment of the association between 
vibrios and chitin. Bacterial cells either randomly collide with chitin particles or move towards them 
through chitin oligosaccharides-driven chemotaxis. This is followed by attachment to chitin particles and 
secretion of extracellular chitinases, which degrade chitin. The generated oligosaccharides are then 
transported into the cells and are ultimately converted to fructose-6-phosphate. Modified from (156). 
3.3.2 Chitin catabolism in Vibrionaceae  
Based on literature data, experimental data and in silico predictions Hunt 
and colleagues (166) developed a model for chitin metabolism that is valid for 
V. cholerae (Figure 15). In the same study, the authors showed that the required 
core genetic potential is spread among Vibrionaceae. Their genomic analysis was 
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done on a limited number of species, possibly due to a small number of whole 
genome sequences available at the time (year 2008). During this PhD work, we 
performed a similar analysis on a larger dataset and confirmed their findings 
(Articles 2 and 3). With respect to the V. cholerae model, chitin is initially cleaved 
by extracellular chitinases and other hydrolases into (GlcNAc)2-6, but also into 
GlcNAc-GlcN, because actually not all chitin residues in Nature are acetylated.  
Distinct chitinases, with diverse substrate preference and specificity, are 
synthesized in the presence of different types of chitin (i.e. α/β-chitin) (173). 
All hydrolysis products are transported by specific and non-specific 
porins into the periplasm, where (GlcNAc)2-6 are degraded to (GlcNAc)1,2 by 
chitodextrinases and acetylglucosaminidases, whilst GlcNAc-Glcn is 
deacetylated to (GlcN)2. These disaccharides are then transported into the 
cytosol by ABC-type transporters and/or PTS systems. (GlcNAc)2 and (GlcN)2 
are converted to 2(GlcNAc-6-phosphate), and then, together with the GlcNAc-
6-phosphate generated during the uptake through the PTS, to acetate, ammonia 
and fructose-6-phosphate, which enters central metabolism.  
The utilization of GlcNAc has been well characterized in Escherichia coli, 
where it depends on the nagE-nagBACD divergent operon. NagE is a GlcNAc 
transporter (PTS), NagB a GlcN-6-phosphate deaminase, NagA a GlcNAc-6-
phosphate deacetylase and NagC a repressor that represses the operon when no 
GlcNAc is present in the environment (174, 175). NagD is a monophosphatase 
but its exact role in GlcNAc utilization has not been defined. In V. cholerae and 
V. fischeri, nagE-nagAC exists as a divergent operon on Chromosome I, nagB is 
on Chromosome II and nagD is not present (176–178). The GlcNAc PTS (NagE) 
is widespread not only among Vibrionaceae (166), but also among marine 
Firmicutes, α-Proteobacteria and other γ-Proteobacteria (167), indicating that a 
vast number of bacteria can uptake this molecule. In V. fischeri, NagC controls 
also a number of other genes required for chitin utilization and efficient 
colonization of E. scolopes (178).  
All in all, it is estimated that chitin degradation requires between 50 and 
100 genes (179, 180). Multiple copies of some of such genes have been observed 
within a genome, and this could be the result of gene duplication and 
horizontal gene transfer (166), which has been described also between distantly 
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related organisms (161). For several genes, transcription is induced by the 
presence of chitin and/or its derived oligosaccharides (167, 173, 177, 180–183). 
This phenomenon is in some cases under the control of the above-mentioned 
NagC repressor (178) and in other cases of the regulatory system ChiS, which is 
described in the following section. 
 
Figure 15 Chitin utilization pathway proposed for vibrios. Extracellular chitinases are responsible for the 
breakdown of chitin into GlcNAc oligosaccharides of different sizes, which are transported into the 
perisplasmic space by porins and/or specific chitoporins. In the perisplams, these chitin-derived 
oligosaccharides are further hydrolyzed to (GlcNAc)2, GlcNAc and (GlcN)2, which enter the cytoplasm 
through ABC transporters and PTS systems. In the cytoplasm, a number of enzymes participate to the 
conversion of these molecules to fructose-6-phosphate, which enters central metabolism. Green: enzyme 
catalyzing a reaction, red: protein name, when known. Adapted from (166).  
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3.3.3 ChiS: a chitin-dependent two-component signaling system 
Li and Roseman (180) identified a two-component signaling system that 
controls the expression of genes required for chitin catabolism in V. cholerae and 
V. furnissii (Figure 16). In this system, the ChiS hybrid sensor kinase of the Arc B 
type is anchored to the inner membrane. In this type of sensors, the cytoplasm 
domain includes three domains: i) histidine kinase (HK); ii) receiver aspartate 
(RR) and iii) histidine-containing phosphotransferase (HPt). When the sensor is 
activated, a phosphoryl group from ATP is sequentially transferred to HK, to 
RR, to a His residue in HPt and, finally, to an Asp residue in the cognate 
response regulator that controls the transcription of target genes (184). 
In the case of the ChiS system, when there is no chitin in the environment 
and, consequently, no (GlcNAc)2-6 in the periplasmic space, a chitin 
oligosaccharide binding protein (CBP) acts as inactivator of ChiS by binding to 
its periplasmic domain. When, on the contrary, chitin is available, CBP 
complexes with (GlcNAc)2 in the periplasmic space. This prevents its binding to 
ChiS and triggers the phosphorylation cascade that activates the cytoplasmic 
cognate response regulator (180). The response regulator associated to ChiS has 
not been identified so far. 
In V. cholerae, the chiS gene (VC0622) is located downstream of a 
(GlcNAc)2 catabolic operon (VC0620-VC0611) (180, 182). The operon encodes 
for the periplasmic CBP, for the ABC-type transporter necessary for the uptake 
of (GlcNAc)2, for the periplasmic β−Ν−acetylglucosaminidase and for the 
enzymes required for the cytoplasmic part of chitin degradation (see Figure 13), 
excluding those encoded in the nag operon. The expression of the (GlcNAc)2 
operon, together with the expression of several other genes involved in chitin 
catabolism and in the synthesis of a pilus that facilitates adherence to chitin 
surfaces, is significantly reduced in chiS mutants, suggesting a ChiS dependent 
regulation (182). Beside regulation of chitin catabolism, ChiS has been directly 
linked to the regulation of natural competence in V. cholerae on chitin (185, 186). 
In this PhD project, we have shown that the chiS gene and the (GlcNAc)2 operon 
are conserved in Vibrio and Photobacterium species and maintain their 
topological organization (Article 2). Hence, it is possible that the ChiS system 
might have a regulatory role in both genera. 
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Figure 16 Model for the hybrid sensor ChiS. When no chitin is present in the environment (left side of the 
figure), a chitin oligosaccharides binding protein (CBP) is bound to the ChiS sensor, which is inactive. When 
chitin is present in the environment (right side of the figure), the CBP binds chitin oligosaccharides instead 
and ChiS is active. Adapted from (180) and (183). 
3.4 Bioactive compounds from Vibrionaceae 
Vibrionaceae, like many other Gram-negative bacteria, have emerged as a 
reservoir of bioactive compounds with therapeutic applicability just in recent 
years (25). Analysis of their genomes with different prediction tools revealed 
great potential for secondary metabolism, but there is no correlation between 
genome size and biosynthetic capacity (6), as exemplified in Table 2, which 
includes the strains on which article 3 and 4 focus. 
Table 2 Number of BGCs identified by the prediction tool antiSMASH (antibiotics and secondary 
metabolites analysis shell) in the genomes of the four strains that were the subject of Articles 3 and 4. 
Strain 
Genome 
size (Mb) 
# BGCs 
(antiSMASH) 
V. furnissii S0821 4.98 6 
V. fluvialis S1110 4.52 5 
V. coralliilyticus S2052 5.43 7 
P. galatheae S2753 4.53 11 
 
 Vibrios are producers of the potent neurotoxic molecule tetrodotoxin 
(TTX), which has been isolated from several marine macroorganisms (e.g. 
pufferfish) hosting vibrios as part of their microbiota (187, 188). Consumption 
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of food containing TTX producers can lead to poisoning and, possibly, to death 
by paralysis due to inhibition of sodium channels. TTX is currently undergoing 
Phase III clinical trials for the treatment of cancer-related pain in substitution of 
morphine, avoiding opioid-like side effects (www.wexpharma.com).  A number 
of other compounds, mostly non-ribosomal peptides, have been isolated from 
vibrios. These molecules exert a range of bioactivities, including anticancer, 
antifungal and anti-algal (4). Some examples are the antibacterial and cytotoxic 
compounds aqabamycins A-G (189) and the anticancer molecule kahalalide F 
(190). 
Besides compounds with pharmaceutical potential, Vibrionaceae are also 
good producers of a range of ecologically important molecules such as acyl-
homoserine lactones (191) and siderophores. Furthermore, many genomes from 
vibrios contain aryl polyene BGCs, whose exact role is not known but, given 
their structural similarity to protectants against oxidative stress, it has been 
speculated that this may be their function, too (75). 
The work included in Article 3 focused on two strains, namely Vibrio 
coralliilyticus S2052 and Photobacterium galatheae S2753. The former is a coral 
pathogen whose virulence is temperature-dependent (154). The antibiotic 
andrimid (see Chapter 2) has been isolated from strain S2052 (5, 84). Andrimid 
was not detected in extracts from cultures of closely related strains and its 
production in strain S2052 was doubled when chitin was used as substrate, 
indicating that different strains have developed distinct eco-physiological 
characteristics (84). P. galatheae S2753 is the type strain of a new species that has 
been described as the result a collaborative project during this PhD (192). It was 
isolated from a mussel, but no further work concerning its role in this 
association or its relationship with other marine organisms has been done, even 
on the closely related species P. halotolerans. P. galatheae S2753 produces the 
antibiotic holomycin (5) (see Chapter 2) and a number of compounds shown to  
reduce virulence in the pathogen Staphylococcus aureus by inhibiting its QS 
machinery. These compounds are the depsipeptides ngercheumicins F, G, H 
and I (193) and solonamides A and B (194). 
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4 CONCLUSION AND PERSPECTIVES 
Bioprospecting provides an extraordinary amount of material and 
information useful for the development of biotechnological processes and 
applications. The exploration of new environments is a condition to access 
novel biodiversity. In this work, the marine Vibrionaceae family was studied for 
its potential as a source of novel biodiversity and for its ecological role in the 
marine environment. The ecology-driven investigation was based on the 
assumption that the understanding of the eco-physiology of an organism 
provides valuable information to be used in the full exploitation of its 
bioprospecting potential. 
The characterization of a novel species, Vibrio galatheae, demonstrated 
that, although approximately one hundred and fifty Vibrionaceae species are 
already known, further work is needed to explore the biodiversity of the family, 
which would also add to the knowledge about its phylogeny, distribution and 
evolution. This and, in general, the exploration of microorganisms, will be 
facilitated by the continuous evolution of technologies that enable the access to 
hitherto unexplored locations and niches, and by the increasing knowledge in 
the field of microbial eco-physiology. This knowledge allows, for example, the 
development of culture media that enable the cultivation of previously 
unculturable microorganisms. 
The use of niche-specific nutrients for the growth of cultures of vibrios in 
the laboratory proved to be an efficient strategy to manipulate the expression of 
gene clusters for the biosynthesis of small molecules. The regulatory 
mechanisms that are responsible for this phenotype remain to be uncovered; 
however, the results of this thesis support the hypothesis that environmental 
clues can influence the biosynthesis of small molecules, suggesting an 
ecological function for these molecules in Nature.  
Knowledge about the ecology of an organism should be used in the 
rational choice of substrates and culture conditions that may elicit the 
production of microbial small molecules. For species that are often found 
associated with algae, fish or mussels possible growth substrates could be, for 
example, extracts from these marine macro-organisms. Genome analysis and 
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identification of specific metabolic pathways may also provide hints about 
substrate preference of microorganisms, as in the case of chitin for Vibrionaceae. 
Also recording the physico-chemical parameters of the place of isolation of 
microorganisms (e.g. temperature, salinity, pH, concentration of heavy metals 
or presence of oil spills) can provide useful information in the choice of growth 
parameters that may affect the biosynthesis of small molecules. 
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Abstract 
Novel bioactive compounds are in high demand due to the development 
of microbial antibiotic resistance, increase in age-related diseases and 
requirements for optimized manufacturing processes. The bioactive compounds 
can act as specific antitumor, anti-inflammatory, and anti-fungal compounds as 
well as pharmaceuticals against metabolic diseases. Bioprospecting from marine 
microorganisms has a tremendous potential for the discovery of novel bioactive 
compounds as enzymes and complex secondary metabolites for industrial as 
well as for biotechnological and therapeutic applications. A bioprospecting 
process usually begins with the isolation of a native microorganism, extraction 
of compounds from a culture sample, or with the isolation of environmental 
DNA for either heterologous expression or sequencing. Extracts from live 
microorganisms can be screened for bioactivity in function-based screening 
assays, while DNA from either the isolated microorganisms or from the 
environment can be screened with sequence-based screening methods or 
genome mining. Once a desired activity has been detected, the bioactive 
compound should be purified, the structure should be elucidated, and 
preferably its mechanism of action should be described. In this chapter we give 
an overview of the bioprospecting process with special focus on compounds 
with therapeutic properties from marine microorganisms, and we evaluate 
some of the most commonly used strategies that have been used at different 
steps in the bioprospecting processes when searching for novel bioactive 
compounds. 
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1. THE NEED FOR NOVEL BIOACTIVE COMPOUNDS 
During the last century, microorganisms have emerged as a valuable 
source of bioactive compounds with a wide range of biotechnological 
applications. Two major groups of such compounds are enzymes and 
compounds with bioactivity on bacterial, archaeal, or eukaryotic cells. Enzymes 
of microbial origin are used as bio-catalyzers in many different industries such 
as feed, detergent, textile, chemical and biofuel industries. Polymer-degrading 
enzymes such as cellulases and xylanases can be used for bioremediation and 
food processing purposes (Adrio & Demain 2014; Schmid et al. 2001). 
Compounds exhibiting bioactivity on bacterial, archaeal, and eukaryotic cells 
(from now on referred to as bioactive compounds) include microbial secondary 
metabolites with therapeutic properties such as antibiotic, antitumor, or anti-
inflammation activity. Secondary metabolites belong to several different 
chemical classes of compounds, which among others include polyketides, non-
ribosomal peptides, terpenes, and terpenoids. Bioactive compounds of 
microbial origin also include bacteriocins and bacterial polysaccharides. 
Bacteriocins are ribosomal peptides produced by bacteria to kill or inhibit the 
growth of closely related bacteria and are used in e.g. dairy and food industries 
to prevent food spoilage (Cleveland et al. 2001), however bacteriocins are also 
increasingly being recognized as potential alternatives to classical antibiotics 
(reviewed in Reen et al. 2015). Bacterial polysaccharides are used in food, 
cosmetic and pharmaceutical industries as well as in bioremediation and for the 
development of biomaterials and bioplastics (Nicolaus et al. 2010; Sutherland 
2001). 
The United Nations’ Convention on Biological Diversity (CBD) defines 
biological prospecting, or just bioprospecting, as “the exploration of 
biodiversity for commercially valuable genetic and biochemical resources” 
(https://www.cbd.int). In other words, bioprospecting is the search for any 
product from Nature, such as genes, enzymes, chemical compounds or 
organisms for commercial purposes. In this chapter, we will focus on 
bioprospecting for small molecules of microbial origin with therapeutic 
properties. 
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The need for novel bioactive compounds is best exemplified by the rapid 
development and spread of antibiotic resistance in bacteria caused by the 
widespread use of antibiotics in both the clinic and the food production sector. 
Infections caused by antibiotic resistant bacteria are increasing (World Health 
Organization 2014) and this is of great concern and a threat to human and 
animal health, since known antibiotics are losing their effectiveness. Novel 
antibiotics, preferably with new mechanisms of action, are therefore urgently 
needed. Many compounds with antibacterial activity are of microbial origin, 
and some classes of such compounds may have the desired effect without being 
hampered by already known resistance mechanisms (reviewed in Clardy et al. 
2006). As an initiative to discover and develop novel therapeutics, the Infectious 
Disease Society of America (IDSA) has launched the “10 x ’20 Initiative” with 
the aim of bringing at least 10 new antibiotics to the marked before 2020 
(http://www.idsociety.org/10x20/). 
With the increase in average life expectancy of the human population, 
age-related diseases such as Alzheimer’s disease, Parkinson’s disease, 
osteoporosis, and several types of cancer are also requiring new and improved 
drugs to optimize treatment. Especially for Alzheimer’s and Parkinson’s 
diseases, the drugs used today only provide symptomatic relief but no cure.  
 
1.1 Bioactive compounds from the marine environment 
Groups of soil microorganisms such as Streptomyces and Micromonospora 
as well as several species of filamentous fungi have for years been the most 
commonly known microbial reservoirs of bioactive compounds (Bérdy 2005; 
Hoffmeister & Keller 2007; Keller et al. 2005; Watve et al. 2001). However, recent 
advances in novel bioprospecting technology are providing the opportunity to 
explore new habitats. These include the ocean, the deep sea, the cryosphere, 
and the deserts (Gerwick & Moore 2012; Molinski et al. 2009). 
The ocean covers more than 70% of the Earth’s surface and represents 
more than 95% of the total biosphere. Thirty-three of the thirty-five known 
animal phyla of life are present in the oceans and thirteen are exclusively 
marine phyla (Heip & McDonough 2012), making it an invaluable source of 
biodiversity potentially useful for bioprospecting purposes. The environmental 
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conditions of the oceans require selection and maintenance of unique 
biosynthetic pathways as a result of adaptation to pressure, salinity, 
temperature, oligotrophic conditions and unique chemical compounds (Fenical 
& Jensen 2006; Lozupone & Knight 2007). Several marine-derived natural 
products therefore have new chemical features as compared to molecules 
isolated from terrestrial environments, exemplified by the incorporation of the 
halogen atoms bromide or chloride (Gerwick & Moore 2012; van Pée 1996).  
Early studies of the marine environment focused on natural products 
from invertebrates such as sponges, bryozoans, algae and corals, and led to the 
isolation of several classes of bioactive natural products including polyketides, 
non-ribosomal peptides, terpenes, and indoles (DeGroot et al. 2015; Proksch et 
al. 2002; Woodhouse et al. 2013). However, evidence is currently emerging, 
based on metagenomics of marine sponges and tunicates and their associate 
microbiota, that many of the compounds originally isolated from eukaryotic 
organisms are in fact of bacterial origin, as will be outlined below. 
Many marine organisms have not developed an adaptive immune 
response and instead rely mostly on an immediate, innate immune system as 
the defense against pathogenic microorganisms. Also, many marine 
microorganisms have developed specialized strategies against predators. It is 
therefore expected that marine bacteria are capable of producing an array of 
anti-inflammatory compounds to better be able to evade the innate immune 
response of the host organism. For instance, several cyanobacteria produce such 
anti-inflammatory compounds, potentially targeting a broad range of molecular 
targets (Stevenson et al. 2002; Villa et al. 2010). 
There are several cases of antitumor compounds originally isolated from 
marine invertebrates and tunicates and later identified in the genomes of 
bacteria (Lane & Moore 2012; Wilson & Piel 2013; Wilson et al. 2014). The 
similar chemical structure between safracin B and ecteinascidins (trabectedin, 
Yondelis®, the first European marine-derived compound approved for cancer 
treatments and developed by PharmaMar) has been corroborated to a genetic 
level by the identification of a NRPS gene cluster for the putative biosynthesis 
of ecteinascidins into a bacterial symbiont living into the ascidian cells (Rath et 
al., 2011). Another example is the anticancer and anti-Alzheimer’s compound 
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bryostatin, which is currently undergoing clinical trials. Bryostatin was first 
identified in extracts from the bryozoan Bugula neritina, but the polyketide 
synthase (PKS) cluster putatively responsible for its biosynthesis has been 
identified in the bacterial symbiont Candidatus Endobugula sertula (Davidson et 
al. 2001). Similarly, the anti-tumor depsipeptide dolastatin 10 was first isolated 
from the sea hare Dollabella auricularia (Pettit et al. 1993) and later from the 
marine cyanobacterium Symploca sp. VP642 (Luesch et al. 2001). Also, the 
Gram-positive Bacillus pumilus, isolated from the marine sponge Acanthella 
acuta, produces diglucosyl-glycerolipids with anti-tumor properties (Ramm et 
al. 2004)  
The Gram-positive actinobacteria, which are already known as an 
excellent reservoir of natural products in the terrestrial environment (Bérdy 
2005), have also emerged as producers of novel bioactive compounds in the 
marine environment. Although several compounds have been isolated from 
marine species of Streptomyces (Khan et al. 2011; Manivasagan et al. 2014; 
Schleissner et al. 2011), probably the best-known example is the novel 
actinomycete genus Salinispora. This genus includes only three species, but has 
already provided a number of bioactive compounds, including the anticancer 
compound salinosporamide A and derivatives of the antibiotic rifamycin 
(Fenical & Jensen 2006). Other interesting actinomycete genera for drug 
discovery are Saccharopolyspora (Pérez et al. 2009), Micromonospora (Romero et al. 
1997) or Nocardiopsis (PharmaMar, personal communication), which contain 
several putative biosynthetic gene clusters.  
Marine Gram-negative bacteria are currently emerging as potential 
producers of such compounds and novel natural products have been 
discovered in marine cyanobacteria (Burja et al. 2001; Calteau et al. 2014; Tan 
2007), and Proteobacteria (Proksch et al. 2002; Schäberle et al. 2010). For 
instance, the gammaproteobacterial genera Pseudomonas, Pseudoalteromonas and 
Vibrio have provided several compounds with bioactivities including 
antibacterial and anti-virulence activity (Bowman 2007; Chellaram et al. 2012; 
Gram et al. 2010; Mansson et al. 2011; Nielsen et al. 2012; Nielsen et al. 2014; 
Vynne et al. 2011; Whalen et al. 2015; Wietz et al. 2010). Furthermore, members 
of the alphaproteobacterial Roseobacter clade produce bioactive compounds, 
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including the antimicrobial compounds indigoidine (Cude et al. 2012) and 
tropodithietic acid (TDA) (Brinkhoff et al. 2004; Bruhn et al. 2007) (Figure 1). 
 
2. BIOPROSPECTING FOR BIOACTIVE COMPOUNDS 
Bioprospecting of microbial natural products can include the following 
steps: 
1. Isolation and molecular characterization of microorganisms  
2. Culture and extract preparation 
3. Construction of metagenomic libraries 
4. Screening for bioactivities 
5. Chemical dereplication, compound purification and structure 
elucidation 
A bioprospecting process is not linear, and many different approaches 
can be used. Sometimes the starting material is a live microorganism, wild type 
or recombinant, in other situations it is a crude extract from cultures of 
microorganisms, and in some cases it is a library of pure compounds. Here we 
will describe a classical methodology following the steps described above, well 
knowing that many researchers choose alternative strategies, and that one often 
has to re-visit a screen or an assay several times before a novel, pure bioactive 
compound can be presented. 
It is important to note that the strategy chosen for bioprospecting is 
independent of the origin of the samples; hence, here we will provide examples 
that have been used in the discovery of natural products from microorganisms 
of both terrestrial and marine origin with a focus on the latter.  
 
3. ISOLATION OF MICROORGANISMS 
The first step in bioprospecting for microbial natural products is to isolate 
microorganisms or to purify microbial DNA from environmental samples. Any 
biological sample collection should be carried out in accordance with the 
Convention on Biological Diversity, the Cartagena Protocol and the Nagoya 
Protocol (https://www.cbd.int). These documents have been created to ensure 
the conservation of biological resources, their sustainable use and the equitable 
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and fair sharing of benefits deriving from the use of biological and genetic 
resources. Despite the fact that several countries in the world have signed the 
convention and the protocols, they have not been ratified by all of them. There 
should be an agreement between those collecting the biological material and the 
country where the sampling takes place. 
The culturability of microorganisms is an important consideration in 
bioprospecting. With the current standard laboratory culture conditions, only 
approximately 1% of all bacteria have been brought into culture. For marine 
bacteria this number is thought to be even lower; between 0.01 and 0.1% (Gram 
et al. 2010; Kogure et al. 1979). The bioprospecting potential of microorganisms 
is therefore potentially overlooked since they simply have never been cultured 
in the laboratory. However, efforts are now being made to develop devices and 
techniques in order to increase microbial culturability or to use microbial DNA 
as the starting material.  
In traditional isolation techniques, microorganisms from e.g. soil, water, 
or invertebrate samples are cultured on artificial substrates and strains able to 
grow into colonies are selected for further analyses. Selective media are often 
used to enrich for a desired group of bacteria. Thaker et al. (2013) succeeded in 
the isolation of scaffold-specific natural product producers; the assumption was 
that producers of antibiotic compounds must have a mechanism of self-
resistance to the produced compounds to avoid suicide. Therefore, the addition 
of a specific antibiotic to the medium will select for resistant microorganisms, 
which would also be likely to produce other compounds with the same scaffold. 
Indeed, the addition of the glycopeptide antibiotic (GPA) vancomycin to the 
isolation medium led to the isolation of the novel GPA pekiskomycin. 
Several strategies are currently being exploited to increase microbial 
culturability. When in their natural habitat, microorganisms are exposed to a 
multitude of factors that most often are not present in traditional laboratory 
culturing, including the presence of other microorganisms, specific substrates 
and growth factors (Marmann et al. 2014; Stewart 2012). Connon and 
Giovannoni (2002) succeeded in the high-throughput isolation of previously 
uncultured marine bacteria using the “dilution-to-extinction” approach based 
on the work of Button et al. (1993). The dilution of seawater samples to a 
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concentration of one to five bacterial cells per ml led to an increase in the 
number of isolated strains of up to three orders of magnitude compared to 
direct inoculum of water samples onto solid medium. In contrast, after plating 
serial dilutions of a microbial suspension obtained from marine environmental 
samples, D’Onofrio et al. (2010) observed that there were significantly more 
colonies on densely inoculated plates as compared to diluted ones. They 
hypothesized and proved that the growth of some of the isolates from the 
densely inoculated plates depended on neighboring colonies providing growth 
factors, in this case siderophores. 
An alternative strategy to increase bacterial culturability is to introduce 
an inoculum of environmental cells into culture chambers spatially delimited by 
semi-permeable membranes, whose pore size prevents cells to pass through but 
enables free exchange of molecules with the external environment. The chamber 
is then incubated either at the original sampling location or in an artificial 
environment simulating it. Several variants of such chambers are available, 
such as the isolation Chip (ichip) (Nichols et al. 2010) which is miniaturized and 
optimized for high-throughput isolation of hundreds of strains in parallel, and 
the MicroDish Culture Chip, which consists of up to 180,000 culture areas 20 
µm across on top of a porous base that allows for passage of nutrients from 
below when the chip is placed on e.g. an agar substrate (www.microdish.nl). 
The use of culture chambers has recently resulted in the isolation of the novel, 
previously uncultured species Eleftheria terrae (provisional name), which 
produces teixobactin, an antibiotic with a novel mode of action active against 
both Staphylococcus aureus and Mycobacterium tuberculosis (Ling et al. 2015). 
In order to construct a collection of unique culturable strains, 
biotechnological methods for molecular de-replication, such as DNA 
fingerprinting, and identification based on sequencing of the 16S rRNA gene 
must be used. In the future, genome sequence based identification and de-
replication is likely to be the method of choice. 
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4. CULTURE AND EXTRACT PREPARATION 
When native organisms are successfully brought into culture, the next 
challenge is to unlock their bioactive potential. The artificial in vitro culture 
conditions are most often not identical to the original environment of the 
microorganisms, and chemical substances, signaling molecules and other 
compounds important for induction of gene expression might be missing. 
In bioprospecting, screening for bioactivity is carried out using either live 
organisms or extracts from whole cultures or sub-fractions hereof (i.e. 
separation of biomass from the supernatant). In preparation of an extract, the 
choice of the solvent depends on the availability of information about the 
nature of the compound to be extracted. For non-polar compounds, organic 
solvents such as hexane and chloroform can be used, while for polar ones 
water, ethanol, or methanol are suitable. When there is no information about 
the nature of the compounds, extraction will have to be carried out by a trial 
and error approach: often medium polarity extractions with ethyl acetate or 
dichloromethane can be applied, or alternatively a mixture of solvents. In the 
case of large liquid cultures where liquid-liquid extraction would be 
challenging due to the big volumes to be handled, it is possible to add an 
adsorptive resin (e.g. DIAION HP 20®) to the culture: after 24-48 hours of 
incubation, the resin is separated from the cultures and the secreted metabolites 
can be extracted from its surface. 
Microbial crude extracts are usually complex mixtures of compounds 
including cellular and media components. The most commonly used strategy to 
narrow down the complexity of the crude extract is bioassay-guided isolation, 
where the complexity is reduced by fractionation, and bioactive fractions are 
identified by means of a bioassay (Gerwick et al. 1994; Wietz et al. 2010). An 
alternative to working with crude extracts is to build libraries containing pure 
compounds, which are then screened for bioactivity. This approach, however, 
requires more resources as compared to the bioassay-guided isolation 
(Wagenaar 2008). 
When it is not possible to bring the native microorganisms into culture, 
an alternative strategy is to extract DNA directly from the environment for 
metagenomic analyses. The isolated DNA can either be used to construct clone 
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libraries to be tested in bioactivity screening assays, or alternatively, the DNA 
sequences can be mined using software developed to search for biosynthetic 
gene clusters or other structures indicating potential production of bioactive 
compounds. 
 
5. CONSTRUCTION OF METAGENOMIC LIBRARIES 
The metagenomic approaches bypasses the microbial isolation and 
culturing steps, however, isolation of DNA directly from an environmental 
sample is a major challenge, especially when dealing with samples from 
extreme environments. Extremophilic microorganisms are often reluctant to 
standard lysis protocols developed for mesophilic microbes and, when lysed, 
they often release stable nucleases that will degrade the purified DNA (Simon 
& Daniel 2011).  
When constructing a metagenomic library, DNA is purified directly from 
an environmental sample, fragmented, and cloned into a host organism using a 
selected vector. This vector can be either an expression plasmid for direct gene 
expression from small DNA fragments (Lynch & Gill 2006; Schmitz et al. 2008) 
or a larger plasmid such as BAC (bacterial artificial chromosome) plasmids. 
Larger plasmids are commonly used to insert and sequence large fragments of 
environmental DNA (eDNA) to search in silico for known or hypothetical genes 
or gene clusters (O’Connor et al. 1989; Shizuya & Kouros-Mehr 2001). However, 
it is important to keep in mind that many gene clusters encoding e.g. polyketide 
synthase/non-ribosomal peptide synthetase (PKS/NRPS) hybrids are too large 
for classical heterologous expression and that novel expression systems should 
be developed for expression of large gene clusters (>50 kb). 
In the preparation of expression libraries for smaller genes or gene 
clusters, both the vector and the host for direct gene expression have to be 
chosen with great care to ensure maximal chance of successful expression of the 
desired gene(s). In case the host has an expression system or a secretion system 
too different from the native donor strain (e.g. the simple issue of Gram type), 
no active compounds will be produced even though the genetic potential was 
actually there. Several commercial host organisms as well as broad-host-range 
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vectors are available, but there is no universal expression system available that 
covers all bacterial species yet (Aakvik et al. 2009; Lale et al. 2011). 
Promoter trap or gene trap libraries have now become more commonly 
used since they rely on only small fragments of eDNA and can be easily 
screened for the presence of a desired gene or promoter by using a 
standardized reporter molecule like green fluorescent protein (GFP) or 
luciferase (Izallalen et al. 2002; Kondo et al. 1993; Rediers et al. 2005). 
A variety of bioactive compounds including primarily enzymes but also 
therapeutics from the marine environment have in the last decade been 
discovered via metagenomic approaches (reviewed in Barone et al. 2014). In a 
study by Piel et al. (2004), DNA was extracted from the marine sponge Theonella 
swinhoei, cloned into cosmids and screened using primers specific for PKS and 
NRPS clusters. This resulted in the identification of two gene clusters 
originating from a bacterial endosymbiont encoding onnamides and 
theopederins, a class of polyketides with anti-tumor activity (Piel et al. 2004). 
Other examples of marine compounds found through metagenomic approaches 
can be seen in table 1. 
 
6. SCREENING FOR BIOACTIVITY  
When screening for bioactivity, two overall approaches are possible: 
sequence-based screening and function-based screening. In sequence-based 
screening, sequence analysis is performed to identify genes or gene clusters 
potentially encoding molecules or biosynthetic pathways of interest. In 
function-based screening, bioassays are performed to identify the desired 
bioactivity directly in the live microorganisms or the extracts. The two 
strategies should not be considered as independent and incompatible, instead 
they are often combined to accelerate and optimize the bioprospecting process 
(Mansson et al. submitted). 
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6.1 Sequence-based screening  
In sequence-based screening, DNA sequences are analyzed to identify 
conserved regions deriving from known gene or protein families. This can be 
achieved in vitro by using e.g. DNA probes or degenerated primers (Ayuso-
Sacido & Genilloud 2005; Ehrenreich et al. 2005) or phage display (Yin et al. 
2007). However, with recent advances in DNA sequencing techniques, such 
analyses are most often done by in silico homology search based on whole 
genome sequencing of an isolated strain or sequencing of metagenomic 
libraries.  
 
6.1.1 Genome mining 
In silico sequence-based screening, often referred to as genome mining, is 
an attractive approach in the natural product discovery pipeline. Several tools 
have been developed for the identification of conserved domains that are likely 
to be part of biosynthetic gene clusters. Some of them are publicly available and 
include NaPDoS for the identification of keto-synthase and condensation 
domains, which are core enzymes in PKS and NRPS, respectively (Ziemert et al. 
2012), BAGEL for the identification of bacteriocins (de Jong et al. 2006), and 
AntiSMASH for the identification of a wide range of biosynthetic clusters, 
ranging from PKS and NRPS to siderophores (Medema et al. 2011). For a 
complete review of the available in silico tools for the genome mining of natural 
products, see Weber (2014).  
These sequence tools are based on homology searches, meaning that only 
previously characterized families of genes and gene clusters are detected, and 
that the discovery of novel classes of bioactive compounds is almost impossible. 
However, efforts are being made to overcome this problem, as demonstrated by 
the recently developed algorithm ClusterFinder (Cimermancic et al. 2014). This 
tool enables the identification of both known and unknown biosynthetic gene 
cluster by converting nucleotide sequences into protein family (Pfam) domains 
and calculating for each domain, the probability of it being part of a gene 
cluster. A comprehensive analysis of 1154 genome sequences using 
ClusterFinder has revealed the presence of large families of biosynthetic gene 
clusters of unknown function, indicating that the microbial biosynthetic 
potential is far from exhausted (Cimermancic et al. 2014). 
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Information obtained with genome mining can accelerate the natural 
product bioprospecting process by identifying isolates or clones that produce 
already known compounds, enabling the prediction of expected classes of 
compounds as well as structural predictions (Jensen et al. 2014). For example, 
mining of the genome of the marine bacterium Salinispora pacifica strain CNT-
133 enabled the identification of a truncated gene cluster related to the 
salinosporamide A biosynthetic gene cluster in Salinispora tropica strain CNB-
440 (Eustáquio et al. 2011). The anticancer compound salinosporamide A has a 
chloroethyl group on C-2 (Figure 2), and the comparison of the two gene 
clusters led to the hypothesis that, if a salinosporamide were to be produced by 
S. pacifica, it would not be halogenated. Indeed, the compound that later was 
isolated and structurally characterized, salinosporamide K, lacks the C-2 
chloroethyl group (Figure 2). 
 
Silent biosynthetic gene clusters  
Genome mining has revealed that microorganisms often have the 
potential to produce other natural products than identified using extractions 
and bio-assay-guided fractionation (Gram 2015; Helfrich et al. 2014; Jensen et al. 
2014; Machado et al. 2015). This has opened up a new branch in natural 
products research, where molecular biology, microbial ecology and physiology 
are merged to elucidate how the silent or cryptic biosynthetic gene clusters can 
be elicited. The “One Strain-MAny Compounds (OSMAC)” approach (Schiewe 
& Zeeck 1999) was successfully used in several studies, where the variation of 
culture parameters (e.g. media composition, culture vessel, aeration, addition of 
enzyme inhibitors or rare earth elements, or co-culturing with other 
microorganisms) elicited previously silent biosynthetic gene clusters (Bode et al. 
2002). Culture parameters can be modified to simulate the environmental niches 
of microorganisms. For example, antibacterial activity was observed in the 
supernatant of cultures of two marine Bacillus strains, only when they were 
grown into an agar-coated roller bottle mimicking the intertidal environment of 
isolation and not when they were cultured in standard shaking flasks (Yan et al. 
2002). Similar results have been obtained with “air-membrane surface” (Yan et 
al. 2003) and “rotating disc” bioreactors (Sarkar et al. 2008). The exposure to low 
concentrations of antibiotics and other small molecules produced by 
microorganisms elicited two cryptic biosynthetic gene clusters in the soil 
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bacterium Burkholderia thailandensis (Seyedsayamdost 2014), whilst co-culturing 
setups caused variations in the secondary metabolism profile of Streptomyces 
coelicolor, as captured by imaging mass spectrometry (Traxler et al. 2013). 
Access to a carbon source typical of the niche of isolation can influence the 
biosynthesis of a given compound. For instance, it has been observed that the 
addition of chitin to the growth medium can elicit a two-fold increase in the 
biosynthesis of the antibiotic compound andrimid in the marine bacterium 
Vibrio coralliilyticus S2052 as compared to glucose (Wietz et al. 2011). 
 
An alternative way to access silent biosynthetic gene cluster relies on 
homologous and heterologous gene expression. In homologous gene 
expression, transcriptional, translational or metabolic elements are manipulated 
to elicit the expression of the targeted biosynthetic gene cluster. However, this 
is possible only when the host is easily culturable and not recalcitrant to genetic 
manipulation. The introduction of drug-resistance mutations in the ribosome 
and in RNA polymerase, so-called ribosomal engineering, greatly influences 
secondary metabolism in actinomycetes (Hosaka et al. 2009). Ribosomal 
engineering has also led to the isolation of the anti-tumor molecule 
fredericamycin A from the deep-sea derived Streptomyces somaliensis SCSIO 
ZH66 (Zhang et al. 2015) and to a 180-fold higher production of the antibiotic 
actinorhodin in Streptomyces coelicor A3(2) (Wang et al. 2008). Moreover, 
homologous overexpression of a regulatory gene controlling the biosynthesis of 
the precursor of the C-2 chloroethyl group in salinosporamide A selectively 
doubled the yield of the compound in the natural producer Salinispora tropica 
(Lechner et al. 2011). 
 
In heterologous expression, single genes or gene clusters are expressed in 
a heterologous host. A prerequisite is the availability of well-developed genetic 
toolboxes that enable the introduction of gene clusters up to 100 kb in size. The 
native promoters of biosynthetic pathways are often not strong enough to 
trigger the expression in heterologous hosts, and it is necessary to place the 
biosynthetic cluster under control of strong, inducible promoters. For instance, 
it has been possible to express the gene cluster encoding biosynthesis of the 
antibiotic polyketide oxytetracycline from Streptomyces rimosus in Escherichia coli 
only when one of the heterologous host’s native sigma factor was 
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overexpressed (Stevens et al. 2013). An example of heterologous expression of a 
large NRPS gene cluster from a marine Micromonospora in an industrial 
Streptomyces is described for the antitumoral peptide thiocoraline (Lombó et al. 
2006). In general, several molecular tools have been used for heterologous 
expression of silent biosynthetic gene clusters in bacteria and fungi. Some 
examples to be mentioned here are the transformation associated recombination 
(TAR) strategy (Ross et al. 2015; Yamanaka et al. 2014), the TRansfer and 
EXpression of biosynthetic pathways (TREX) system (Loeschcke et al. 2013), the 
red/ET (Wenzel et al. 2005) and the RecE/RecT recombination systems (Fu et al. 
2012). For further examples and strategies, the review from Ongley et al. (2013) 
exhaustively covers advances on the topic until 2013. 
 
6.2 Function-based screening  
In function-based screening, bioassays are performed to detect a desired 
bioactivity in collections of isolated microorganisms, on sequence-based sub-
selections of such, on recombinant expression hosts, or on culture extracts. 
Strategies that are most commonly used in function-based screening campaigns 
can be sub-divided into phenotypic screens and target-based screens. By 
definition, phenotypic screens measure the effect, or phenotype, that the tested 
compounds induce in target cells or organisms, whereas target-based screens 
investigate the ability of a compound to bind or inhibit purified targets in vitro 
(Kotz 2012). Phenotypic screens can be cell-based (in vitro screens on single cells 
or tissues), or involve model organisms (in vivo screenings) such as 
Saccharomyces cerevisiae (yeast), Drosophila melanogaster (fruit fly), or 
Caenorhabditis elegans (nematode). In target-based screens, the target of interest 
is purified and in vitro biochemical assays are established to investigate the 
effects of a range of compounds on the target. 
Traditionally, phenotypic screens were favored by the pharmaceutical 
industry. However, difficulties encountered in target identification as well as 
advancement in multiple disciplines such as molecular biology, flow cytometry, 
chemical proteomics and imaging techniques led to the establishment of target-
based screens. The outcome of target-based screening campaigns was not as 
high as expected, though, and today there is a renewed interest in phenotypic 
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screens both in academia and in the pharmaceutical industry in companies such 
as Novartis AG and GlaxoSmithKline (Eggert 2013; Kell 2013; Kotz 2012; 
Swinney & Anthony 2011; Zheng et al. 2013). The two approaches are often 
combined: phenotypic screens are not completely target-agnostic and targets for 
target-based screens can be chosen based on results from phenotypic assays 
(Kell 2013; Moffat et al. 2014; Sams-Dodd 2005). Examples on how the two 
screening strategies can be used and combined can be seen in sections 6.2.1-6.2.4 
on strategies for discovery of antibacterial, anti-viral, anti-tumor, anti-
Alzheimer’s, and anti-Parkinson’s compounds.  
 
6.2.1 Screens for antibacterial activity 
Due to the increased antimicrobial drug resistance in many pathogenic 
microorganisms and the lack of therapeutic alternatives to the classical 
antibiotics, prospecting for novel antibacterial compounds has become of high 
priority. Classical function-based screening of live bacteria or extracts is often 
based on agar plate or broth based assays where for instance growth inhibition 
by an antagonistic compound or a colorimetric reaction indicative of a desired 
activity or molecule can be observed.  
 
Live targets 
A commonly used approach to detect antibacterial compounds is the 
overlay method developed by Waksman (Schatz et al. 1944). In brief, a potential 
producer strain is grown on a solid medium, which is then overlaid with soft 
agar seeded with a target bacterium. After a period of incubation, the presence 
of antibacterial compounds, to which the target is susceptible, is indicated by a 
clear halo in the top agar due to the lack of growth of the target strain. 
Alternatively, the potential producer strain can be on the seeded medium. The 
latter option can be used directly during the isolation procedure to select for 
strains displaying antibacterial activity or by replica plating a master plate on 
the seeded medium (Gram et al. 2010). The production of antagonizing 
compounds will be seen as a clear zone in the agar or the by lack of growth of 
the target strain, respectively (Figure 3).  
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BioMAP (antiBIOtic Mode of Action Profile) is an assay that can be used 
for the growth-independent function-based screening of crude extracts. The 
BioMAP assay consists of a panel of 15 clinically relevant bacterial pathogens 
and provides a function-based high-throughput platform for screening natural 
products in order to identify new lead compounds with unique biological 
profiles. The activity profile of a given extract can then be compared to profiles 
of known antibiotics and used to determine the structural class of the anti-
bacterial compound in the extract (Higginbotham et al. 2014; Wong et al. 2012). 
 
Biosensors 
Another strategy to screen for novel antibiotic compounds is to apply the 
whole-cell antibiotic biosensors strategy described by Urban et al. (2007). 
Promoter regions selectively and strongly induced by bactericidal antibiotics 
were identified in Bacillus subtilis and used to construct five biosensors 
consisting of the B. subtilis promoters fused to the firefly luciferase reporter 
gene lucFF. This allowed for high-throughput detection of compounds 
interfering with DNA synthesis (yorB promoter), RNA synthesis (yvgS 
promoter), protein synthesis (yheI promoter), cell wall synthesis (ypuA 
promoter), and fatty acid synthesis (fabHB promoter). The biomarker-carrying 
strains of B. subtilis were then subjected to approximately 14,000 pure natural 
compounds, screened in a 384-well microtiter plate format using a 
luminescence detector, and the study led to the discovery of novel antibiotics in 
the form of DNA synthesis and translation inhibitors.  
 
Since several bacterial virulence factors are under quorum sensing (QS) 
regulation, there is a great interest in compounds that can specifically block QS 
as potential novel classes of antibiotics (Rasmussen & Givskov 2006). Biosensors 
have been designed allowing for identification of such compounds. One 
example is the detection of the bacterial QS molecules N-acyl-homoserine 
lactones (AHLs). In Agrobacterium tumefaciens lacZ::traG, the lacZ reporter gene 
encoding a β-galactosidase is fused to the promoter of the QS-regulated tra 
operon. The AHL-induced expression of the operon and reporter gene is then 
visible as a blue precipitate due to β-galactosidase-mediated hydrolysis of X-gal 
present in the medium (Cha et al. 1998). High-throughput functional screening 
of single cells for AHL production is also possible as described by Williamson et 
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al. (2005), who prepared a soil metagenomic library using E. coli cells containing 
a green fluorescence protein (GFP)-based AHL biosensor. Clones producing QS 
inducers could then be detected by fluorescence microscopy due to GFP 
expression, while clones producing QS inhibitors were identified using 
fluorescence-activated cell sorting (FACS) on cells in which GFP expression was 
induced by an exogenous AHL.  
 
Molecular targets 
Novel antimicrobial compounds are also identified by screens that are 
aimed directly at the targets of the antimicrobial compounds such as 
components of cellular pathways. Typically, assays are performed to screen for 
inhibitors of macromolecular synthesis using radioactively labeled precursors 
of protein, RNA, DNA, lipid or peptidoglycan synthesis (Cotsonas King & Wu 
2009; Nonejuie et al. 2013). However, these assays do not allow for 
determination of the mechanism of action (MOA), and often they do not 
distinguish between inhibitors that affect the same pathway.  
 
Transcriptional profiling measures total gene expression to give an 
overall picture of the cellular functions. Even though transcriptional profiling 
sometimes can be used to identify the molecular targets of a bioactive 
compound, the method is slow and often fails to identify the target. Instead, 
Nonejuie et al. (2013) developed a bacterial cytological profiling (BCP) assay, 
which can distinguish between antibacterial compounds with different MOA 
and also predict the MOA of novel compounds. In practice, the bacterial cells 
were treated with the potential antibacterial compounds and after incubation 
stained with FM4-64 which stains the membrane (Pogliano et al. 1999), with 
DAPI which stains DNA (Kapuscinski 1979), and with SYTOX Green Nucleic 
Acid Stain, which functions as a live/dead stain, since it is only able to penetrate 
membranes that have been made permeable (Molecular Probes, Thermo Fisher 
Scientific Inc.). The cells were then subjected to fluorescence microscopy and 
the intensity of the stains was determined and used as a measure of the cell’s 
cytological profile. 
 
Several assays are available to screen for membrane-damaging 
compounds. However, such compounds have to be specific with respect to their 
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target, since compounds targeting the cytoplasmic membrane would potentially 
not limit their activity to bacteria and ultimately cause toxicity in the 
mammalian host. Therefore, a range of assays to detect membrane damaging 
compounds specific against e.g. Staphylococcus aureus have been developed. 
O’Neill et al. (2004) applied a β-galactosidase (BG) assay, where the lacZ gene 
from E. coli has been put under the control of a strong staphylococcal promoter, 
cap1A. Leakage of BG from the strain subjected to potential membrane 
damaging compounds could then be detected using a fluorescence assay. Other 
assays to detect membrane damage in bacteria includes ATP release (Johnston 
et al. 2003), leakage of nucleic acids (material absorbing at OD260) (Carson et al. 
2002), and the commercially available LIVE/DEAD® BacLightTM Bacterial 
Viability Kit from Molecular Probes (Thermo Fisher Scientific Inc.).  
 
Other molecular targets used in screening for novel antibacterial 
compounds are components of the major signal transduction pathways such as 
histidine kinases (Bem et al. 2015) or cell wall components like 
lipopolysaccharides and transporter complexes (Nayar et al. 2015). Nayar et al. 
(2015) applied a high-throughput phenotypic screening assay based on a 
Citrobacter freundii AmpC β-lactamase reporter system to discover novel 
compounds inhibiting cell wall synthesis. Inhibitors of cell wall synthesis also 
induce expression of AmpC β-lactamase (Sun et al. 2002). Hence, when β-
lactamase was expressed, degradation of nitrocefin (a chromogenic 
cephalosporin substrate added to the cultures) could be detected in a plate 
reader, allowing for a 384-well microtiter plate format. Using this strategy, 
Nayar et al. (2015) successfully discovered two novel antibacterial compounds, 
sulfonyl piperazine and pyrazole, which are not cross-reactive with any known 
antibiotic and with completely novel MOAs. 
 
6.2.2 Antiviral drug screening with CPE inhibition test 
From the screening perspective, most antiviral test systems are based on 
infection of a host cell line or an animal. Many animal virus models have been 
established but for high-throughput screening of natural products cell lines are 
the better choice also because of animal ethical reasons. In most cases, a virus is 
highly specific, shows organ tropism, and infects defined parts of the body. The 
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susceptibility for infection of the used viral type therefore regulates which type 
of host or cell line should be chosen for screening purposes.  
 
Respiratory viruses like influenza, respiratory syncytial virus, para-
influenza and especially human rhino virus, infect the upper respiratory tract 
including nose and throat and are some of the most common viruses in humans 
(Denny 1995). Being not highly virulent with low morbidity and weak 
symptoms, these types of viruses are in many cases precursors for more severe 
bacterial and fungal infections and can causes enormous financial damage 
(Gonzalez et al. 1987; Gonzales et al. 1997). With more than 100 different 
serotypes (Greve et al. 1989; Hofer et al. 1994) it is important to screen against as 
many viruses as is possible to check activity against the whole group, otherwise 
some serotypes will be preferred and might quickly become dominant (Andries 
et al. 1992). 
 
The cytopathic effect (CPE) refers to the structural changes in a host 
caused by a viral infection. As screening method, the CPE inhibition assay is a 
fast and effective tool to verify if a natural product has antiviral potential 
(Schmidtke et al. 2001). Read-out from the assay is the inhibition of the CPE i.e. 
the survival of the targeted cells. In infected and non-treated cell cultures, an 
increasing cytopathic effect with characteristic cell granulation, shrinking cells, 
plaque production and spherical cell shapes can be observed. This cell 
morphology starts to change as the result of the reprogramming of the cell for 
viral production. At the end, most viruses replicates by destroying the host cell 
via lysis. In combination with plaque assay, the CPE inhibition assay could 
furthermore be used for definition of the detailed viral titer (Bachrach et al. 
1957; Cooper 1961). 
 
In general, there are two different types of screening in the CPE 
inhibition assay. In the prophylactic assay, the ability of a compound to affect 
the virus directly is tested. In this approach, the virus is mixed with the 
compound and incubated. This time allows the compound to target straight at 
the virus and block it or destroy it before it gets in touch with host cell line. 
Many antiviral blocking agents and biocides work with this mode of actions 
(Gonzalez et al. 1987). In contrast, in the therapeutic assay the compound 
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attacks the virus after cell infection, and, hence, mainly stays inside the host 
cell. Here the bioactive candidate is added to the cell culture media and the 
impact is on important switches in viral replication and packaging. Due to the 
fact that these approached require incubation time during the entire 
experiment, toxicity, solubility and stability are critical factors to be considered. 
Therefore, it is recommended to collect as much as possible pre-information 
about the compound to be tested. 
 
6.2.3 Screening for antitumor activity 
The fundamental goal in cancer drug discovery is to kill or re-program 
malignant cells while minimizing adverse effects on non-tumoral cells. Cancer 
encompasses a large number of molecularly and phenotypically distinct 
diseases, and hence it demands a much larger repertoire of drugs with distinct 
MOAs than most other diseases. For the past 50 years, phenotypic screenings in 
cancer drug discovery has been based on cytotoxicity assays using cancer cell 
lines that exhibit the phenotype of unrestrained fast growth. Such 
antiproliferative assays in cancer drug discovery have resulted in the 
development of a repertoire of chemotherapeutic agents (DeVita & Chu 2008) 
and are currently used in many oncology drug discovery programs. The 
National Cancer Institute 60 (NCI60) platform introduced the concept of high-
throughput cell-based profiling using a panel of 60 different tumor cell lines. 
 
The most frequently used cytotoxicity assay in a high throughput 
screening platform is usually a colorimetric method, for example 
sulforhodamine B (SRB), for quantitative measurement of cell growth and 
viability (Vichai & Kirtikara 2006). Cultured cell lines derived from many 
different types of human cancer are used in such assays. Cytotoxicity is 
typically estimated using the National Cancer Institute (NCI) algorithm (Boyd 
& Paull 1995) which gives three end-points that can be used to determine 
compound activity. These are GI50 (concentration required to inhibit 50% of 
cells), TGI (concentration required for total growth inhibition), and LC50 
(concentration required to kill 50% of the cells) (Holbeck 2004). This screening 
technology requires the use of microplates, automated liquid handling and 
involves a high volume of data analysis. 
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Recent technologies that facilitate the parallel analysis of large panels of 
cell lines, together with genomic technologies that define their genetic 
constitution, have revitalized efforts to use cancer cell lines to assess the clinical 
utility of new investigational cancer drugs and to discover predictive 
biomarkers (Moffat et al. 2014). A human tumor cell line platform has been 
established to provide as broad a representation as possible of different cancers 
and includes 1,200 cell lines. This panel is referred to as the Centre for 
Molecular Therapeutics 1000 (CMT1000) and is being used to probe the genetic 
basis for sensitivity to approved and investigational anticancer agents (Sharma 
et al. 2010). 
 
Several bioactive anti-cancer compounds have been isolated from marine 
invertebrates, but have later been proven to be of microbial origin. The 
structural similarity between safracin B and ecteinascidins (trabectedin, 
otherwise known as Yondelis®, which was the first European marine derived 
compound approved for some cancer treatments and developed by PharmaMar 
has been resolved to the genetic level by the identification of a NRPS gene 
cluster for the putative biosynthesis of ecteinascidins in a bacterial symbiont 
living in the ascidian cells (Rath et al. 2011). The biosynthetic gene cluster is 
closely related to the NRPS genes of safracin B produced by Pseudomonas 
fluorescens A2-2 (Velasco et al. 2005) which is the starting material for the 
current semisynthetic manufacture of Yondelis® (Cuevas et al. 2000). The 
common building blocks are two units of the unusual amino acid 3-hydroxy-5-
methyl-O-methyltyrosine (Fu et al. 2009). Another interesting example of a 
widespread NRPS gene cluster is the case of the antitumor compounds 
didemnins, initially isolated from the marine Caribbean tunicate Trididemnum 
solidum and recently described by several authors as a bacterial compound 
produced by free living Alphaproteobacteria (Tsukimoto et al. 2011; Xu et al. 
2012). This includes the isolation of several strains belonging to the Tistrella 
genus during PharmaMar’s program for isolation of marine bacteria 
(PharmaMar, personal communication). 
 
Technical and biological advances, especially with the sequencing of 
cancer genomes and analysis of tumor cell transcriptions, have provided new 
insights into the molecular basis and classification of tumor phenotypes. The 
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knowledge emerged from systematic cancer genome characterization during 
the last decades not only allows the discovery of new targets for target-based 
drug discovery programs, but also enables the definition of relevant and 
predictive phenotypic end points and cellular models for phenotypic screens 
(Moffat et al. 2014). 
 
Some types of screening are in an intermediate category termed 
‘mechanism-informed phenotypic drug discovery’ (MIPDD) where the 
mechanism of action can be detected by a specific phenotype. Moffat et al. 
(2014) have reviewed the screening origins of new small-molecule cancer drugs 
approved by the FDA between 1999 and 2013, as shown in Table 2. 
 
For the 47 oncology NMEs (New Molecular Entities) approved by FDA 
between 1999 and 2013, the majority (30 compounds) originated from target-
based drug discovery, seven originated from MIPDD and 10 originated from 
phenotypic screens. If the group of kinase inhibitors (21 compounds, 
highlighted in bold) is excluded, a higher number of drugs were discovered by 
mixed or phenotypic screening approaches. 
 
Phenotypic assays have the advantage of identifying drug leads and 
clinical candidates that are more likely to possess therapeutically relevant 
molecular mechanisms of action (MMOAs) and clinical efficacy (Moffat et al. 
2014; Swinney 2013). However, target-based approaches have also been 
prominent in the past two decades, particularly those directed against 
oncogenic kinases (Hoelder et al. 2012; Zhang et al. 2009) and have resulted in a 
new generation of anticancer agents with fewer side effects and impressive 
results in clinical trials. 
  
Chapter 6 ⎪ Research articles. Article 1 
81 
 
6.2.4 Screens for novel drug candidates for Alzheimer’s and Parkinson’s 
disease. 
Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s 
disease (PD) cause serious public health problems due to the exponential 
increase in incidence of the diseases with age. The currently approved drugs for 
treatment only provide symptomatic relief to mild AD patients and do not stop 
progression of the disease. Therefore novel drug candidates are of great interest 
and besides the chemical synthesis of compounds natural compounds are again 
becoming of interest, including those of marine origin.  
 
The difficulty in this area of drug research is the lack of validated 
therapeutic targets. In the absence of a target or in complex mechanisms like the 
human brain a drug screening method is almost impossible to set up. An 
alternative may come from phenotypic chemical screens using a whole 
organism. The mouse Mus musculus is the most commonly used animal model. 
But the costs limit its use in large-scale therapeutic screening. Instead, small 
invertebrate models like Caenorhabditis elegans or Drosophila melanogaster are 
suitable models combining genetic amenability, low cost and culture conditions 
used in large-scale screenings (Giacomotto & Ségalat 2010). The invertebrate 
models bridge the gap between traditional high-throughput screenings and the 
validation in mammalian models. They allow identifications of new active 
compounds, targets or molecular mechanisms, which can be further used in 
traditional screening assays.  
 
Using live animals it is possible to screen bioactive compounds that are 
able to induce a certain phenotype (e.g. paralysis or fluorescence) or reverse an 
abnormal phenotype (e.g. ß-amyloid deposits, also known as plaques) to the 
wild-type phenotype (Arya et al. 2010). ß-amyloid and α-synuclein are 
aggregation-prone proteins typically associated with AD and PD, where the 
misfolding and accumulation of these proteins lead to neuronal cell death 
(Marsh & Blurton-Jones 2012). In order to discover novel drugs against AD and 
PD, marine derived extracts and compounds are screened for their effect 
against ß-amyloid and α-synuclein toxicity, with the proteins being 
transgenetically expressed in different strains of C. elegans in a high-throughput 
system (Sealife Pharma, Austria, personal communication). The transgenic 
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strains display different phenotypes allowing for direct detection of effect of the 
tested compound. For example, toxicity of soluble oligomers can be measured 
by a phenotypic read out because upshift of temperature leads to expression of 
ß-amyloid in muscle cells of the worms, which in turn get paralyzed. 
Alternatively, expression of toxic ß-amyloid or α-synuclein can be measured 
using a plate reader, because the proteins are coupled to fluorescent proteins 
like GFP or YFP. The ability of unknown compounds to prevent plaque 
building can be assessed because plaques can be stained with the fluorescent 
dye Thioflavin T and visualized using a fluorescence microscope. Fluorescence 
can also be used to detect expression of the reporter protein GFP in 
dopaminergic neurons. By using the neurotoxic molecule MPP+ (1-methyl-4-
phenylpyridinium), which leads to neuronal cell death as it occurs in PD it is 
therefore possible to detect compounds, which are able to reverse neuronal cell 
death. Positive controls, which are compounds protective against ß-amyloid 
toxicity, include coffee extract (Dostal et al. 2010), thioflavin T (Alavez et al. 
2011), and reserpine (Arya et al. 2009), which are all known to protect C. elegans 
from ß-amyloid peptide toxicity.  
 
7. CHEMICAL DEREPLICATION, COMPOUND PURIFICATION AND 
STRUCTURE ELUCIDATION 
When interesting lead activities have been detected in the bioassays 
described above, a key challenge is to isolate and identify the compound(s) 
responsible for the activity. As for the screening process, several strategies are 
possible, depending on the starting material and to which level the compound 
needs to be identified.   
 
An example of a strategy to identify bioactive fractions followed by 
identification of the bioactive compound is the Explorative Solid-Phase (E-SPE) 
strategy, where microbial extracts are loaded into columns whose stationary 
phases display different functionalities; the eluted fractions are tested in a 
bioassay and results are organized in a bioactivity matrix. The pattern of the 
matrix gives indications about size and functional groups of the bioactive 
compounds, accelerating both the dereplication and isolation process, as 
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demonstrated for the extracts from Pseudoalteromonas luteoviolacea and 
Penicillum roqueforti (Mansson et al. 2010).  
 
A key step to avoid rediscovery of already known compounds is 
dereplication. The identification of already known compounds occurs 
frequently, even in microorganisms not belonging to the same species (Egan et 
al. 2001; Ginolhac et al. 2005; Jin et al. 2006; Ziemert et al. 2014). Dereplication 
relies on analytical methods like LC-UV, LC-MS, LC-MS/MS, and LC-NMR, 
compound databases and, in recent years, metabolomics, molecular 
networking, and genome mining (El-Elimat et al. 2013; Helfrich et al. 2014; 
Tawfike et al. 2013; Vynne et al. 2012; Yang et al. 2013). Experimental data like 
UV profiles or fragmentation patterns are searched against databases such as 
PubChem, ChemSpider, AntiBase, or the Dictionary of Natural Products 
(170,000 entries as of July 2015). With increased focus on the marine 
environment as a reservoir of natural compounds, a number of databases 
containing only compounds of marine origin has become available, e.g. the 
Dictionary of Marine Natural Products (http://dmnp.chemnetbase.com) and 
MarinLit (http://pubs.rsc.org/marinlit/). However, research groups often 
developed their own dereplication strategies, databases and tools, see for 
example Klitgaard et al. (2014), Macintyre et al. (2014), and Kildgaard et al. 
(2014).  
 
When a desired bioactivity is observed in an extract or a fraction thereof, 
the active compound should be purified in order to proceed to structure 
elucidation. As in the case of extraction of crude extracts, it is important to 
develop an isolation protocol that considers the physical and chemical nature of 
the compound, particularly its lipophilic and hydrophilic characters (Ebada et 
al. 2008). Qualitative tests like thin-layer chromatography (TLC) can be 
performed to gather information about its polarity, charge, size, solubility and 
acid-base properties, and such tests are able to indicate the most suitable 
chromatographic technique. 
 
For low to medium polarity compounds, column chromatography (CC, 
normal or reverse phase) or high performance liquid chromatography (HPLC) 
is often preferred to produce a pure compound, whereas for high polarity 
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compounds, reverse phase CC with elution in H2O/MeOH followed by another 
round of CC with a hydrophobic matrix, size-exclusion chromatography or 
HPLC is preferred (Ebada et al. 2008).  
Once a pure compound has been produced, the compound is most often 
subjected to another round of bioactivity assaying to confirm its bioactivity, 
before continuing to structure elucidation. Structure elucidation can be carried 
out by either stereochemistry methods or by spectroscopic methods (Ebada et 
al. 2008). The latter includes mass spectrometry (MS) and nuclear magnetic 
resonance spectroscopy (NMR), which is one of the most commonly used and 
versatile techniques for elucidation of the structure of organic compounds 
(Fuloria & Fuloria 2013; Kwan & Huang 2008). One of the possible approaches 
in natural products discovery from culturing of the microbial producer to 
structure elucidation by NMR of the bioactive compound is exemplified in 
Figure 4. 
 
8. CONCLUDING REMARKS 
Bioprospecting for natural products is in rapid development, especially 
within marine microbiology. The discovery of novel bioactive compounds 
continues to pose innovative and (bio)technological challenges. Recent 
advances in microbial cultivation techniques, genomics, molecular biology, and 
tools for chemical analyses and dereplication, mean that an ever expanding and 
diverse toolbox is becoming available for bioprospecting. These new tools, in 
combination with biological assays and the genetic analysis of organisms, 
means that marine bioprospecting is entering a new era. A key question in 
bioprospecting is “where to search?” for novel bioactive molecules and the 
marine environment is due to its chemical and physical uniqueness a promising 
source of novel chemistry. Whilst marine eukaryotic macro-organisms were the 
first to be analyzed and provided us with several compounds with therapeutic 
properties, we are now realizing that many of these metabolites are actually of 
bacterial origin and, hence, the marine microbial world is re-emerging as a 
promising source for bioprospecting.  
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TABLES AND FIGURES 
 
Table 1. Natural products discovers through metagenomic approaches. 
Modified from Barone et al. (2014). 
 
Compound Source Type of screening 
Onnamide A Theonella swinhoei, bacterial symbiont Sequence-based  
Bryostatin Bugula neritina, bacterial symbiont Sequence-based  
Minimide Didemnum molle, microbiome Sequence-based  
Apratoxin A Lyngbya bouillonii Sequence-based  
Patellamides Lissoclinum patella Function-based  
Zn-coproporphyrin III Discodermia calyx Function-based  
 
Table 2. Origin of new small-molecule cancer drugs approved by the FDA 
between 1999 and 2013. Kinase inhibitors are highlighted in bold. Information 
on the drugs to be analyzed was obtained from the (FDA) website. *First-in-
class therapeutics. Modified from Moffat et al. (2014). 
 
Lead Discovery 
Inhibition or modulation of 
target 
Mechanism-informed 
phenotypic screen 
De novo phenotypic 
screen 
Abiraterone*  
Bendamustine  
Bexarotene*  
Bortezomib*  
Clofarabine  
Decitabine  
Exemestane  
Temozolomide  
Enzalutamide  
Fulvestrant 
Lapatinib  
Nilotinib  
Pazopanib  
Ponatinib  
Regorafenib  
Afatinib  
Axitinib  
Bosutinib  
Cabozantinib  
Crizotinib*  
Dabrafenib  
Dasatinib  
Erlotinib  
Ibrutinib*  
Imatinib*  
Ruxolitinib*  
Sorafenib*  
Sunitinib* 
Vandetanib  
Vemurafenib* 
Epirubicin 
Ixabepilone 
Nelarabine 
Vismodegib* 
Cabazitaxel 
Pemetrexed 
Azacitidine* 
Carfilzomib 
Everolimus  
Temsirolimus 
Eribulin  
Omacetaxine*  
Lenalidomide  
Pomalidomide  
Romidepsin  
Vorinostat* 
Trametinib*  
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Figure 1. Structures of the antimicrobial compounds indigoidine and 
tropodithietic acid (TDA) derived from members of the marine Roseobacter 
clade. 
 
 
 
Figure 2. Structures of the anti-tumor compounds salinosporamide A and 
salinosporamide K derived from the marine bacteria Salinispora tropica and 
Salinispora pacifica, respectively. 
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Figure 3. Agar plate assay for screening for antimicrobial compounds 
containing a solid medium seeded with a target strain (here, the fish pathogen 
Vibrio anguillarum) on which four potential producer strains have been spotted. 
The clear halo surrounding the red colony in the bottom part of the picture 
indicates production of an antibacterial compound. 
 
 
Figure 4. Simplified HPLC-MS approach used for the analysis and separation of 
the different compounds present in the crude extract of a bacterial culture. The 
pure compounds can be used in bioassays and undergo several analyses for 
structure elucidation. 
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Abstract 
Many factors, such as substrate and growth phase, influence biosynthesis of 
secondary metabolites in microorganisms. Therefore, it is crucial to consider 
these factors when establishing a bioprospecting strategy. Mimicking the 
conditions of the natural environment has been suggested as a means of 
inducing or influencing microbial secondary metabolite production. The 
purpose of the present study was to determine how bioactivity of Vibrionaceae 
was influenced by carbon sources typical of their natural environment. We 
determined how mannose and chitin as compared to glucose influenced the 
antibacterial activity of a collection of Vibrionaceae strains isolated because of 
their ability to produce antibacterial compounds, but that in subsequent 
screenings seemed to have lost this ability. The number of bioactive isolates was 
two and 3.5 folds higher when strains were grown on mannose and chitin, 
respectively, as compared to glucose. As secondary metabolites are typically 
produced during late growth, potential producers were also allowed 1-2 days of 
growth before exposure to the pathogen. This strategy led to three-fold increase 
in the number of bioactive strains on glucose and eight-fold increase on both 
chitin and mannose. We selected two bioactive strains belonging to species 
where antibacterial activity had not previously been identified. Using UHPLC-
HRMS and bio-assay-guided fractionation, we found that the siderophore 
fluvibactin was responsible for the antibacterial activity of Vibrio furnissii and 
Vibrio fluvialis. These results suggest a role of chitin in the regulation of 
secondary metabolism in vibrios and demonstrate that considering bacterial 
ecophysiology during development of screening strategies will facilitate 
bioprospecting. 
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Significance 
A challenge in microbial natural product discovery is the elicitation of the 
biosynthetic gene clusters that are silent when microorganisms are grown 
under standard laboratory conditions. We hypothesized that since the clusters 
are not lost during proliferation in the natural niche of the microorganisms, 
they must, under such conditions, be functional. Here, we here demonstrate 
that an ecology-based approach in which the producer organism is allowed a 
temporal advantage and where growth conditions are mimicking the natural 
niche remarkably increases the number of Vibrionaceae strains producing 
antibacterial compounds.    
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Introduction 
Following the first era of discovery of bioactive compounds from natural 
sources, high throughput screenings of compound libraries produced by 
combinatorial chemistry and rational drug design were preferred over natural 
product discovery (1). Disappointingly, the discovery rate of this approach was 
much lower than expected and the lack of new leads triggered a return to 
search for novel bioactive molecules from microorganisms (1, 2).  
Recent progress in genome sequencing and mining has demonstrated a 
significant number and degree of diversity in microbial biosynthetic gene 
clusters. However, this potential can often not be unfolded and detected under 
standard laboratory conditions (3, 4) and, today, one challenge in discovery of 
natural products is to elicit these silent/cryptic biosynthetic gene clusters. The 
One Strain MAny Compounds (OSMAC) method, where strains are cultivated 
in a range of growth conditions, has been suggested as a solution (5). 
Secondary metabolites are likely to play many different roles in natural 
bacterial behavior, including antagonistic interactions and intercellular 
communication (6, 7). Hence, elicitation of the expression of silent biosynthetic 
gene clusters could rely on re-creating the natural environmental conditions in 
the research laboratory (8–10). With this in mind, Seyedsayamdost (11) 
demonstrated that two previously silent biosynthetic gene clusters in 
Burkholderia thailandensis could be elicited by low concentrations of molecules of 
microbial origin. Also, antibacterial compounds have been shown to be 
produced by marine bacteria only when they were cultivated under conditions 
mimicking their natural intertidal environment (12–14).  
Following the increasing interest in natural products from the marine 
environment during the last decades of the 20th century, several groups are 
now pursuing methods for the identification and production of natural product 
in marine microorganisms (15, 16). Our group took part in the global marine 
research expedition Galathea 3 (http://www.galathea3.dk) with the aim of, on a 
global scale, isolating marine bacteria with bioactivity potential. We cultured 
microorganisms on marine agar and subsequently screened all colonies for 
antagonism against the fish pathogen Vibrio anguillarum, which is very 
sensitive to antibacterial compounds produced by marine bacteria. We isolated 
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approximately three hundred bioactive Vibrionaceae strains (17). During re-
screening, only 39 strains retained their antagonistic activity (18).  We isolated 
the potent antibiotics holomycin and andrimid from V. coralliilyticus and 
Photobacterium galatheae, respectively (9, 18), as well as modulators of virulence 
in Staphylococcus aureus, such as ngercheumicins F, G, H, I (19), nigribactin (20) 
and solonamide B (21). However, we were challenged by the marked reduction 
in bioactivity during re-screening.  
We reasoned that one cause for this loss of activity could be that significant 
secondary metabolite production mostly occurs during the late exponential and 
in the stationary phase of microbial growth, and we hypothesized that the bio-
discovery rate could be increased if the producing organisms were allowed 
more time to grow before being exposed to the target organism. In the initial 
screening and isolation, colonies were allowed to grow for 3-5 days before 
being tested (17), but this temporal advantage was not given during the re-
screening (18). We also questioned whether the use of naturally co-occurring 
substrates such as mannose and chitin would restore bioactivity. Mannose is 
ubiquitous in the marine environment where it is commonly used by algae for 
protein glycosylation and production of extracellular polysaccharides (22, 23). 
Chitin is the most abundant organic molecule in the marine environment, being 
a component of the exoskeleton of crustacean and zooplankton (24). It is a 
polysaccharide composed of N-acetylglucosamine (GlcNAc) units. Vibrionaceae 
are considered among the major actors in marine chitin catabolism and the 
chitin utilization pathway is conserved within the family (25, 26). In V. cholerae 
chitin and derivatives can regulate the expression of genes involved in chitin 
metabolism (27) but also in biofilm formation and in virulence (28). In V. 
coralliilyticus, growth on chitin doubles the yield of the antibiotic andrimid in 
comparison to glucose (9). 
The aim of this study was to determine to which extent the use of substrates 
naturally present in the niche of isolation and the growth phase of the producer 
could restore (or induce) the biosynthesis of antibacterial compounds in a 
collection of 295 Vibrionaceae isolates. The number of antagonizing strains was 
greatly increased when the assay was performed on chitin and up to eight folds 
higher when the potential producers were given a temporal advantage over the 
target strain. 
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Material and methods 
Bacterial strains.  Two hundred and ninety-five Vibrionaceae strains were 
isolated during the Danish Galathea 3 global research expedition (17). Strains 
were selected based on their ability to inhibit the growth of Vibrio anguillarum 
and identified as Vibrionaceae based on their 16S rRNA gene sequences (17). 
Species affiliation of strains producing antibacterial extracts (see below), which 
had not been previously assigned to a species by multilocus sequence analysis, 
was carried out by analysis of the fur gene (29). The fur gene sequences were 
retrieved from whole genome sequences (WGSs) or sequencing of PCR 
products obtained as described elsewhere (29). 
Preparation of colloidal chitin. Colloidal chitin was prepared following a 
modified version of the method published by Hsu and Lockwood (30). Ten 
grams of practical grade shrimp shell chitin (Sigma C9213) was added to 400 
mL of 37% HCl at 4°C and stirred at this temperature for 6 hours. The solution 
was poured into 4 L of cold H2O and incubated overnight at 4°C, before it was 
neutralized with solid NaOH. After centrifugation (6000 g for 10 minutes), 
supernatant was discarded and the chitin pellet was suspended in 500 mL of 
H2O and autoclaved. The concentration of colloidal chitin was calculated from 
the dry weight (100°C) of a subsample.  
Screening of Vibrionaceae strains for antibacterial activity. Square Petri dishes 
containing 20 g/L Sea Salts (Sigma S9883), 3 g/L casamino acids (BD 223050), 15 
g/L agar (AppliChem A0949) and either 2 g/L of colloidal chitin or 2 g/L of 
mannose were prepared. As control, the same was done with the same medium 
used in the original screening procedure (30 g/L Instant Ocean, 3 g/L casamino 
acids, 4 g/L glucose, 10 g/L agar) (17). Bacterial strains were grown overnight, 
aerated (200 rpm) at room temperature in half strength YTSS (½ YTSS) (31). One 
microliter of each culture was spotted onto the three media. On each plate 35 
strains were spotted in rows, where the distance between two strains was 20 
mm horizontally and 15 mm vertically. Each plate was produced three times. 
On one plate, 1 µL of an overnight culture of the target strain Vibrio anguillarum 
90-11-287 grown in ½ YTSS was spotted simultaneously at a distance of 5 mm 
from the potential producers of antimicrobial compound. On the second copy 
of each plate an identical process was performed after 24 hours and on a third 
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plate after 48 hours. Plates were incubated at 25°C and examined 24/48 hours 
after the target strain had been spotted. A biological replicate was performed 
for the isolates being bioactive in the first screening.  
In silico analysis of the distribution of chiS and (GlcNAc)2 operon. The chiS 
(VC0622) gene and the (GlcNAc)2 operon (VC0611-VC0620) of Vibrio cholerae 
were searched against a custom-built database using MultiGeneBlast (32). For 
the preparation of the database, genome sequences were downloaded from the 
GenBank database (Figures 2 and 3). 
Extraction of bioactive compounds from liquid cultures. All strains showing a 
consistent bioactivity were grown aerated (200 rpm) in 10 ml of 2% Sigma Sea 
Salts solution with 0.3% casamino acids and 0.2% colloidal chitin (SSBC) for 48 
hours at 25°C. Cultures were extracted with an equal volume of HPLC-grade 
ethyl acetate (EtOAc) for 20 minutes. The organic phase was transferred to fresh 
vials and evaporated until dryness under a stream of nitrogen. Extracts were 
dissolved in 250 µL methanol (MeOH) and stored at -20°C until further 
analysis. The activity of the extracts against Vibrio anguillarum 90-11-287 was 
tested in a well diffusion agar (WDA) assay (33).  
Genome sequencing and bioinformatics analysis. High purity DNA was 
obtained for V. furnissii S0821 and V. fluvialis S1110 by repeated 
phenol:chloroform:isoamyl alcohol purification  followed by RNase treatment 
and DNA precipitation, as described previously (34). Quantification was 
performed on a NanoDrop Spectrometer (Saveen Werner, Sweden) and a Qubit 
2.0 Analyzer (Invitrogen, United Kingdom). Construction of 500 bp libraries 
and 100 bp paired-end sequencing of genomes were performed by the Beijing 
Genome Institute (Hong Kong) on a HiSeq2000. Sequencing data were 
assembled to contigs in CLC Genomic Workbench (CLC Bio, Aarhus, Denmark) 
using the de novo assembly algorithm. The draft genomes of strains S0821 and 
S1110 were annotated with the NCBI Prokaryotic Genome Annotation Pipeline 
(PGAP) (35) and submitted to antiSMASH 2.0 (36) and BAGEL3 (37) for 
analysis of biosynthetic gene clusters. 
UHPLC-HRMS. Ultra-high Performance Liquid Chromatography-High 
Resolution Mass Spectrometry (UHPLC-HRMS) was performed on an Agilent 
Infinity 1290 UHPLC system (Agilent Technologies, Santa Clara, CA, USA) 
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equipped with a diode array detector. Separation was obtained on an Agilent 
Poroshell 120 phenyl-hexyl column (2.1 × 250 mm, 2.7 µm) with a linear 
gradient consisting of H2O (A) and acetonitrile (B) both buffered with 20 mM 
formic acid, starting at 10% B and increased to 100% in 15 min where it was 
held for 2 min, returned to 10% in 0.1 min and remaining for 3 min (0.35 
mL/min, 60 °C). An injection volume of 1 µL was used. MS detection was 
performed on either an Agilent 6545 QTOF MS equipped with Agilent Dual Jet 
Stream electrospray ion source with a drying gas temperature of 160 °C, gas 
flow of 13 L/min, sheath gas temperature of 300 °C and flow of 16 L/min, or an 
Agilent 6540 QTOF MS equipped with Agilent Dual Jet Stream electrospray ion 
source with a drying gas temperature of 250 °C, gas flow of 8 L/min, sheath gas 
temperature of 300 °C and flow of 12 L/min. Capillary voltage was set to 4000 V 
and nozzle voltage to 500 V. Mass spectra were recorded at 10, 20 and 40 eV as 
centroid data for m/z 85–1700 in MS mode and m/z 30–1700 in MS/MS mode, 
with an acquisition rate of 10 spectra/s. Lock mass solution in 70:30 MeOH:H2O  
was infused in the second sprayer using an extra LC pump at a flow of 15 
µL/min using a 1:100 splitter. The solution contained 1 µM tributylamine 
(Sigma-Aldrich) and 10 µM Hexakis(2,2,3,3-tetrafluoropropoxy)phosphazene 
(Apollo Scientific Ltd., Cheshire, UK) as lock masses. The [M + H]+ ions (m/z 
186.2216 and 922.0098 respectively) of both compounds was used.  
Influence of culture conditions on bioactivity and characterization of the 
antibacterial compound. Extracts from the cultures V. furnissii S0821 and V. 
fluvialis S1110 were analyzed by UHPLC-HRMS as described above. Extracts 
from the strains grown in SSBC supplemented with 0.1 g/L ferric citrate were 
also prepared and analyzed. For the bioassay-guided fractionation, fifty 
cultures of strain S0821 grown in 10 mL SSBC for 48 hours were extracted with 
equal volume of EtOAc, extracts were pooled together and evaporated until 
dryness under nitrogen. Portions of the pooled S0821 culture extracts were 
fractionated by Mixed-Mode Anion Exchange SPE on an Oasis MAX cartridge 
(Waters, Milford, MA, 30 µm, 30 mg, 1 mL). The sample was dissolved in 400 
µL of 3:1 H2O:MeOH containing 2% ammonium hydroxide then directly loaded 
onto a conditioned SPE column. The column was sequentially eluted with 2 mL 
of 3:1 H2O:MeOH (F1), 2 mL of 1:1 H2O:MeOH (F2), 2 mL of MeOH (F3), 1 mL 
of H2O and 1 mL of 3:1 H2O:MeOH containing 1% formic acid (F4), 2 mL of 1:1 
H2O:MeOH containing 1% formic acid (F5) and finally 2 mL of MeOH 
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containing 1% formic acid (F6). The fractions were dried under a stream of 
nitrogen before being resuspended in 200 µL MeOH. Fractions were tested for 
antibacterial activity in a WDA assay and for siderophore activity in a Chrome 
Azurol S (CAS) assay (38). Extracts were mixed with CAS solution in 1:1 ratio 
and the color change from blue to orange, indicating siderophore activity, was 
checked after 15 minutes and 24 hours. 
Nucleotide sequences accession numbers. Sequence data generated in this 
study were deposited in GenBank under accession numbers LKHS00000000 
(WGS of strain S0821), LKHR00000000 (WGS of strain S1110) and KT952522-26 
(fur gene sequences of strains S1162, S1732, S2054, S2056 and S2150, 
respectively). 
 
Results 
Screening of strains for antibacterial activity. Of the 295 Vibrionaceae strains, 
four isolates antagonized V. anguillarum when grown on the glucose medium, 
six when grown on the mannose medium and eleven when grown on the chitin 
medium using a procedure where the potential producers were not given any 
temporal advantage over the target strain. When the target strain was spotted 
twenty-four hours after the potential bioactive strains, six isolates were 
bioactive on glucose, nineteen on mannose and seventy-eight on chitin. Twenty-
six, forty nine and ninety-one strains were bioactive on glucose, mannose and 
chitin, respectively, when the target strain was spotted with a forty-eight hour 
delay (Figure 1). Examples of one plate and of the behavior of one strain (V. 
furnissii S0821) over time on the mannose and the chitin-based media are shown 
in Figure S1. 
Ethyl acetate extracts from the 91 antagonizing strains grown in chitin 
containing liquid medium for 48 hours were tested in a well-diffusion assay 
against V. anguillarum. Extracts from V. coralliilyticus (strains S2043, S2052, 
S2054, S2056 and S4053), V. nigripulchritudo (S2601, S2600 and S2604), V. fluvialis 
(S1110 and S1162), V. furnissii (S0821) and two Vibrio sp. (S1732 and S2150) 
inhibited the growth of V. anguillarum (Table 1). The strongest inhibition (i.e. the 
largest inhibition zone) was observed in extracts from the V. coralliilyticus 
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strains. The extracts from the V. furnissii and V. fluvialis strains were moderately 
growth inhibitory based on the size of the clearing zone. The remaining extracts 
exhibited a weak antibacterial activity. 
Distribution of chiS and (GlcNAc)2 operon. Given the pronounced increase in 
bioactivity when chitin was used as growth substrate, we speculated that this 
could be due to simple substrate change (e.g. catabolite repression) or to a direct 
involvement of chitin in the regulation. Since chitin is indeed involved in 
regulation of phenotypes in Vibrio species (27, 39–41), we addressed the possible 
chitin-dependent regulation of secondary metabolism in Vibrionaceae, possibly 
through the ChiS regulatory system (see discussion). Therefore, we investigated 
the distribution of the chiS gene and of the (GlcNAc)2 operon  in thirty-three 
genomes of vibrio species belonging to eight of the seventeen proposed Vibrio 
clades (42) and to three of the four proposed Photobacterium clades (42).  In total, 
twenty-two Vibrio and eleven Photobacterium genomes were included in the 
analysis. This choice was driven by the quantity and the quality of the publicly 
available genome sequences. MultiGeneBlast-based analysis showed that the 
chiS gene and the complete (GlcNAc)2 operon are widely distributed in both 
Vibrio and Photobacterium species, both being present in all analyzed species 
(Figure 2 and 3).  
Genome mining of Vibrio furnissii and Vibrio fluvialis. Contig-based draft 
genomes of V. furnissii S0821 and V. fluvialis S1110 were obtained by assembling 
the sequencing data in CLC Genomics Workbench. The genome size was 5.0 Mb 
for V. furnissii S0821 and 4.5 Mb for V. fluvialis S1110. antiSMASH analysis of the 
genomes found six putative biosynthetic gene clusters in V. furnissii S0821 and 
five in V. fluvialis S1110 (Table 2). Due to the phylogenetic relatedness of V. 
furnisii and V. fluvialis (42) and the similarity of the antiSMASH results for the 
two strains, we thought it likely that the antibacterial activity of the two extracts 
could be due to the same compound(s).  
Both genomes harbored a biosynthetic gene cluster for the production of the 
quorum sensing auto-inducer molecules acyl-homoserine lactones (AHLs) and 
biosynthetic gene clusters with a relatively high gene similarity to those for the 
biosynthesis of ectoine, vibriobactin and aryl polyenes. A cluster for bacteriocin 
production was identified in both strains, but the bacteriocin prediction tool 
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BAGEL3 was not consistent with the antiSMASH results. Although BAGEL3 
did predict the presence of one bacteriocin gene cluster, it differed from the one 
predicted by antiSMASH. A BLAST-based homology search using the 
bacteriocin amino acid sequences predicted in the two genomes (Table S1) as 
queries revealed a high similarity (E value=0, homology>98%) with 
endopeptidases from the M23 superfamily involved in cell wall biogenesis.  
Investigation on the antibacterial compound produced by Vibrio furnissii and 
Vibrio fluvialis. There are no reports in the literature describing antibacterial 
compounds in V. furnissii and V. fluvialis. Given the importance of these two 
species as human pathogens (43, 44), we focused on these strains to determine 
the nature of the compound(s) responsible for the activity. Working under the 
hypothesis that these closely related species likely produced similar 
antimicrobial compounds, the bioactive extracts were dereplicated through a 
two phase approach: first, by comparison with extracts from cultures of related 
strains, which did not display bioactivity in the well diffusion assay. 
Compounds that were found in both the active and inactive strains were 
assumed to not be responsible for the observed antibacterial activity. The 
remaining unassigned compounds were further dereplicated by searching for 
all known compounds produced by Vibrio species found in AntiBase 2012, 
MarinLit 2012 and The Dictionary of Natural Products. Analysis of the 
dereplicated UHPLC-HRMS data revealed the presence of an abundant 
compound with ions at m/z 623.2342 [M+H]+ and 645.2158 [M+Na]+ in extracts 
from cultures of V. furnissii S0821 and V. fluvialis S1110 which was tentatively 
identified as the siderophore fluvibactin based on the accurate mass (mass 
deviation 0.96 ppm). Subsequent MS/MS analysis, comparison with the 
literature UV spectrum as well as isolation and NMR analysis confirmed this 
assignment (Figures S2-S5 and Tables S2-S3). The UHPLC-HRMS analysis also 
found another abundant ion with m/z 404.1818, which was assigned to the 
known compound 4 (N,N-bis-(2,3-dihydroxybenzoyl)-norspermidine (mass 
deviation 0.49 ppm) (Figure 4A and 4B).  
These compounds (fluvibactin and compound 4) were not detected when 
extracts were prepared from V. furnissii S0821 and V. fluvialis S1110 grown in 
chitin medium supplemented with 0.1 g/L of ferric citrate (Figure S6). These 
extracts were not inhibitory against V. anguillarum 90-11-287 (Figure S7). The 
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bioactive extract was then divided into fractions by Mixed-Mode Anion 
Exchange SPE. Only the extract fraction containing the putative fluvibactin was 
inhibitory to V. anguillarum (Table 3 and Figure S8). A Chrome Azurol S assay 
performed on the same fraction confirmed the siderophoric nature of the 
compound (Table 3). The use of anion exchange chromatography allowed for 
the separation of fluvibactin from N-(3-oxo-decanoyl-L)-homoserine lactone (O-
C10-HSL), which co-eluted under the reverse phase conditions used for 
UHPLC-HRMS analysis. Fractions containing the AHL (F3) (Figure S6) did not 
show bioactivity and the AHL was also found to be present in non-bioactive 
iron supplemented cultures (Figure S7). O-C10-HSL was identified based on 
accurate mass, retention time and the characteristic homoserine fragment ion at 
m/z 102.0549 ion (45).     
 
Discussion 
We investigated to what extent culture parameters could affect (restore or 
induce) the production of antibacterial compounds in a collection of marine 
Vibrionaceae whose members were initially isolated based on their ability to 
antagonize the fish pathogen V. anguillarum. However, in later re-screenings, 
only approximately 10% of them retained the activity. With the use of 
substrates typical to the natural niche of isolation and allowing potential 
producer strains to reach a late growth phase, we could restore the bioactivity 
in one third of the strains. Allowing V. fluvialis and V. furnissii to reach a late 
growth phase before exposure to the target strain led to the identification of the 
siderophore fluvibactin as responsible for their antibacterial activity.  
Different carbon sources can lead to significantly different profiles in microbial 
secondary metabolism (5, 9, 46). In our investigation, we used three molecules 
(glucose, mannose and chitin) that are abundant in the marine environment (22, 
24) as substrate for marine Vibrionaceae. The number of bioactive (antibacterial) 
strains was nearly two and 3.5-fold higher when mannose and chitin were used 
as carbon-source, respectively, as compared to glucose.  
The high efficacy of chitin in restoring (or inducing) the production of 
antibacterial compounds in the tested strains is in agreement with the ecology 
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and lifestyle of Vibrionaceae that are adapted to live in marine niches richer in 
this polysaccharide than in other carbohydrates (25, 26). Indeed, vibrios are well 
known for their association with chitin-rich biotic surfaces, such as zooplankton 
(24, 47). Chitinase genes and the chitin utilization pathway are conserved in 
Vibrionaceae (25, 26), and natural competence is induced by chitin in V. vulnificus 
(48) and V. cholerae (49).  In the latter, chitin affects also chitin catabolism (27), 
biofilm formation and virulence (28, 50).  
Chitin-dependent regulation of secondary metabolism mediated by the 
transcriptional regulator DasR occurs in the soil bacterium Streptomyces 
coelicolor A3(2) (51). In vibrios, one possible mechanism for a similar regulation 
could be through the two-component histidine kinase sensor ChiS, which has 
been characterized in Vibrio cholerae and is activated by chitin derived 
oligosaccharides (27). In the proposed model, a putative cognate receptor 
regulates the expression of target genes involved in the above-mentioned 
phenomena (27). Hunt and colleagues (25) suggested that genes with high 
homology to chiS (VC0622) and to some of the genes from the downstream 
(GlcNAc)2 operon (VC0611-VC0613 and VC0616-VC0619) are widespread 
among Vibrionaceae. However, their genome analysis included a limited number 
(ten) of species, possibly due to low availability of genome sequences at the 
time the study was conducted. We performed a broader analysis and showed 
that, indeed, both chiS and the complete (GlcNAc)2 operon (VC0611-VC0620), 
which were detected in all analyzed genomes, are very conserved and maintain 
their topological organization in Vibrio and Photobacterium species (Figures 2 
and 3). The (GlcNAc)2 operon includes the gene encoding for the periplasmic 
(GlcNAc)2 binding protein which inactivates ChiS when chitin is not present in 
the environment (27). Given its importance in V. cholerae, such a degree of 
conservation of genes hypothesized to be involved in the ChiS regulatory 
system in Vibrionaceae indicates that chitin could serve a regulatory role in the 
whole family. Certainly, chitin-dependent regulation of phenomena such as 
biofilm formation and biosynthesis of antibacterial compounds would be 
advantageous during competition for nutrients with other microorganisms in 
the marine environment. 
Although the use of chitin restored or induced the production of antibacterial 
compounds in approximately one third of the isolates, this approach was not 
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effective with the majority of the strains, even when they were allowed longer 
time before exposure to the target strain. Induction of silent/cryptic biosynthetic 
gene clusters has been achieved by exposing bacteria or fungi to small 
molecules produced by naturally co-occurring microorganisms (11, 52, 53). 
Similarly, it is likely that molecules that were present in the local seawater used 
to prepare the medium for the original screening/isolation procedure or that 
were produced by strains that were tested on the same plate (“co-cultivated”) 
might have elicited the biosynthesis of antibacterial compounds. Co-cultivation 
could therefore also be a strategy to be used to induce the production of 
antibacterial compounds in our strain collection. 
 
Extracts of cultures from V. furnissii S0821 and V. fluvialis S1110 had 
antibacterial activity against V. anguillarum. The bioactivity was present in all 
tested media, however on chitin the antagonistic activity could be observed 
earlier than on the other media (data not shown). Genome analysis of the 
strains provided a list of four biosynthetic gene clusters potentially responsible 
for the biosynthesis of the antibacterial compound. Three of them (AHL, ectoine 
and arylpolyenes) could be excluded as the cause of bioactivity through testing 
of pure standards in WDA and analysis of UV/Vis spectra of the extracts 
(Figures SI8- SI9). 
The remaining predicted biosynthetic gene cluster had 72% gene similarity to 
the biosynthetic gene cluster for the catechole siderophore produced by V. 
cholerae vibriobactin(54). Due to the phylogenetic relatedness of V. furnissii and 
V. fluvialis with V. cholerae (42), we hypothesized that the identified biosynthetic 
gene cluster encodes for the fluvibactin non-ribosomal peptide synthetase. 
Fluvibactin is a siderophore produced by V. fluvialis (55), which differs from 
vibriobactin only in that it contains a single L-threonine residue rather than two 
(Figure 4). Siderophores similar to fluvibactin can inhibit bacterial and fungal 
growth (20, 56), and catechol iron chelators have also been suggested to protect 
bacteria from oxidative stress (57, 58). Hence, beside the competitive advantage 
during surface colonization due to the antibacterial activity of fluvibactin, 
producers of this compound might as well be protected from oxidative stress, 
which is a prevalent phenomenon in the marine environment (59). 
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Conclusion. We have shown that a rational choice of substrates typical of the 
niche of isolation of microorganisms is a valid cultivation strategy to enhance 
the numbers of bioactive strains in a screening step. Our results suggest a role 
of chitin in the production of secondary metabolism in Vibrionaceae. The 
genomes of members of this family of bacteria harbor great potential for chitin 
catabolism. Hence, genomic studies could predict which substrates other 
families of microorganisms might prefer and, subsequently, lead to the 
elicitation of biosynthetic gene clusters. Also, allowing the potential producing 
strain a temporal advantage (reaching stationary phase) is an important aspect 
to consider when designing a screening strategy. 
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Table 1. Antibacterial activity of 13 ethyl acetate extracts against V. anguillarum 
shown as the diameter of clearing zones (+: between 1 and 15 mm; ++: between 
16 and 25 mm; +++: over 25 mm). 
Strain Species Inhibition of V. anguillarum 
S0821 V. furnissii ++ 
S1110 V. fluvialis ++ 
S1162 V. fluvialis ++ 
S1732 Vibrio sp. + 
S2043 V. coralliilyticus +++ 
S2052 V. coralliilyticus +++ 
S2054 V. coralliilyticus +++ 
S2056 V. coralliilyticus ++ 
S2150 Vibrio sp. + 
S2600 V. nigripulchritudo + 
S2601 V. nigripulchritudo + 
S2604 V. nigripulchritudo + 
S4053 V. coralliilyticus +++ 
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Table 2 Potential for the production of secondary metabolites from V. furnissii 
S0821 and V. fluvialis S1110 based on AntiSMASH (upper part of the table) and 
Cluster Finder algorithms (lower part of the table). In the “Similarity” column, 
the percentages on the left and on the right sides of each slash refer to V. 
furnissii S0821 and to V. fluvialis S1110, respectively. BGC: biosynthetic gene 
cluster; NRPS: non-ribosomal peptide synthetase; APE: arylpolyene 
 
* for V. furnissii S0821: two clusters with 29% gene similarity to the O&K antigen BGC; 
for V. fluvialis S1110:  two clusters with 3 and 18% gene similarity to the O&K antigen 
BGC ¤ for V. furnissii S0821: one cluster with 4% gene similarity to the xantholipin BGC; 
for V. fluvialis S1110: one cluster with 14% gene similarity to the O-antigen BGC and one 
cluster with 36% gene similarity to the vibrioferrin BGC 
  
Algorithm 
 
Type of 
cluster 
# clusters 
Similarity V. furnissii 
S0821 
V. fluvialis 
S1110 
A
nt
iS
M
A
SH
 
Hserlactone 1 1  
Ectoine 1 1 66/66% ectoine BGC 
NRPS 1 1 72/72% vibriobactin BGC 
Arylpolyene 1 1 90/75% APE BGC 
Bacteriocin 1 1  
Other 
1 0 
5% lipopolysaccharide 
BGC 
C
lu
st
er
 F
in
de
r Saccharide 2 3 * 
Putative 8 9 ¤ 
Fatty acid 2 2  
Saccharide-
Fatty acid 
1 1 
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Table 3. Siderophore (column “CAS assay”) and antibacterial activity of the 
raw extract from a culture of V. furnissii S0821 and of the six derived fractions 
(F1-F6). The addition of a siderophore to the CAS solution causes a change in 
color from dark blue to orange-yellow. Activity against V. anguillarum is 
measured as the diameter of inhibition zones. 
Sample CAS assay Inhibition zone (mm) 
Raw extract Yellow 20 
F1 Blue - 
F2 Blue - 
F3 Blue - 
F4 Blue - 
F5 Dark orange 9 
F6 Yellow 23 
Blank Blue - 
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Figure 1. Number of bioactive Vibrionaceae strains (of 295 in total) on glucose 
(rhombus), mannose (square) and chitin (triangle) allowing 0, 24 and 48 hours 
pre-growth of the potential producer before exposing the target strain, Vibrio 
anguillarum. 
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Figure 2.Distribution of the chiS gene and of the (GlcNAc)2 operon among Vibrio 
spp.. GenBank/EMBL/DDBJ accession numbers of the used genomes are 
indicated in brackets.  
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Figure 3.Distribution of the chiS gene and of the (GlcNAc)2  operon (VC0611-
VC0620) among Photobacterium spp.. GenBank/EMBL/DDBJ accession numbers 
of the used genomes are indicated in brackets. 
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Figure 4 (A) Structures of vibriobactin (1) (54), fluvibactin (2) (55), 3 and 4. (B) 
UHPLC-HRMS Total Ion Chromatogram (TIC) of the culture extract from V. 
furnissii. The peaks assigned to fluvibactin (2) and compound 4 are highlighted.  
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Figure S1. (A) Example of a plate prepared spotting the potential producers 
(PP) and the target strain V. anguillarum (T) on chitin medium. Clear haloes 
surrounding the colonies indicate chitinolytic activity. (B) Detailed behavior of 
V. furnissii S0821 over time and on the two media. “Control” is the target strain 
spotted alone on the same two media. 
 
 
Figure S2 UV/Vis spectra of fluvibactin.  
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Figure S4 Proposed fragments of fluvibactin.  
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Figure S5 1D 1H NMR spectrum of fluvibactin at 800 MHz. 
 
Figure S6 EIC of fluvibactin for S0821 and S1110 grown with and without iron 
supplementation.  
S0821	with	Iron
supplementation
S1110	with	Iron
supplementation
S0821	without Iron
supplementation
S1110	without Iron
supplementation
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Figure S7 Test of the antibacterial activity of ethyl acetate extracts obtained 
from cultures of V. furnissii S0821 and V. fluvialis S1162 grown in presence (top 
panel) and in absence (lower panel) of Fe(III). 
 
Figure S8 EIC of fluvibactin in SPE fractions from V. furnissii S0821 culture.  
S0821	crude
F1
F2
F3
F4
F5
F6
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Figure SI 9 Assessment of antibacterial activity of ectoine (Fluka 81619, 
dissolved in sterile milliQ water). 50 µL of 10, 20, 40, 80 mg/mL solutions were 
transferred to wells punched in solid medium seeded with V. anguillarum 90-11-
287. No growth inhibition of the pathogen was observed after 48 hours of 
incubation of the plate at 25 °C.  
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Table S1 Amino acid sequences of the putative bacteriocins predicted by Bagel3 
based on the analysis of the genomic sequences of V. furnissii S0821 and V. 
fluvialis S1110.  
Species Strain Pfam Predicted	amino	acid	sequence
V.	furnissii	 S0821 Peptidase_M23
VAALSSSLSNPSYPRKIELSIPESHIVESILSETTEPRQSYPDYEYEIKSGDNLSTI
FNQLGFSYQELMKIMETDLNYLALDTLKPGNVLRFWRSQDGRSLAKMELK
FSLVERAVYVRTDDGSFEFKDVKIPGTWKEYPLIGEIQGSFSQSANQLGLGS
SDIDQIVTLLKDKINFVRDVRAGDRFEVVLSRQFVGDQLTGNSEIQAIKIFSR
SNDVTAYLYKDGQYYDKNGESLQRAFQRYPTTGKWRLSSGFDPNRRHPVT
GRIAPHNGTDFAAPTGTPVVSTGDGVVVMTRNHPYAGNYVVIQHGSTYM
TRYLHLSKILVSKGQKVSRGQRIGLSGATGRVTGPHIHYELIVRGRPVDAMK
ANIPMANSVPKKDMANFTARRNELDRMLAHQEGLLASTNSQATPES
V.	fluvialis	 S1110 Peptidase_M23
LSIPESQIVESILSETAEPRRSYPDY YEIKSGDNLSTIFNQLGFSYQELMKIME
TDLNYLALDTLKPGNILRFWRGQDGHSLAKMELEFSLVERAVYARTDDGSFE
FKDVKIPGKWKEYPLIGEIQGSFSQSANQLGLGSSDIDQIVSLLKDKINFVR
DIRAGDRFEVVLSRQFVGEKMTGNSEIQAIKIFSRSNEVTAYLYKDGQYYDK
NGESLQRAFQRYPTTQKWRMSSGFDPNRHHPVTGRIAPHNGTDFAAPIG
TPVVSTGDGVVVMTRNHPYAGNYVVIQHGSTYMTRYLHLSKILVRKGQKV
SRGQRIGLSGATGRVTGPHIHYELIVRGRPVDAMKANIPMANSVPKKEMA
SFVSRRNELDKMLAHQESLLASNSSPDNPES  
Table S2 MS/MS fragments of Fluvibactin 
Observed Mass Predicted Formula Assignment Predicted Mass Error (ppm) 
645.2158 C31H34N4O10Na [M+Na]+ 645.2167 -1.394880201 
623.2342 C31H35N4O10 [M+H]+ 623.2348 -0.962719027 
513.1963 C25H29N4O8 See figure S4 513.198 -3.312561623 
487.2186 C24H31N4O7 See figure S4 487.2187 -0.205246638 
470.1918 C24H28N3O7 See figure S4 470.1922 -0.850715941 
443.192 C22H27N4O6 See figure S4 443.1925 -1.128177936 
404.1813 C20H26N3O6 See figure S4 404.1816 -0.742240617 
386.1708 C20H24N3O5 See figure S4 386.171 -0.51790528 
351.2023 C17H27N4O4 See figure S4 351.2027 -1.138943408 
334.1758 C17H24N3O4 See figure S4 334.1761 -0.897730269 
307.176 C15H23N4O3 See figure S4 307.1765 -1.627728684 
277.1182 C14H17N2O4 See figure S4 277.1183 -0.360856717 
268.1656 C13H22N3O3 See figure S4 268.1656 0 
194.0812 C10H12NO3 See figure S4 194.0812 0 
137.0234 C7H5O3 See figure S4 137.0233 0.729802888 
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Table SI3 NMR assignment for Fluvibactin in CD3OD. 
Atom assignment 13C chemical shift [ppm] 
1H chemical shift [ppm], 
Integral,multiplicity, J [Hz] 
1 150.2 - 
2 147.3 - 
3 119.7* 6.90, 1H, dd, 7.8, 1 
4 119.6* 6.69, 1H, t, 8 
5 118.6# 7.18, 1H, br. d, 8 
6 116.7 - 
7 171.5 
 9a 37.8¤ 3.39, 1H, m 
9b 37.8¤ 3.35, 1H, m 
10 28.4 1.89, 2H, p, 7 
11a 45 3.56, 1H, m 
11b 45 3.49, 1H, m 
13a 46.7 3.84, 1H, m 
13b 46.7 3.65, 1H, m 
14a 30.3 2,09, 1H, m 
14b 30.3 2.05, 1H, m 
15a 37.9¤ 3,52, 1H, m 
15b 37.9¤ 3.47, 1H, m 
17 171.8 - 
18 116.7 - 
19 150.2 - 
20 147.3 - 
21 119.6* 6.86, 1H, dd, 7.8,1 
22 119.6* 6.63, 1H, t, 8 
23 118.6# 7.19, 1H, br. d, 8 
24 171.4 - 
25 73 4.81, 1H, d, 6.4 
26 79.8 5.25, 1H, p, 6.4 
27 20.2 1.39, 3H, d, 6.4 
28 167.8 - 
30 111.8 - 
31 149.4 - 
32 146.7 - 
33 120.2 6.93, 1H, dd, 8,1.4 
34 119.9^ 6,72, 1H, t, 8 
35 119.9^ 7,13, 1H, dd, 8,1.4 
^,*,¤,# : indicates overlap and thereby specific assignment impossible. 
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All spectra were acquired on a Bruker Advance 800 MHz NMR spectrometer 
using standard pulse sequenced. Chemical shifts are reported in ppm relative to 
deuterated solvent peaks as internal standards (δH, CD3OD 3.30 ppm; δC, 
CD3OD 49 ppm). Coupling constants (J) are given in hertz (Hz). Multiplicities of 
1H NMR signals are reported as follows: d, doublet; br.d, broad doublet; t, 
triplet; p, pentet; m, multiplet. 
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Summary 
Members of the Vibrionaceae family are often found associated with chitin-
containing organisms and they are thought to play a major role in chitin 
degradation. The purpose of the present study was to determine how chitin 
affected the transcriptome and metabolome of two bioactive Vibrionaceae strains, 
Vibrio corallilyticus and Photobacterium galatheae. We focused on chitin 
degradation genes and secondary metabolites based on the assumption that 
these molecules in Nature confer an advantage to the producer. Growth on 
chitin caused up-regulation of genes related to chitin metabolism and of genes 
potentially involved in host colonization and/or infection. The expression of 
genes involved in secondary metabolism was also significantly affected by 
growth on chitin, in one case being thirty-four folds upregulated. This was 
reflected in the metabolome, where the antibiotics andrimid and holomycin 
were produced in higher amounts on chitin. Interestingly, in cultures of P. 
galatheae grown on chitin we detected high amounts of the biogenic amine 
phenylethylamine. Overall, these results suggest that both V. coralliilyticus and 
P. galatheae have a specific lifestyle for growth on chitin, and that the secondary 
metabolites they produce are likely to play a crucial role during chitin 
colonization. 
 
191 words (limit: 200 words)  
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Introduction 
Chitin, a polysaccharide composed by N-acetyl-glucosamine (GlcNAc) units, is 
the most abundant molecule in the marine environment, where it is the primary 
component of the exoskeleton of zooplankton (Gooday, 1990). Members of the 
Vibrionaceae family (vibrios) are often associated with chitinous surfaces 
(Thompson et al., 2004) and, although the ability to metabolize this molecule 
has been suggested to be an ancestral feature of the whole family (Hunt et al., 
2008), characterization of the chitin catabolic pathway has been performed only 
on a limited number of species from the Vibrio genus, mostly V. cholerae and V. 
furnissii.  
The first steps of the establishment the bacteria-chitin association rely on a 
gradient of chitin-derived oligosaccharides released by chitin-containing 
organisms, which drives bacteria to the chitin surface by chemotaxis (Keyhani 
and Roseman, 1999). This is followed by adhesion of the bacteria to the surface 
(Keyhani and Roseman, 1999). In the chitin-utilization model proposed by Hunt 
and colleagues (Hunt et al., 2008) for V. cholerae, the next step is the secretion of 
chitinases, enzymes that hydrolyze chitin into GlcNAc oligosaccharides. These 
oligosaccharides are then transferred into the periplasmic space, where they are 
further cleaved and/or modified before being transported into the cytoplasm 
and converted to fructose-6-phosphate, which enters central metabolism (Hunt 
et al., 2008). Most of the genes required for the steps of this model occurring in 
the periplasmic and the cytoplasm are organized in the nag and in the 
(GlcNAc)2 operons. The former has been well characterized in Escherichia coli, 
and is controlled by the transcriptional regulator NagC, which represses the 
operon when no GlcNAc is present in the environment (Plumbridge, 1991; 
Plumbridge and Kolb, 1993). The latter has been identified in V. cholerae, and its 
expression depends on ChiS, an hybrid sensor kinase that is active only when 
(GlcNAc)2 is available (Li and Roseman, 2004; Meibom et al., 2004).  
Genome mining has revealed that vibrios harbor the genetic potential for the 
production of numerous secondary metabolites (Machado, Sonnenschein, et al., 
2015), and several bioactive molecules have been isolated from members of the 
Vibrionaceae family (Månsson et al., 2011). Microbial secondary metabolites are 
thought to have several ecological roles in Nature, including antagonism and 
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intercellular communication (Shank and Kolter, 2009; O’Brien and Wright, 
2011). When grown on chitin, the coral pathogen V. coralliilyticus doubles the 
production of the antibiotic andrimid per cell and we hypothesized that its 
increased production may confer an advantage over competitors to the 
producer during chitin colonization (Wietz et al., 2011).  
The purpose of this study was to investigate the influence of chitin on the 
metabolism of two species belonging to different genera of the Vibrionaceae 
family using a multi-omics approach. Analysis of the genomes of the two 
strains (V. coralliilyticus S2052 and Photobacterium galatheae S2753) revealed 
genetic potential for both chitin utilization and biosynthesis of secondary 
metabolites, and the transcriptomic and metabolite profiles of the two strains 
grown on chitin revealed insights about cellular components, processes and 
small molecules potentially involved in the colonization of chitinous surfaces in 
Nature. 
 
Results 
The genetic potential of V. coralliilyticus S2052 and P. galatheae S2753 for 
chitin degradation. We identified 15 and 7 genes in V. coralliilyticus S2052 and 
P. galatheae S2753, respectively, whose translated sequences contain one or more 
Pfam domains involved in the binding of chitin and/or cellulose (Pfam domains 
CBM_5_12, CBM_12_2, CHB_HEX, chiA_N term, chiC) and in the hydrolysis of 
chitin, chitin derived oligosaccharides or cellulose (Pfam domains GH3, GH18, 
GH19, GH20, LPMO_10) (Table SI1). Based on the presence of signal peptides in 
their amino acid sequence, most of these proteins are likely to be secreted in the 
extracellular environment, but putative outer membrane and periplasmic 
proteins were also predicted. In both genomes, one (P. galatheae S2753) or more 
(V. coralliilyticus S2052) putative cytoplasmic β-N-acetylhexosaminidase are 
present. Both genomes contain genes with high homology to chiP, which 
encodes for the chitoporin ChiP in V. furnissii (Keyhani et al., 2000). They also 
harbor both the nag and the (GlcNAc)2 operons. The organization of the nag 
operon, however, is different in the two strains. In P. galatheae S2753 the four 
genes included in the operon are adjacent in the genome, whereas nagB is 
separated from the other genes in V. coralliilyticus S2052 (Figure 1). As for the 
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(GlcNAc)2 operon (VC0611-VC0620 in V. cholerae), it is completely present in the 
genome of  V. coralliilyticus S2052, whilst we did not detect any gene homolog of 
VC0611 and VC0612 in the genome of P. galatheae S2753 (Figure 1).  
V. coralliilyticus S2052 and P. galatheae S2753 harbor genetic potential for the 
biosynthesis of secondary metabolites. antiSMASH analysis of the genomes of 
V. coralliilyticus S2052 and P. galatheae S2753 found seven and thirteen putative 
biosynthetic gene clusters (BGC), respectively (Table SI2). Several of the 
predicted gene clusters included polyketide synthases and/or non-ribosomal 
peptide modules, which were present in five of the BGCs from V. coralliilyticus 
S2052 and in seven of the BGCs from P. galatheae S2753. Both genomes harbor a 
putative siderophore BGC and have the genetic potential for the production of 
the osmolyte ectoine. antiSMASH predicted one putative gene cluster for 
bacteriocin production in both genomes; however, BAGEL3 and Pfam domain 
analyses did not confirm these results (not shown). 
Global transcription profile of V. coralliilyticus S2052 grown on chitin. We 
mapped 97.7% (±1.5%) and 83.40% (±3.5%) of the sequencing reads to the 
reference genomes of V. coralliilyticus S2052 and P. galatheae S2753, respectively. 
After statistical analysis, we evaluated the up and down regulation (abs. fold 
change >5) of the genes when the strains were grown on chitin as compared to 
growth on glucose (Figure 2). For V. coralliilyticus S2052, 231 genes were 
significantly upregulated and 42 were downregulated when cultures were 
harvested in the exponential phase, whereas 90 genes were upregulated and 96 
were down regulated when RNA samples were prepared from cultures in the 
stationary phase. Genes encoding for proteins that are part of the respiratory 
chain and for components of the type III secretion system were downregulated 
at both samplings. Genes related to host colonization such as those encoding for 
proteins containing HCP effector domain or involved in the production of R-
bodies were upregulated both in the exponential and the stationary phase. The 
same observation was made for genes potentially involved in natural 
competence (e.g. TW71_22895). Genes that were upregulated only in the 
exponential phase included genes encoding for components of transporters, 
including C4-dicarboxylate ABC transporters, for enzymes involved in fatty 
acid degradation and for proteins required for the synthesis of the storage 
compounds polyhydroxyalkanoates (PHA). Genes related to adhesion and 
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biofilm formation, including pilus assembly and production of cell capsule 
polysaccharides and exopolysaccharides, were upregulated on chitin in the 
stationary phase. 
Global transcription profile of P. galatheae S2753 grown on chitin. For P. 
galatheae S2753, 23 genes were significantly upregulated and 21 were 
downregulated in the exponential phase, while 171 and 74 genes were up- and 
downregulated, respectively, when cultures reached stationary phase (Figure 
2). Most of the genes predicted in the genome of this strain were annotated as 
“hypothetical protein”, and unfortunately the use of alternative annotations 
and additional information as described in material and methods did not 
facilitate the analysis. However, genes related to the respiratory chain were 
downregulated and genes involved in histidine metabolism were upregulated 
in both exponential and stationary phase. Genes related to fatty acid 
degradation, phosphate uptake and biosynthesis of aromatic amino acids were 
up-regulated in stationary phase when grown on chitin as was genes encoding 
for proteins containing Pfam domains related to the biosynthesis of 
lipoproteins. While in V. coralliilyticus S2052 the most upregulated genes in the 
stationary phase were related to chitin utilization, in P. galatheae S2753 genes 
EA_20780 (encoding for a putative benzoylformate decarboxylase) and 
EA_20785 (encoding for a hypothetical protein including a flavin containing 
amine oxidoreductase Pfam domain) were the most significantly differentially 
expressed genes (Tables SI5).  
Chitin-utilization related genes are significantly upregulated in exponential 
and stationary phase when V. coralliilyticus S2052 is grown on chitin. In V. 
coralliilyticus S2052, eight of the fourteen genes that do not belong to the 
(GlcNAc)2 or to the nag operons but that we predicted to be required for chitin 
utilization were upregulated on chitin during exponential and stationary phase 
(Figure 3, Table SI3). Gene TW71_20615, encoding for a putative porin, was 
upregulated in the exponential but not in the stationary phase. In contrast, gene 
TW71_13355, encoding for a putative β-N-acetylhexosaminidase, was 
significantly upregulated on chitin only in the stationary phase. The (GlcNAc)2 
operon was upregulated both in the late exponential and in the stationary 
phase. With respect to the nag operon, the homolog of the NagC transcriptional 
regulator encoding gene (TW71_13375) was positively differentially expressed 
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at both time points, while the rest of the operon was upregulated only in the 
stationary phase. 
Chitin-utilization related genes are upregulated mostly in the late stages of 
growth on chitin in P. galatheae 2753. All the genes predicted to be related to 
chitin utilization beside the (GlcNAc)2 and the nag operons were positively 
differentially expressed in the stationary phase except EA58_19965, which was 
not differentially expressed at any time point. The (GlcNAc)2 operon was 
upregulated both in exponential and stationary  phase (Figure 3, Tables SI4). 
With respect to the nag operon, the homolog of the NagC transcriptional 
regulator encoding gene (TW71_13375) was positively differentially expressed 
at both time points, while the rest of the operon was upregulated only in the 
stationary phase. As for the same operon in P. galatheae S2753, nagA, nagB and 
the homolog of nagE were upregulated only in the stationary phase, while the 
gene encoding for the transcriptional regulator (EA58_03240) was not 
significantly differentially expressed in the exponential nor in the stationary 
phase.  
The BGCs of V. coralliilyticus S2052 undergo both up and downregulation on 
chitin as compared to glucose. When we looked at the fold change in the 
expression levels of the putative biosynthetic genes that are part of the BGCs 
predicted by antiSMASH in the genomes of V. coralliilyticus S2052, we found 
that the biosynthetic genes of one of the predicted type 3 polyketide synthase 
(T3PKS) BGC was not differentially expressed when grown on chitin, while 
those from the remaining five predicted BGC were either up- or down-
regulated (Table 1). In all cases but the andrimid BGC (see below), the change in 
gene expression was observed in the stationary phase. For one of the two 
predicted hybrid non ribosomal peptide-type 1 PKS (NRPS-T1PKS) and the 
siderophore and ectoine BGCs, some of the biosynthetic genes were 
upregulated while others were downregulated. The biosynthetic genes of the 
second predicted NRPS-T1PKS clusters were downregulated, while those from 
the putative NRPS and the arylpolyene-NRPS BGC were upregulated. The 
latter encodes for the machinery required for the biosynthesis of the acetyl-CoA 
carboxylase inhibitor andrimid, as suggested by the antiSMASH results and 
confirmed by BLAST search against the genome of V. coralliilyticus S2052 using 
the nucleotide sequence of the andrimid BGC from Pantoea agglomerans (Jin et 
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al., 2006) as query (not shown). While the andrimid biosynthetic genes were 
significantly upregulated only in the exponential phase (Table 1), gene 
TW71_08085, encoding for a putative acetyl-CoA carboxylase carrying the 
single amino acid mutation M203L required for andrimid resistance (Liu et al., 
2008) (Figure SI2), was significantly upregulated in both exponential and 
stationary phase . The gene encoding for a putative LysR family transcriptional 
regulator (TW71_08080) and located downstream of the andrimid biosynthetic 
genes was also slightly upregulated (fold change: 1.61). 
The majority of BGCs of P. galatheae S2753 are upregulated on chitin as 
compared to glucose. In P. galatheae S2753, the expression of biosynthetic genes 
from five of the putative BGCs predicted by antiSMASH was not different 
when grown on chitin as compared to glucose. Five BGCs (one NRPS-T1PKS, 
two NRPSs, one “other”, one ectoine BGCs) were significantly upregulated on 
chitin, and no BGC was downregulated. As in the case of V. coralliilyticus S2052, 
one BGC was upregulated in the exponential phase, whilst four BGCs were up-
regulated only in the stationary phase (Table 1). By homology search, we 
identified the biosynthetic genes from one of the most upregulated putative 
NRPS BGC as those required for the production of the antibiotic holomycin (not 
shown). The gene encoding for the ArsR family transcriptional regulator 
(EA58_20500) that is located upstream of the holomycin biosynthetic genes was 
slightly downregulated (-1.45 fold change).  
Influence of chitin on the metabolite profiles of V. coralliilyticus S2052 and 
P. galatheae S2753. The levels of andrimid and of the related compound 
moiramide detected in extracts from 24 hour old cultures of V. coralliilyticus 
S2052 grown on chitin were much higher than those detected in extracts from 
cultures grown on glucose, which is in agreement with the upregulation of the 
andrimid biosynthetic genes observed during exponential phase. Solonamides 
and ngercheumicins were present in similar levels in extracts from cultures of P. 
galatheae S2753 grown on the two substrates. We identified two new members of 
the solonamide family (solonamide C and D) based on their accurate mass and 
retention time. These analogues differed from the known solonamides and 
ngercheumicins in the composition and order of the constituent amino acids. 
The amino acid sequence of solonamide C and D could be tentatively assigned 
based on analysis of the MS/MS fragmentation pattern and by analogy with the 
Chapter 6 ⎪ Research articles. Article 3 
155 
 
observed fragments in the known solonamides (Fig SI3-SI6). Extracts from 
cultures grown in chitin contained higher levels of holomycin than those from 
cultures grown in glucose, which reflects the different expression levels of the 
related biosynthetic genes observed in the stationary phase. Interestingly, these 
extracted contained also approximately twice the amount of 2-
phenylethylamine (identified by HRMS/MS and comparison to a standard) 
(Figure SI7) found in extracts from cultures grown on glucose. 
 
Discussion 
Studying the dynamics and evolution of the interactions between 
microorganisms and the surrounding environment is crucial for understanding 
their role in ecological systems. We studied the genetic potential of two 
members of the Vibrionaceae family for the utilization of chitin, the most 
abundant molecule in the marine environment (Gooday, 1990), and analyzed at 
the transcriptional and metabolome levels their response to the presence of this 
polysaccharide. We found that both strains possess the genetic information to 
produce a range of enzymes for chitin degradation and utilization, and that 
their metabolite repertoire greatly varies when grown on chitin as compared to 
growth on glucose, suggesting a role of the secondary metabolites during chitin 
colonization and utilization. 
Most work on chitin utilization in Vibrionaceae has been done on Vibrio species, 
although the core gene set has been shown to be widespread in the whole 
family (Hunt et al., 2008). Therefore, besides a Vibrio species (V. coralliilyticus), 
we also studied a species from the genus Photobacterium (P. galatheae). The 
former is a coral pathogen (Ben-Haim et al., 2003), while the latter is a newly 
described species (Machado, Giubergia, et al., 2015) and, although it was 
isolated from a mussel (Gram et al., 2010), its preferred niche of colonization is 
unknown. 
Both V. coralliilyticus S2052 and P. galatheae S2753 have the potential to produce 
a broad range of enzymes capable of binding and/or hydrolyzing chitin, chitin 
derived molecules and/or cellulose. Some of these enzymes contain the 
LPMO_10 domain, which is also present in GbpA (Loose et al., 2014), a 
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colonization factor contributing to V. cholerae adhesion to chitinous surfaces 
(Kirn et al., 2005). The putative cytoplasmic localization for all of the GH3 
domain containing proteins indicates that they may actually be involved in 
other functions rather than chitin degradation, like in the case of the GH3 
hydrolase NagZ from Salmonella typhimurium and Bacillus subtilis, which 
participate in peptidoglycan recycling (Bacik et al., 2012). The organization of 
the nag operon in V. coralliilyticus S2052 in which, unlike Escherichia coli 
(Plumbridge, 1991; Plumbridge and Kolb, 1993) and P. galatheae, the nagB gene 
is separated from the rest of the operon, resembles the organization of the same 
operon in V. cholerae (Yamano et al., 1997; Ghosh et al., 2011). Notably, the two 
different organizations of this operon in V. coralliilyticus S2052 and P. galatheae 
S2753 reflect those occurring in a number of other Vibrio and Photobacterium 
species, respectively (Figures SI8 and SI9). In contrast, the lack of homologues 
of genes VC0611 and VC0612 in the (GlcNAc)2 operon of P. galatheae seems to be 
a peculiarity only of this strain and of the very closely related species P. 
halotolerans (Figure SI10).  
With respect to the dynamics of chitin colonization and utilization program, the 
models currently available in literature (see introduction) would cover the 
species used in this study, although for P. galatheae S2753 the poor annotation of 
the genome and the lack of complementary information in literature and 
databases did not allow a thorough analysis. During exponential growth V. 
coralliilyticus S2052 upregulated a number of genes encoding for chemotaxis 
proteins (Table SI6) and transporters. These were transporters involved in the 
uptake of chitin and chitin derived oligosaccharides, but also C4-dicarboxylate 
ABC transporters, and this upregulation was observed also in P. galatheae S2753 
in the stationary phase. C4-dicarboxylate ABC transporters have different 
substrates, including sialic acids. Sialic acids are GlcNAc derivative molecules 
used by mammals to glycosylate proteins on cell surfaces, where they act as 
determinants in bacterial adhesion events (Tanner, 2005). Indeed, the ability to 
catabolize sialic acid is thought to be an important feature in V. cholerae during 
intestinal colonization (Almagro-Moreno and Boyd, 2009). Some prokaryotes 
can produce sialic acids, and V. coralliilyticus BAA450 harbors the genes for their 
biosynthesis (Lewis et al., 2011). However, the homologs of such genes in V. 
coralliilyticus S2052 were not differentially expressed in our experimental setup. 
Therefore, the upregulation of these transporters indicates that they may also 
Chapter 6 ⎪ Research articles. Article 3 
157 
 
use substrates such as chitin-derived oligosaccharides, or that V. coralliilyticus 
S2052 was deceived by the presence of GlcNAc and activated a response for the 
colonization of a potential host. The latter hypothesis would be in agreement 
with the upregulation of genes encoding for proteins containing one Hcp 
effector domain. In V. cholerae, Hcp proteins in are involved in its virulence 
towards eukaryotic (Pukatzki et al., 2006) and prokaryotic cells, conferring a 
competitive advantage to the producer (MacIntyre et al., 2010). Furthermore, in 
V. coralliilyticus S2052, a set of genes (TW71_18705 to TW71_18720) annotated as 
“glycerol-3-phosphate dehydrogenase” were upregulated in both the 
exponential phase and in the stationary phase. However, we believe these genes 
were misannotated since their encoded products contain a RebB domain, 
necessary for the production of R-bodies. These are cytoplasmic inclusions 
occurring widely in Proteobacteria whose exact function is not known, but have 
been suggested to play a role during host infection (Raymann et al., 2013).   
Growth on chitin resulted in changes of expression of biosynthetic genes for the 
production of secondary metabolites. Expression changes were seen in both 
strains and were most pronounced in stationary phase. This strongly indicates 
that the molecules produced by the biosynthetic machinery encoded by those 
genes may have ecological functions, and may confer an advantage to the 
producers during chitin colonization, as it was suggested for andrimid (Wietz et 
al., 2011). The upregulation of the andrimid biosynthetic genes and of the LysR 
family transcriptional regulator located just downstream of them supports the 
recently suggested hypothesis that such regulator may have an important 
regulatory role in andrimid biosynthesis (Matilla et al., 2016). Similarly, the 
downregulation of the ArsR family transcriptional regulator gene located 
upstream of the holomycin biosynthetic genes may indicate a role of the 
encoded regulator as repressor of holomycin production. For most of the 
remaining differentially expressed biosynthetic genes, however, we do not 
know the metabolite produced and could not be revealed by comparing 
transcriptomics and metabolomics data. An interesting observation was the 
detection of high amounts of 2-phenylethylamine when P. galathae S2753 was 
grown on chitin. The biogenic amine phenylethylamine is produced by 
decarboxylation of phenyalanine. Genes related to the biosynthesis of aromatic 
amino acids were upregulated during stationary phase in P. galatheae S2753 
grown on chitin, and the one of most upregulated gene encodes for a putative 
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benzoylformate decarboxylase. Given the structural similarity between 
benzoylformate and phenyalanine, we suggest that the substrate of the 
decarboxylase may actually be phenylalanine. The product of the gene next to 
the one encoding for the benzoylformate decarboxylase, which was also highly 
upregulated, is a hypothetical protein containing an amide oxidoreductase 
domain. We propose that this enzyme removes the amine group from 
phenyethylamine with the production of ammonia and phenylacetaldehyde 
(Figure SI6), although we did not detect this molecule in culture extracts. The 
production of biogenic amines has recently been reported in other 
Photobacterium species (Torido et al., 2014; Bjornsdottir-Butler et al., 2016), but 
their role in Nature remains unclear.  
In conclusion, the results of this study show that growth on chitin triggers a 
comprehensive response at the transcriptional and biosynthetic levels in 
vibrios, providing insights into the dynamics of colonization of chitinous 
surfaces in Nature. We showed that the up-regulation of genes related to the 
production of secondary metabolites is reflected into the metabolite profile, 
suggesting a role of these molecules during chitin colonization. We showed 
that, when grown on chitin, P. galatheae produces high amounts of the biogenic 
amine phenylethylamine. Additional work, possibly in experimental setups 
with live chitin containing zooplankton, may help to identify its function in 
natural settings. 
 
Experimental procedures 
Genomes analyses. A list of genes possibly involved in chitin utilization was 
compiled based on the analysis of the genomes of Vibrio coralliilyticus S2052 and 
Photobacterium galatheae S2753 (accession numbers: JXXR01 and JMIB01, 
respectively). The choice of the genes to be included in the list was made based 
on: i) the NCBI gene annotation list associated with each genome, ii) homology 
searches using genes known to be related to chitin metabolism as queries and 
iii) the presence of Pfam and/or InterPro domains related to chitin metabolism 
in the amino acid sequences encoded by the genes. Pfam and InterPro domains 
were obtained by running through Blast2GO (Conesa et al., 2005) the amino 
acid sequences encoded by all predicted genes in each genome. Amino acid 
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sequences of the identified proteins were also submitted to the bacterial protein 
subcellular localization prediction tool (PSORTb 3.0) (Yu et al., 2010) to identify 
signal peptides linked to specific cellular compartments. Furthermore, genomes 
were submitted to antiSMASH 3.0 (Weber et al., 2015) for the prediction of 
putative biosynthetic gene cluster involved in the production of secondary 
metabolites. 
Bacterial strains and media composition. Photobacterium galatheae S2753 and 
Vibrio coralliilyticus S2052 were isolated during the Galathea 3 global research 
expedition (Gram et al., 2010). The composition of the media used in this work 
was: 2% Sigma Sea Salts (Sigma S9883) solution with 0.3% casamino acids (BD 
223050) supplemented with either 40 mM MOPS pH 7.5 and 0.2% glucose 
(SSBG) or 0.2% colloidal chitin (SSBC). Colloidal chitin was prepared as 
described previously (Giubergia et al, 2016). 
Growth conditions. Unless stated otherwise, all cultures in liquid medium 
were grown aerated (200 rpm) at 25°C in four biological replicates. Single 
colonies of P. galatheae S2753 or V. coralliilyticus S2052 were grown in 10 mL of 
half-strength YTSS medium (½ YTSS) (González et al., 1996) for 24 hours. 100 
µL of each culture were then used to inoculate 10 mL of fresh ½ YTSS medium. 
After 24 hours, each culture was used to inoculate 50 mL of SSBG or SSBC in 
250 mL Erlenmeyer flasks at approximately 103 CFU/mL. When cultures 
reached late exponential and early stationary phase (Figure SI1), a subsample 
was taken and mixed with 0.2 volumes of ice-cold STOP solution (95% [v/v] 
ethanol, 5% [v/v] phenol], incubated on ice for 5 minutes and pelleted by 
centrifugation. Supernatants were removed and cell pellets were stored at -80°C 
until RNA extraction.  
RNA isolation and sequencing. RNA was extracted using the RNAeasy kit 
(Qiagen, 74104) following manufacturer’s instructions. DNA was removed on-
column with the RNase-free DNase set (Qiagen 79254). Integrity and quality of 
total RNA were assessed with a NanoDrop Spectrometer (Saveen Werner, 
Sweden) and an Agilent 2100 Bioanalyzer (Agilent Technologies). For each 
strain in each condition, the three best total RNA samples were sent to the 
Beijing Genome Institute (BGI, Hong Kong), where rRNA was removed using 
the Ribo-Zero rRNA removal kit (Illumina). Libraries were then constructed 
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with the TruSeq RNA Library Preparation kit (Illumina) and 100 bp paired-end 
sequenced on a HiSeq 2000. Sequencing data have been deposited in the Gene 
Expression Omnibus (GEO) database under accession number GSE80783. 
Data analysis. RNA-seq data were analyzed using CLC Genomics Workbench 
version 8 (CLC Bio, Aarhus, Denmark). Quality control of the reads was done 
based on GC%, PHRED-score, nucleotide contribution and enriched 5mers 
sequences. Reads were trimmed removing the first 15 nucleotides from the 5’ 
end when nucleotide contribution was not normally distributed. Subsequently, 
reads were mapped to the reference genomes and expression values were 
calculated as Reads Per Kilobase per Million mapped reads (RPKM). Gene 
expression profiles of biological replicates were merged and, for each strain at 
each time point, the profiles deriving from the two media were compared. The 
quality of the transcriptomic data was evaluated using hierarchal clustering and 
principal component analysis. Datasets that did not pass the quality control 
were discarded, however no less than two biological replicates per stain per 
condition per data point were used. Statistically significant gene expression 
differences were assessed through a Baggerly’s test (Baggerly et al., 2003) using 
p-value < 0.05 and false discovery rate (FDR) q-value < 0.05. For the analysis of 
the global transcription profiles, only genes with an absolute fold change > 5 
were considered. For other analyses (chitin utilization related genes and 
secondary metabolism biosynthetic genes), no fold change limit was set.  
Extraction of liquid cultures for chemical analysis. Sub-samples (2 mL) of the 
24 hours old cultures (harvest point in the stationary phase) were collected to be 
used for secondary metabolite analysis. Cultures were extracted sequentially 
with an equal volume of HPLC-grade ethyl acetate (EtOAc) (neutral extract), 
EtOAc containing 1% formic acid (acidic extract) and then EtOAc containing 2% 
ammonia (basic extract). The organic phases were transferred to fresh vials and 
evaporated until dryness under a stream of nitrogen. Extracts were dissolved in 
250 µL methanol (MeOH) and stored at -20°C. The neutral, acidic and basic 
extracts were kept separate and analyzed separately. For each species three 
biological replicates and two technical replicates were analyzed. 
UHPLC-HRMS. Ultra-high Performance Liquid Chromatography-High 
Resolution Mass Spectrometry (UHPLC-HRMS) was performed on an Agilent 
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Infinity 1290 UHPLC system (Agilent Technologies, Santa Clara, CA, USA) 
equipped with a diode array detector. Separation was obtained on an Agilent 
Poroshell 120 phenyl-hexyl column (2.1 × 250 mm, 2.7 µm) with a linear 
gradient consisting of water (A) and acetonitrile (B) both buffered with 20 mM 
formic acid, starting at 10% B and increased to 100% in 15 min where it was 
held for 2 min, returned to 10% in 0.1 min and remaining for 3 min (0.35 
mL/min, 60 °C). An injection volume of 1 µL was used. MS detection was 
performed in both positive and negative detection on an Agilent 6540 QTOF MS 
equipped with Agilent Dual Jet Stream electrospray ion source with a drying 
gas temperature of 250 °C, gas flow of 8 L/min, sheath gas temperature of 300 
°C and flow of 12 L/min. Capillary voltage was set to 4000 V and nozzle voltage 
to 500 V. Mass spectra were recorded at 10, 20 and 40 eV as centroid data for 
m/z 85–1700 in MS mode and m/z 30–1700 in MS/MS mode, with an acquisition 
rate of 10 spectra/s. Lock mass solution in 70:30 methanol:water  was infused in 
the second sprayer using an extra LC pump at a flow of 15 µL/min using a 1:100 
splitter. The solution contained 1 µM tributylamine (Sigma-Aldrich) and 10 µM 
Hexakis(2,2,3,3-tetrafluoropropoxy)phosphazene (Apollo Scientific Ltd., 
Cheshire, UK) as lock masses. The [M + H]+ ions (m/z 186.2216 and 922.0098 
respectively) of both compounds was used. 
Dereplication. The extracts were dereplicated by searching by formula for all 
compounds known to be produced by Vibrio and Photobacterium species found 
in AntiBase 2012, MarinLit 2012 and The Dictionary of Natural Products. The 
chromatograms were then examined for peaks of intensity which correlated to 
the change in expression levels revealed by the transcriptomic data.  Unknown 
compounds of potential interest were analyzed by examination of the MS/MS 
data to assist with identification of the compound class and derive structural 
information. 
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Table 1 Range of the expression fold change (FC) of the biosynthetic genes 
contained in the biosynthetic gene clusters predicted by antiSMASH in the 
genomes of Vibrio coralliilyticus S2052 and Photobacterium galatheae S2753. The 
time point at which the up- or downregulation was observed is indicated. Exp: 
time point in the exponential growth phase; Stat: time point in the stationary 
growth phase; X: not differentially expressed.   
 
Cluster Range FC 
biosynthetic genes
Time point
Cluster 1 - T3PKS X X
Cluster 2 - NRPS 2/3.8 Stat
Cluster 3 - Arylpolyene - NRPS (Andrimid) 2.6/6.8 Exp
Cluster 4 - NRPS-T1PKS -3/-18 Stat
Cluster 5 - NRPS-T1PKS -4.8/-7.6 Stat
Cluster 6 - Siderophore-ectoine -2.2/2.5 Stat
Cluster 1 - Other X X
Cluster 2 - NRPS X X
Cluster 3 - Other X X
Cluster 5 - NRPS-T1PKS 2.2/3 Exp
Cluster 6 - NRPS 34.6 Stat
Cluster 7 - Siderophore X X
Cluster 8 - T1PKS X X
Cluster 9 - Other 2.3/3.4 Stat
Cluster 10 - Ectoine 9 Stat
Cluster 11 - NRPS (Holomycin) 5/10 Stat
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Figure 1 A) nag operon in E. coli, in which the operon was originally 
characterized, Vibrio coralliilyticus S2052 and Photobacterium galatheae S2753 B) 
(GlcNAc)2 operon in V. cholerae O1, in which the operon was identified first, V. 
coralliilyticus S2052 and P. galatheae S2753. The analysis was done using 
MultiGeneBlast (Medema et al., 2013). 
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Figure 2 Venn diagrams representing the mRNAs which are up- (+5X) or down- 
(-5X) regulated (at least fivefold change, p-value < 0.05, q-value < 0.05) during 
exponential (exp) or stationary phase (stat) when Vibrio coralliilyticus S2052 A) 
and Photobacterium galatheae S2753 B) are grown on chitin compared to growth 
on glucose. The analysis was done using the InteractiVenn web-tool (Heberle et 
al., 2015).  
Chapter 6 ⎪ Research articles. Article 3 
169 
 
 
Figure 3 Heat map and hierarchical cluster analysis of the fold change of genes 
related to chitin utilization identified in the genome of Vibrio corallilyticus S2052 
(top) and Photobacterium galatheae S2753 (bottom) at the two time points 
analyzed in this study (exponential and stationary phases). FC: fold change *: 
genes from the (GlcNAc)2 operon plus chiS homolog; ¤: genes from the nag 
operon.
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Table SI1 List of genes identified in the genomes of Vibrio coralliilyticus S2052 
and Photobacterium galatheae S2753 and encoding for proteins containing Pfam 
domains related to the binding or the hydrolysis of chitin and cellulose. The 
predicted cellular localization is indicated as well. DUF: domain of unknown 
function. 
C
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EX
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C
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H
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18
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H
19
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20
LP
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D
U
F
TW71_05305 chitodextrinase Unknown (not cytoplasmic)
TW71_06185 chitinase Outer membrane (95.2%)
TW71_06390 beta-hexosaminidase Cytoplasmic (99.7%)
TW71_06415 chitin-binding protein no Pfam match Extracellular (97.1%)
TW71_06495 Spindolin Extracellular (97.2%)
TW71_07485 beta-hexosaminidase Cytoplasmic (99.7%)
TW71_09905 chitinase 5011 Extracellular (100%)
TW71_10755 chitinase Extracellular (96.5%)
TW71_10895 chitin-binding protein Extracellular (97.1%)
TW71_11275 chitin-binding protein Extracellular (100%)
TW71_13115 carbohydrate-binding protein Unknown (not cytoplasmic)
TW71_13355 beta-N-acetylhexosaminidase Outer membrane (99.2%)
TW71_14675 beta-N-acetylhexosaminidase Periplasmic (97.6%)
TW71_19985 chitinase Extracellular (97.2%)
TW71_23380 chitinase Unknown (not cytoplasmic)
EA58_02560 chitinase Unknown (not cytoplasmic)
EA58_04755 hypothetical protein Extracellular (98.4%)
EA58_07035 chitodextrinase Periplasmic (59.1%) Extracellular (40.8%)
EA58_12180 hypothetical protein Unknown (may have multiple  localization sites)
EA58_13100 hypothetical protein Extracellular (100%)
EA58_19900 chitinase Extracellular (100%)
EA58_19965 beta-hexosaminidase Cytoplasmic (99.7%)
PSORTb cellular localization (probability)
Predicted domains
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Gene PGAP annotation
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Table SI2 antiSMASH prediction of the genetic potential of Vibrio coralliilyticus 
S2052 and Photobacterium galatheae S2753 for the biosynthesis of secondary 
metabolites. The table lists the type of putative biosynthetic gene cluster (BGC), 
the locus tags of the genes predicted to be part of them and, when known, the 
most similar known biosynthetic gene cluster. T3PKS: type 3 polyketide 
synthase; NRPS: non ribosomal peptide synthase; T1PKS:  type 1 polyketide 
synthase. 
    
Type BGC Locus_tags 
Most similar known BGC                  
(% genes showing 
similarity) 
V
. c
or
al
li
il
yt
ic
us
 
S2
05
2 
1 T3PKS TW71_00340-TW71_00545 - 
2 NRPS TW71_01010-TW71_01220 Cupriachelin BGC (11%) 
3 Arylpolyene-NRPS TW71_07885-TW71_08150 Andrimid BGC (71%) 
4 NRPS-T1PKS TW71_09375-TW71_09590 - 
5 NRPS-T1PKS TW71_15090-TW71_15305 - 
6 Siderophore-Ectoine TW71_15330-TW71_15480 Aerobactin BGC (88%) 
7 Bacteriocin TW71_23595-TW71_23645 - 
P
. g
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27
53
 
1 Other EA58_01380-EA58_01585 Indigoidine BGC (80%) 
2 NRPS EA58_06305-EA58_06400 - 
3 Other EA58_06305-EA58_06400 - 
4 Bacteriocin EA58_06515-EA58_06820 - 
5 NRPS-T1PKS EA58_09560-EA58_09700 - 
6 NRPS EA58_10530-EA58_10790 - 
7 Siderophore EA58_10780-EA58_10830 Aerobactin BGC (88%) 
8 T1PKS EA58_15485-EA58_15615 - 
9 Other EA58_15310-EA58_15400 - 
10 Ectoine EA58_16435-EA58_16480 Ectoine BGC (66%) 
11 NRPS EA58_20400-EA58_20585 Thiomarinol BGC (16%)  
12 NRPS  - 
13 NRPS EA58_21730 - 
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Table SI3 Fold change values of the (GlcNAc)2 operon, chiS homolog 
(TW71_19280), nag operon and other putative chitin utilization-related genes 
present in the genome of Vibrio coralliilyticus S2052. 
   Fold change 
 Gene PGAP annotation (NCBI) Exp 
phase 
Stat 
phase 
(G
lc
N
A
c)
2 o
pe
ro
n 
+ 
ch
iS
 
TW71_19230 phosphomutase 8.2 34.3 
TW71_19235 N'-diacetylchitobiose phosphorylase 11.6 52.5 
TW71_19240 beta-hexosaminidase 8.3 31.8 
TW71_19245 N-acetylglucosamine kinase 9.7 23.7 
TW71_19250 chitobiase 11.4 56.6 
TW71_19255 chemotaxis protein 27.2 50.3 
TW71_19260 sugar ABC transporter ATP-binding protein 16.7 62.9 
TW71_19265 peptide ABC transporter permease 24.7 75.4 
TW71_19270 peptide ABC transporter permease 34.4 140.1 
TW71_19275 peptide ABC transporter substrate-binding protein 41.8 158.7 
TW71_19280 histidine kinase 3.0 2.6 
na
g 
op
er
on
 
TW71_13385 PTS N-acetylmuramic acid transporter subunit 
IIBC 
1 7.2 
nagB 
(TW71_15705) 
glucosamine-6-phosphate deaminase 1 28.8 
nagA 
(TW71_13380) 
N-acetylglucosamine-6-phosphate deacetylase 1 15.6 
TW71_13375 transcriptional regulator 2.5 6.7 
O
th
er
 c
hi
tin
 re
la
te
d 
ge
ne
s 
TW71_20615 porin (PGAP) 12.7 1 
TW71_05305 chitodextrinase 5.8 47.8 
TW71_06185 chitinase 1 1 
TW71_06390 beta-hexosaminidase 1 1 
TW71_06415 chitin-binding protein 1 1 
TW71_06495 Spindolin 2.8 10.1 
TW71_07485 beta-hexosaminidase 1 1 
TW71_09905 chitinase 6.6 2.9 
TW71_10755 chitinase 14.4 18.3 
TW71_10895 chitin-binding protein 1 1 
TW71_11275 chitin-binding protein 1 1 
TW71_13115 carbohydrate-binding protein 2.6 28.3 
TW71_13355 beta-N-acetylhexosaminidase 1 39.7 
TW71_14675 beta-N-acetylhexosaminidase 1 1 
TW71_19985 chitinase 3.6 31.9 
TW71_23380 chitinase 18.4 85.1 
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Table SI4 Fold change values of the (GlcNAc)2 operon, chiS, nag operon and 
other putative chitin utilization-related genes present in the genome of 
Photobacterium galatheae S753. 
   
Fold change 
 
Gene PGAP annotation (NCBI) Exp 
phase 
Stat 
phase 
(G
lc
N
A
c)
2 o
pe
ro
n 
+ 
ch
iS
 
EA58_16895 beta-hexosaminidase 2.9 6.3 
EA58_16900 N-acetylglucosamine kinase 2.1 3.8 
EA58_16905 chitobiase 2.7 2.8 
EA58_16910 chemotaxis protein 2.0 7.9 
EA58_1691½5 sugar ABC transporter ATP-binding protein 3.8 11.0 
EA58_16920 peptide ABC transporter permease 4 9.5 
EA58_16925 peptide ABC transporter permease 5.6 9.5 
EA58_16930 peptide ABC transporter substrate-binding 
protein 
8.6 9.1 
EA58_16935 ChiS 2.4 1 
na
g 
op
er
on
 EA58_03255 PTS glucose transporter subunit IIBC 1 4.4 
nagB 
(EA58_03250) glucosamine-6-phosphate deaminase 1 4.4 
nagA 
(EA58_03245) 
N-acetylglucosamine-6-phosphate 
deacetylase 1 2.2 
EA58_03240 transcriptional regulator 1 1 
O
th
er
 c
hi
tin
 re
la
te
d 
ge
ne
s 
EA58_02185 porin (PGAP) 1 4.2 
EA58_02560 chitinase 1 13.9 
EA58_04755 hypothetical protein 1 18.6 
EA58_07035 chitodextrinase 1 89.8 
EA58_12180 hypothetical protein 1 8 
EA58_13100 hypothetical protein 1 14.5 
EA58_19900 chitinase 1 60.8 
EA58_19965 beta-hexosaminidase 1 1 
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Table SI5 The ten most up and down regulated genes for each strain in each 
condition at the two sampling points (late exponential and stationary phase). 
Values refer to chitin compared to glucose. Up: upregulated; down: 
downregulated; FC: fold change 
Sample Gene FC PGAP annotation 
V
. c
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us
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20
52
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l p
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p 
TW71_04295 196 aldehyde dehydrogenase 
TW71_05770 89 C4-dicarboxylate ABC transporter 
TW71_07295 81 acetyl-CoA synthetase 
TW71_07940 79 hypothetical protein 
TW71_19770 70 hypothetical protein 
TW71_00320 68 hypothetical protein 
TW71_07870 63 hypothetical protein 
TW71_00325 57 dehydrogenase 
TW71_07945 51 hypothetical protein 
TW71_18840 50 hypothetical protein 
V
. c
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20
52
 
st
at
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se
 u
p 
TW71_19275 159 peptide ABC transporter substrate-binding protein 
TW71_19270 140 peptide ABC transporter permease 
TW71_18580 140 Trp operon leader peptide 
TW71_14655 103 amino acid deaminase 
TW71_23380 85 chitinase 
TW71_16830 83 
5-methyltetrahydropteroyltriglutamate-- 
homocysteine methyltransferase 
TW71_19265 75 peptide ABC transporter substrate-binding protein 
TW71_15905 68 hypothetical protein  
TW71_19260 63 sugar ABC transporter ATP-binding protein 
TW71_19250 57 chitobiase 
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EA58_07425 39 dethiobiotin synthetase 
EA58_12415 21 formimidoylglutamase 
EA58_12420 17 urocanate hydratase 
EA58_12425 17 histidine ammonia-lyase 
EA58_20235 12 hypothetical protein 
EA58_07075 12 hypothetical protein 
EA58_10775 12 glyceraldehyde-3-phosphate dehydrogenase 
EA58_18255 12 thioesterase 
EA58_12410 11 imidazolonepropionase 
EA58_16300 9 hypothetical protein 
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EA58_20785 799 hypothetical protein 
EA58_20780 648 benzoylformate decarboxylase 
EA58_06000 239 glycosyltransferase 
EA58_06005 150 hypothetical protein 
EA58_21470 137 lactonizing lipase 
EA58_15365 102 hemolysin 
EA58_16750 94 hypothetical protein 
EA58_07035 90 chitodextrinase 
EA58_12040 73 phosphonate ABC transporter substrate-binding 
protein 
EA58_19900 61 chitinase 
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Sample Gene FC PGAP annotation 
V
. c
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al
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 S
20
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l p
ha
se
 d
ow
n 
TW71_11480 -50 maltoporin 
TW71_00570 -34 hypothetical protein 
TW71_14985 -33 maltodextrin phosphorylase 
TW71_14690 -28 cytochrome O ubiquinol oxidase 
TW71_14695 -24 cytochrome o ubiquinol oxidase subunit I 
TW71_04930 -23 oxalate:formate antiporter 
TW71_14990 -22 4-alpha-glucanotransferase 
TW71_14700 -19 cytochrome o ubiquinol oxidase subunit III 
TW71_14705 -17 cytochrome O ubiquinol oxidase 
TW71_14095 -16 glyoxalase 
V
. c
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 d
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n 
TW71_00500 -2273 secretion protein 
TW71_00505 -2235 type III secretion protein 
TW71_00510 -2115 secretion protein EspA 
TW71_00495 -1833 pathogenicity island effector protein 
TW71_00490 -1197 type III secretion protein 
TW71_00515 -990 secretion protein EspA 
TW71_00485 -693 hypothetical protein 
TW71_00345 -551 hypothetical protein 
TW71_00355 -275 hypothetical protein 
TW71_00430 -249 type III secretion system needle protein SsaG 
P
. g
al
at
he
ae
 S
27
53
 
ex
po
ne
nt
ia
l p
ha
se
 d
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EA58_17070 -17 glutamate synthase 
EA58_02025 -15 hypothetical protein 
gltD -15   
EA58_16650 -12 cytochrome D ubiquinol oxidase subunit I 
EA58_07025 -11 hypothetical protein 
EA58_19405 -10 acetate kinase 
EA58_07020 -9 cytochrome o ubiquinol oxidase subunit I 
EA58_07015 -8 cytochrome o ubiquinol oxidase subunit III 
EA58_17025 -8 lactoylglutathione lyase 
EA58_07010 -7 cytochrome O ubiquinol oxidase 
P
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ae
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st
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se
 d
ow
n 
EA58_06945 -47 flagellar basal body rod protein FlgC 
EA58_07025 -47 hypothetical protein 
EA58_00065 -37 hypothetical protein 
EA58_12415 -30 formimidoylglutamase 
EA58_07020 -26 cytochrome o ubiquinol oxidase subunit I 
flgB_2 -24   
EA58_12410 -23 imidazolonepropionase 
EA58_20875 -23 hypothetical protein 
EA58_01880 -21 acetate kinase 
EA58_11270 -21 hypothetical protein 
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Table SI6 Fold changes (FC) of genes related to chemotaxis in Vibrio 
coralliilyticus S2052 and Photobacterium galatheae S2753 when the organisms are 
grown on chitin as compared to glucose. 
 Gene FC PGAP annotation 
V. coralliilyticus S2052 exponential phase 
TW71_01215 2,4 chemotaxis protein CheY 
TW71_01445 -2,1 chemotaxis protein 
TW71_05740 3,7 chemotaxis protein CheY 
TW71_06500 -5,9 chemotaxis protein 
TW71_07880 2,5 chemotaxis protein CheY 
TW71_09420 2,3 chemotaxis protein CheY 
TW71_11490 21,1 chemotaxis protein 
TW71_11670 3,5 chemotaxis protein 
TW71_13190 2,2 chemotaxis protein 
TW71_14260 2,2 chemotaxis protein CheY 
TW71_14270 2,6 chemotaxis protein 
TW71_14275 4,2 chemotaxis protein 
TW71_14290 2,9 chemotaxis protein 
TW71_14295 3,9 chemotaxis protein CheW 
TW71_14305 5,9 chemotaxis protein CheA 
TW71_14320 4,2 chemotaxis protein 
TW71_14940 9,5 chemotaxis protein 
TW71_15635 -4,8 chemotaxis protein 
TW71_16580 2,7 chemotaxis protein CheX 
TW71_18425 2,2 chemotaxis protein 
TW71_18985 7,8 chemotaxis protein CheY 
TW71_19075 8,1 chemotaxis protein 
TW71_19255 27,2 chemotaxis protein 
TW71_24705 4,5 chemotaxis protein 
V. coralliilyticus S2052 stationary phase 
TW71_07720 2,2 chemotaxis protein 
TW71_11490 -2,1 chemotaxis protein 
TW71_15165 2,0 chemotaxis protein 
TW71_19255 50,3 chemotaxis protein 
TW71_24705 -2,1 chemotaxis protein 
P. galatheae S2753 exponential phase 
EA58_05570 2,2 chemotaxis protein CheY 
EA58_15700 -2,9 chemotaxis protein 
P. galatheae S2753 stationary phase 
EA58_01610 -5,1 chemotaxis protein CheY 
EA58_02020 4,1 chemotaxis protein 
EA58_02250 -2,2 chemotaxis protein CheW 
EA58_02255 -2,2 chemotaxis protein CheR 
EA58_02470 2,4 chemotaxis protein CheA 
EA58_05760 2,3 chemotaxis protein 
EA58_07330 2,9 chemotaxis protein 
EA58_07600 -4,2 chemotaxis protein 
EA58_10710 4,6 chemotaxis protein 
EA58_16910 7,9 chemotaxis protein 
EA58_18325 3,7 chemotaxis protein 
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Figure SI1 Growth curves of Vibrio coralliilyticus S2052 (top) and Photobacterium 
galatheae S2753 (bottom) in glucose (SSBG triangles) and chitin (SSBC squares). 
The beige and light green time points indicate the harvest points in the late 
exponential and in the stationary phase, respectively. 
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Figure SI2 Alignment of the amino acid sequences of the acetyl-CoA 
carboxylases encoded by TW71_24015 and TW71_08085 in Vibrio coralliilyticus 
S2052, and by admT in Pantoea agglomerans. The one encoded by TW71_08085, 
which is part of the andrimid BGC by antiSMASH in V. coralliilyticus S2052, 
carries the same single amino acid mutation (MàL) present in AdmT 
(highlighted by the black frame) that confers andrimid resistance to the carrier 
(Liu et al., 2008).  
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Figure SI3 HRMS/MS spectra of solonamide C.  
Name Observed mass Predicted formula Predicted Mass Error (ppm) 
Solonamide C   C31H48N4O6 572.3574   
M+Na 595.3473 C31H48N4O6Na+ 595.3466 1.175784 
M+H 573.366 C31H49N4O6+ 573.3647 2.267313 
  545.3697 C30H49N4O5+ 545.3697 0 
  460.2805 C25H38N3O5+ 460.2806 -0.21726 
  432.2854 C24H38N3O4+ 432.2857 -0.69399 
  403.2597 C23H35N2O4+ 403.2591 1.487875 
  385.2462 C18H33N4O5+ 385.2445 4.412763 
  347.1968 C19H27N2O4+ 347.1965 0.864063 
  290.1752 C17H24NO3+ 290.1751 0.344619 
  262.1796 C16H24NO2+ 262.1802 -2.28851 
  120.0801 C8H10N+ 120.0808 -5.82944 
  86.0963 C5H12N+ 86.0964 -1.16149 
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Name Observed Mass Predicted Formula Predicted Mass Error (ppm) 
Solonamide D   C33H52N4O6 600.3887   
M+Na 623.3779 C33H52N4O6Na+ 623.3779 0 
M+H 601.396 C33H53N4O6+ 601.396 0 
  573.3993 C32H53N4O5+ 573.401 -2.964775157 
  488.3115 C27H42N3O5+ 488.3119 -0.819149252 
  460.3161 C26H42N3O4+ 460.317 -1.955178192 
  417.2743 C24H37N2O4+ 417.2748 -1.198252564 
  399.2656 C24H35N2O3+ 399.2642 3.50643782 
  304.191 C18H26NO3+ 304.1907 0.986222472 
  286.1803 C18H24NO2+ 286.1802 0.349430062 
  185.128 C9H17N2O2+ 185.1285 -2.700834018 
  120.0803 C8H10N+ 120.0808 -4.163880337 
  86.0962 C5H12N+ 86.0964 -2.322982896 
 
Figure SI4 HRMS/MS spectra of solonamide D.  
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Figure SI5 Proposed major MS/MS fragments of solonamide C. 
 
 
 
 
 
 
 
 
 
Figure SI6 Proposed major MS/MS fragments of solonamide D.  
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Figure SI7 MS/MS spectra of 2-phenylethylamine standard (top) and of the 
compound present in the extracts from cultures of Photobacterium galatheae.  
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Figure SI8 Distribution of the nag operon in Vibrio species. The homology 
search was done by MultiGeneBlast (Medema et al., 2013) with the well 
characterized nagE-BAC operon from Escherichia coli as search query.  
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Figure SI9 Distribution of the nag operon in Photobacterium species. The 
homology search was done by MultiGeneBlast (Medema et al., 2013) with the 
well characterized nagE-BAC operon from Escherichia coli as search query.  
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Figure SI10 Distribution of the (GlcNAc)2 operon in Photobacterium species. The 
homology search was done by MultiGeneBlast (Medema et al., 2013) with the 
(GlcNAc)2 operon from V. cholerae (VC0611-VC0620) as search query. 
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Figure SI11 Proposed phenylalanine degradation pathway occurring in 
Photobacterium galatheae S2753. 
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ARTICLE 4 
 
Vibrio galatheae sp. nov., a member of the family 
Vibrionaceae isolated from a mussel. 
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